id,generic_name,company_name,contact_info,presentation,update_type,update_date,availability,related_info,resolved_note,reason_for_shortage,therapeutic_category,status,change_date,date_discontinued
5110,Abacavir Sulfate and Lamivudine Tablets,Teva Pharmaceuticals,800-545-8800,600 mg and 300 mg  (NDC 0093-5382-56),New,10/2/20,,,,,Antiviral,To be Discontinued,10/2/20,10/2/20
5111,Abiraterone Acetate Tablets,"Janssen Research and Development, LLC",800-526-7736,250 mg tablets (NDC 57894-155-12),New,6/5/20,,,,,Oncology,To be Discontinued,6/5/20,6/5/20
5112,Acetazolamide Injection,"Mylan Institutional, a Viatris company",800-796-9526,"500 mg, Lyophilisate in Single Dose Vials 1PK (NDC 67457-853-50)",Reverified,11/29/21,Available,,,Demand increase for the drug,Cardiovascular;Ophthalmology,Current,,
5113,Acetazolamide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9503-01),Reverified,10/12/21,Inventory is currently available.,Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular;Ophthalmology,Current,,
5114,Acetazolamide Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,500mg per vial (NDC 39822-0190-1),Revised,7/8/21,Available,Check wholesaler inventory,,Demand increase for the drug,Cardiovascular;Ophthalmology,Current,,
5115,Acitretin Capsules,GlaxoSmithKline,888-825-5249,25 mg (NDC 0145-0091-25),New,4/23/21,,This product discontinuation is a business-related decision. The anticipated date that GSK will cease distribution of the product is approximately September 2021.,,,Dermatology,To be Discontinued,4/23/21,4/23/21
5116,Acitretin Capsules,GlaxoSmithKline,888-825-5249,10 mg (NDC 0145-0090-25),New,4/23/21,,This product discontinuation is a business-related decision. The anticipated date that GSK will cease distribution of the product is approximately September 2021.,,,Dermatology,To be Discontinued,4/23/21,4/23/21
5117,Acrivastine and Pseudoephedrine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.",800-462-3636,"Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10)",New,6/2/20,,Endo has made a business decision to permanently discontinue the drug product.,,,Pulmonary/Allergy,To be Discontinued,6/2/20,6/2/20
5118,Acyclovir Ointment 5%,"Tolmar Pharmaceuticals, Inc.",877-986-5627,15 mg (NDC 63646-300-15),New,12/15/20,,,,,Dermatology,To be Discontinued,12/15/20,12/15/20
5119,Acyclovir Ointment 5%,"Tolmar Pharmaceuticals, Inc.",877-986-5627,30 mg (NDC 63646-300-30),New,12/15/20,,,,,Dermatology,To be Discontinued,12/15/20,12/15/20
5120,Adalimumab (Humira) Pre-filled Syringe,Abbvie,800-255-5162,10 mg/0.2 mL pre-filled syringe (NDC 0074-6347-02),New,7/27/20,,The company has discontinued manufacture of these products based on a market assessment and product demand.,,,Dermatology;Gastroenterology;Ophthalmology;Rheumatology,To be Discontinued,7/27/20,7/27/20
5121,Adalimumab (Humira) Pre-filled Syringe,Abbvie,800-255-5162,20 mg/0.4 mL pre-filled syringe (NDC 0074-9374-02),New,7/27/20,,The company has discontinued manufacture of these products based on a market assessment and product demand.,,,Dermatology;Gastroenterology;Ophthalmology;Rheumatology,To be Discontinued,7/27/20,7/27/20
5122,Adapalene/Benzoyl Peroxide Topical Gel,Teva Pharmaceuticals,800-545-8800,0.1/2.5% PMP 45 g (NDC 0472-0310-38),New,1/27/21,,Discontinuation of the manufacture of the drug.,,,Dermatology,To be Discontinued,1/27/21,1/27/21
5123,"Albuterol Sulfate Aerosol, Metered","Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",90 mcg  (NDC 0254-1007-52),New,7/6/21,,,,,Pulmonary/Allergy,To be Discontinued,7/6/21,7/6/21
5124,Alprostadil Suppository,"Mylan Specialty, a Viatris Company",800-796-9526,125 mcg (NDC 0037-8110-06),New,6/14/21,,,,,Urology,To be Discontinued,6/14/21,6/14/21
5125,Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Liquid Regular Strength, 95 mg/15mL, 358 mg/15mL, Mint 12oz, (NDC 0135-0094-41)",New,8/6/21,,This product discontinuation is a business-related decision.,,,Gastroenterology,To be Discontinued,8/6/21,8/6/21
5126,Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Liquid Regular Strength, 95 mg/15mL, 358 mg/15mL, Mint 6oz, (NDC 0135-0094-42)",New,8/6/21,,This product discontinuation is a business-related decision.,,,Gastroenterology,To be Discontinued,8/6/21,8/6/21
5127,Aluminum Hydroxide and Magnesium Carbonate (Gaviscon Regular Strength),GlaxoSmithKline,888-367-6471,"Gaviscon Chewable Tablet, Regular Strength, 80 mg/1, 14.2 mg/1, 100ct Bottle, (NDC 0135-0096-26)",New,8/6/21,,This product discontinuation is a business-related decision.,,,Gastroenterology,To be Discontinued,8/6/21,8/6/21
5128,Amantadine Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,100 mg capsules (NDC 0591-4930-01 & 0591-4930-05),New,1/4/21,,A business decision was made to discontinue this presentation.,,,Antiviral;Neurology,To be Discontinued,1/4/21,1/4/21
5129,Amantadine Hydrochloride Capsules,Sandoz,800-525-8747,100 mg capsules  (NDCs 0781-2320-01 and 0781-2320-05),New,7/16/20,,,,,Antiviral;Neurology,To be Discontinued,7/16/20,7/16/20
5130,Amifostine Injection,"Clinigen, Inc.",877-776-5385,ETHYOL® (amifostine) for injection: 3 x 500 mg vials (NDC 76310-017-50),New,5/21/20,Shortage anticipated from June 2020; Estimated shortage duration:  Unknown,,,Other,Oncology;Other,Current,,
5131,Amino Acids,B. Braun Medical Inc.,800-227-2862,"Plenamine 15% Amino Acids Injection 1,000mL S4500 (NDC 00264-4500-00)",Reverified,8/9/21,Product on allocation to contracted customers,,,Other,Gastroenterology,Current,9/24/19,
5132,Amino Acids,"ICU Medical, Inc.",877-976-7747,Aminosyn II 15% Sulfite-Free BLK PK 2000 mL (Legacy Hospira NDC 0409-7171-17)(ICU Medical NDC 0990-7171-17),Reverified,11/10/21,Available to contracted customers only,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology,Current,,
5133,Amino Acids,"ICU Medical, Inc.",877-946-7747,Aminosyn II 10% Sulfite-Free BLK PK 2000 mL (NDC 0409-7172-17) (ICU Medical NDC 0990-7172-17),Reverified,11/10/21,Available to contracted customers only,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology,Current,,
5134,Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN™-PF 7%, Sulfite-Free, 500 mL (NDC 0409-4178-03)",Reverified,11/10/21,Unavailable,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology,Current,,
5135,Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN II 10%, Sulfite-Free, (Pediatric Formula) 1000 mL (Legacy Hospira NDC 0409-4179-05) (ICU Medical NDC 0990-4179-05)",Reverified,11/10/21,Available to contracted customers only,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Gastroenterology,Current,,
5136,Amino Acids,Baxter Healthcare,888-229-0001,"15% CLINISOL - sulfite-free (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion. Product Codes: 2B6189 15% 2000 mL (NDC 0338-0502-06), 2B6187 15% 500 mL (NDC 0338-0502-03)",Reverified,11/23/21,Available,,,,Gastroenterology,Current,,
5137,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 60 count bottle (NDC 0185-0144-60)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
5138,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 90 count bottle (NDC 0185-0144-09)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
5139,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 500 count bottle (NDC 0185-0144-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
5140,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 500 count bottle (NDC 0245-0145-15)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
5141,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 30 count bottle (NDC 0245-0145-30)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
5142,Amitriptyline Hydrochloride Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,10 mg (NDCs 0378-2610-01 and 0378-2610-10),New,8/2/21,,,,,Psychiatry,To be Discontinued,8/2/21,8/2/21
5143,Amitriptyline Hydrochloride Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,25 mg (NDCs 0378-2625-01 and 0378-2625-10),New,8/2/21,,,,,Psychiatry,To be Discontinued,8/2/21,8/2/21
5144,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 tablets (NDC 0591-5714-01)",Revised,11/8/21,Available,,,,Psychiatry,Current,3/9/20,
5145,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 tablets (NDC 0591-5713-01)",Revised,11/8/21,On backorder,Recovery Dec 2021,,Other,Psychiatry,Current,3/9/20,
5146,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"100 mg, 100 tablets (NDC 0591-5715-01)",Revised,11/8/21,Available,,,,Psychiatry,Current,3/9/20,
5147,Amoxapine Tablets,Teva Pharmaceuticals,800-545-8800,"150 mg, 30 tablets (NDC 00591-5716-30)",Revised,11/8/21,Available,Recovery Oct 2021,,,Psychiatry,Current,3/9/20,
5148,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"5 mg, 100 Count Bottle (NDC 68382-950-01)",Revised,7/12/21,,Availability and Estimated Shortage Duration (Discontinuance): January 2022,,,Psychiatry,To be Discontinued,7/12/21,7/12/21
5149,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"7.5 mg, 100 Count Bottle (NDC 68382-951-01)",Revised,7/12/21,,Availability and Estimated Shortage Duration (Discontinuance): January 2022,,,Psychiatry,To be Discontinued,7/12/21,7/12/21
5150,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"10 mg, 100 Count Bottle (NDC 68382-952-01)",Revised,7/12/21,,Availability and Estimated Shortage Duration (Discontinuance): January 2022,,,Psychiatry,To be Discontinued,7/12/21,7/12/21
5151,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"12.5 mg, 100 Count Bottle (NDC 68382-953-01)",Revised,7/12/21,,Availability and Estimated Shortage Duration (Discontinuance): January 2022,,,Psychiatry,To be Discontinued,7/12/21,7/12/21
5152,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"15 mg, 100 Count Bottle (NDC 68382-954-01)",Revised,7/12/21,,Availability and Estimated Shortage Duration (Discontinuance): January 2022,,,Psychiatry,To be Discontinued,7/12/21,7/12/21
5153,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"20 mg, 100 Count Bottle (NDC 68382-955-01)",Revised,7/12/21,,Availability and Estimated Shortage Duration (Discontinuance): January 2022,,,Psychiatry,To be Discontinued,7/12/21,7/12/21
5154,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"30 mg, 100 Count Bottle (NDC 68382-956-01)",Revised,7/12/21,,Availability and Estimated Shortage Duration (Discontinuance): January 2022,,,Psychiatry,To be Discontinued,7/12/21,7/12/21
5155,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"30 mg, 100 Count Bottle (NDC 0185-0864-01)",Reverified,11/16/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5156,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"20 mg, 100 Count Bottle (NDC 0185-0853-01)",Reverified,11/16/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5157,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"10 mg, 100 Count Bottle (NDC 0185-0842-01)",Reverified,11/16/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5158,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"5 mg, 100 Count Bottle (NDC 0185-0831-01)",Reverified,11/16/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5159,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 10mg 100 (NDC 57844-0110-01),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5160,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 12.5mg 100 (NDC 57844-0112-01),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5161,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 15mg 100 (NDC 57844-0115-01),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5162,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 20mg 100 (NDC 57844-0120-01),Reverified,11/8/21,Currently unavailable. Expected resupply end of September and product recovery October 2021,,,,Psychiatry,Current,,
5163,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 30mg 100 (NDC 57844-0130-01),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5164,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 5mg 100 (NDC 57844-0105-01),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5165,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 7.5mg 100 (NDC 57844-0117-01),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5166,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,5mg [1.25/1.25/1.25/1.25mg] 100s (NDC 0378-4541-01),Reverified,11/29/21,Out of Stock/Unavailable,,,Other,Psychiatry,Current,,
5167,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,7.5mg [1.875/1.875/1.875/1.875mg] 100s (NDC 0378-4542-01),Reverified,11/29/21,Out of Stock/Unavailable,,,Other,Psychiatry,Current,,
5168,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,10mg [2.5/2.5/2.5/2.5mg] 100s (NDC 0378-4543-01),Reverified,11/29/21,Out of Stock/Unavailable,,,Other,Psychiatry,Current,,
5169,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,12.5mg [3.125/3.125/3.125/3.125mg] 100s (NDC 0378-4544-01),Reverified,11/29/21,Out of Stock/Unavailable,,,Other,Psychiatry,Current,,
5170,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,15mg [3.75/3.75/3.75/3.75mg] 100s (NDC 0378-4545-01),Reverified,11/29/21,Out of Stock/Unavailable,,,Other,Psychiatry,Current,,
5171,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,20mg [5/5/5/5mg] 100s (NDC 0378-4546-01),Reverified,11/29/21,Out of Stock/Unavailable,,,Other,Psychiatry,Current,,
5172,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,30mg [7.5/7.5/7.5/7.5mg] 100s (NDC 0378-4547-01),Reverified,11/29/21,Out of Stock/Unavailable,,,Other,Psychiatry,Current,,
5173,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 13107-0068-01)",Reverified,11/10/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5174,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 13107-0070-01)",Reverified,11/10/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5175,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 13107-0072-01)",Reverified,11/10/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5176,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 13107-0073-01)",Reverified,11/10/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5177,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 13107-0074-01)",Reverified,11/10/21,Available,,,Demand increase for the drug,Psychiatry,Current,,
5178,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,12.5  mg 100 count (NDC 0555-0776-02),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5179,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,15  mg 100 count (NDC 0555-0777-02),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5180,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,7.5  mg 100 count (NDC 0555-0775-02),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5181,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,10  mg 100 count (NDC 0555-0972-02),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5182,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,20 mg 100 count (NDC 0555-0973-02),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5183,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,30 mg 100 count (NDC 0555-0974-02),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5184,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 100 count (NDC 0555-0971-02),Reverified,11/8/21,Available,,,,Psychiatry,Current,,
5185,Ampicillin for Injection,"Mylan Institutional, a Viatris company",800-796-9526,250 mg (NDC 67457-353-10),New,9/23/21,,,,,Anti-Infective,To be Discontinued,9/23/21,9/23/21
5186,Ampicillin for Injection,"Mylan Institutional, a Viatris company",800-796-9526,500 mg (NDC 67457-350-10),New,9/23/21,,,,,Anti-Infective,To be Discontinued,9/23/21,9/23/21
5187,"Ampicillin for Injection, USP","Hospira, Inc.",844-646-4398,250 mg/vial; Single Dose Vial (powder) (NDC 00409-3719-01),New,12/14/20,,Discontinuation of the manufacture of the drug,,,Antiviral,To be Discontinued,12/14/20,12/14/20
5188,Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,1 MG 100 Capsules (NDC 0172-5240-60),Revised,7/20/21,,,,,Hematology,Resolved,7/20/21,
5189,Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,0.5 MG 100 Capsules (NDC 0172-5241-60),Revised,7/20/21,,,,,Hematology,Resolved,7/20/21,
5190,Anagrelide Hydrochloride Capsules,Takeda Pharmaceuticals USA Inc.,877-825-3327,"AGRYLIN 0.5 mg Capsule,100 capsules in 1 bottle (NDC 54092-063-01)",Revised,7/20/21,,,Available,,Hematology,Resolved,7/20/21,
5191,Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,0.5 mg per capsule Bottles of 100 (NDC 13668-453-01),Revised,7/20/21,,,Available,,Hematology,Resolved,7/20/21,
5192,Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,"1 mg per capsule, Bottles of 100 (NDC 13668-462-01)",Revised,7/20/21,,,Available,,Hematology,Resolved,7/20/21,
5193,Asenapine (Saphris®) Sublingual Tablets,Allergan,800-678-1605,5 mg (NDC 0456-2405-63),New,3/3/21,,The company has made a business decision to discontinue manufacturing this product. All other Saphris® SKU’s remain available.,,,Psychiatry,To be Discontinued,3/3/21,3/3/21
5194,Asenapine (Saphris®) Sublingual Tablets,Allergan,800-678-1605,10 mg (NDC 0456-2410-63),New,3/3/21,,The company has made a business decision to discontinue manufacturing this product. All other Saphris® SKU’s remain available.,,,Psychiatry,To be Discontinued,3/3/21,3/3/21
5195,Asenapine Maleate (Saphris®) Sublingual Tablets,Allergan,800-678-1605,Box of 100 (10 blisters with 10 tablets) (NDC 00456-2405-63),New,2/8/21,,The company has made a business decision to discontinue manufacturing this product.  All other Saphris® SKU’s remain available.,,,Psychiatry,To be Discontinued,2/8/21,2/8/21
5196,Asenapine Maleate (Saphris®) Sublingual Tablets,Allergan,800-678-1605,Box of 100 (10 blisters with 10 tablets) (NDC 0456-2410-63),New,2/8/21,,The company has made a business decision to discontinue manufacturing this product.  All other Saphris® SKU’s remain available.,,,Psychiatry,To be Discontinued,2/8/21,2/8/21
5197,Aspirin/Dipyridamole (Aggrenox) Extended Release Capsules,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,25mg/200mg capsules (NDC 0597-0001-60),New,5/26/20,,"Business decision made by the applicant, BIPI. BIPI will no longer be supplying the market with AGGRENOX capsules after June 11, 2020.",,,Cardiovascular,To be Discontinued,5/26/20,5/26/20
5198,Atazanavir Capsules,Bristol Myers Squibb Co.,800-332-2056,150mg (NDC 0003-3624-12),New,4/28/21,,"Product available until December 31, 2021.",,,Antiviral,To be Discontinued,4/28/21,4/28/21
5199,Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25)",Reverified,5/19/21,Available,"American Regent is currently releasing the 0.4mg/mL, 1 mL vial, NDC 00517-0401-25",,Other,Anesthesia;Neurology;Pediatric,Current,,
5200,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.4 mg/mL, 1 mL single dose vial, pack of 25 (NDC 16729-525-08)",New,9/10/21,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
5201,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.4 mg/mL, 20 mL multi-dose vial, pack of 10 (NDC 16729-512-43)",New,9/10/21,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
5202,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","1 mg/mL, 1 mL single dose vial, pack of 25 (NDC 16729-526-08)",New,9/10/21,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
5203,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.05 mg/mL, 5 mL prefilled syringe, pack of 10 (NDC 16729-483-03)",New,9/10/21,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
5204,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.1 mg/mL, 10 mL prefilled syringe, pack of 10 (NDC 16729-484-45)",New,9/10/21,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
5205,Atropine Sulfate Injection,Accord Healthcare Inc.,"866-941-7875, option 2","0.1 mg/mL, 5 mL prefilled syringe, pack of 10 (NDC 16729-484-90)",New,9/10/21,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
5206,Atropine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20),Reverified,11/23/21,5 month expiry (4/2022 expiry) dating available  by request.,Check wholesaler inventory,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
5207,Atropine Sulfate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,0.1 mg/mL; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3340-1),Revised,11/2/21,Backorder due to the increase in demands,,,,Anesthesia;Neurology;Pediatric,Current,,
5208,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); Ansyr Plastic Syringe
(NDC 0409-1630-10)",Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
5209,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"0.25 mg/5 mL (0.05 mg/mL); Ansyr Plastic Syringe
(NDC 0409-9630-05)",Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: January 2022,,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
5210,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,0.5 mg/5 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4910-34),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
5211,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4911-34, pack of 10; NDC 0409-4911-11, individual)",Revised,11/18/21,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
5212,Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25)",Reverified,5/19/21,Available,"American Regent is currently releasing the 1mg/mL, 1 mL vial, (NDC 00517-1010-25)",,Other,Anesthesia;Neurology;Pediatric,Current,,
5213,Atropine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.4 mg/mL, 20 mL vial (NDC 0641-6006-10)",Revised,10/12/21,Inventory is currently available.,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
5214,Atropine Sulfate Ophthalmic Ointment,Bausch Health,800-321-4576,"1% (10 mg/g), 3.5 g tube (NDC 24208-825-55)",Revised,9/20/21,,,Available,,Ophthalmology,Resolved,9/20/21,
5215,Azacitidine for Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,100 mg per vial (NDC 71288-115-30),New,10/7/21,Available,Check wholesalers for inventory,,,Oncology,Current,,
5216,Azacitidine for Injection,Teva Pharmaceuticals,800-545-8800,100 mg/vial Lyophilized Powder (NDC 68001-0313-56),Reverified,11/8/21,No supply disruption - we are meeting current demand.,Product is manufactured and labeled for Blue Point Laboratories,,,Oncology,Current,,
5217,Azacitidine for Injection,Breckenridge Pharmaceutical,860-828-8140,100 mg per vial (NDC 51991-797-98),Reverified,9/29/21,Available,,,,Oncology,Current,,
5218,Azacitidine for Injection,Cipla Limited,844-247-5287,100 mg per vial (NDC 69097-805-40),Revised,6/8/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Oncology,Current,,
5219,Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"100 mg single-dose vial in cartons of 1 vial, (NDC 0781-3253-94)",Revised,10/1/21,Available,"Distributed by Sandoz, Inc. Contact number 800-525-8747",,,Oncology,Current,,
5220,Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"100 mg single-dose vial in cartons of 1 vial, (NDC 0781-9253-94)",Revised,10/1/21,Available,"NOVAPLUS labeling. Distributed by Sandoz, Inc. Contact number 800-525-8747",,,Oncology,Current,,
5221,Azacitidine for Injection,Celgene Corporation,1-888-423-5436,"VIDAZA, , 100 mg single-dose vial in cartons of 1 vial, (NDC 59572-102-01)",Revised,10/1/21,Available,,,,Oncology,Current,,
5222,Azacitidine for Injection,"Fresenius Kabi USA, LLC",1-888-386-1300,"100 mg per vial, single dose vial, PF, (NDC 63323-771-39)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Oncology,Current,,
5223,Azacitidine for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",1-800-631-2174,"100 mg per vial, (NDC 0143-9606-01)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology,Current,,
5224,Azacitidine for Injection,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"100 mg per vial, (NDC 43598-305-62)",Revised,11/8/21,Low inventory,Partial shipments on allocation through December,,Demand increase for the drug,Oncology,Current,,
5225,Azacitidine for Injection,Armas Pharmaceuticals Inc,1-732-637-1971,100 mg per vial (NDC 72485-201-01),Reverified,5/19/21,Limited availability,Additional lots are manufactured. Product will be made available as it is released.,,Demand increase for the drug,Oncology,Current,,
5226,Azacitidine for Injection,Accord Healthcare Inc.,"866-941-7875, option 2",100 mg per vial (NDC 16729-306-10),Revised,6/10/21,Limited availability.,,,Shortage of an active ingredient,Oncology,Current,,
5227,Azacitidine for Injection,"Mylan Institutional, a Viatris company",800-796-9526,100 mg per vial (NDC 67457-254-30),Reverified,11/29/21,Unavailable,,,Other,Oncology,Current,,
5228,Azithromycin (Azasite) Ophthalmic Solution 1%,Akorn Pharmaceuticals,800-932-5676,Azasite (Azithromycin Ophthalmic Solution) 1% 2.5 mL in 5 mL bottle (NDC 17478-307-03),Revised,9/11/19,,,,,Ophthalmology,Resolved,9/11/19,
5229,Azithromycin for Injection,"Mylan Institutional, a Viatris company",800-796-9526,500 mg (NDC 67457-860-50),New,4/26/21,,,,,Anti-Infective,To be Discontinued,4/26/21,4/26/21
5230,Bacitracin Ophthalmic Ointment,Padagis US LLC,763-732-0225,3.5 g (NDC 0574-4022-35),New,9/10/21,,,,,Ophthalmology,To be Discontinued,9/10/21,9/10/21
5231,Belatacept (Nulojix) Lyophilized Powder for Injection,Bristol Myers Squibb Co.,800-721-5072 ; 877-417-1523,20cc vial 250mg lyophilized powder per vial for IV infusion (NDC 0003-0371-13),Revised,2/25/21,"No disruption to existing patients is anticipated. Until further notice, BMS will continue to limit distribution of Nulojix via the US NULOJIX Distribution Program, initiated 2/15/2017. Starting in August 2018, the restrictions of the NDP were eased to allow for expansion of use to appropriate new patients if the treating physician determines that Nulojix is the best treatment option for the patient. For further information, contact BMS Medical Information.",Increased demand for the drug exacerbated by a delay in transition to a more efficient manufacturing process.,,Demand increase for the drug,Transplant,Current,,
5232,Benzonatate Capsules,Pfizer Pharmaceuticals,800-533-4535,Tessalon 100 mg perles; Bottle of 100 (NDC 0069-0122-01),New,6/8/21,,Discontinuation of the manufacture of the drug.,,,Pulmonary/Allergy,To be Discontinued,6/8/21,6/8/21
5233,Budesonide Capsules,Teva Pharmaceuticals,800-545-8800,3 mg capsules (NDC 0093-7445-01),New,12/23/19,,,,,Gastroenterology,To be Discontinued,12/23/19,12/23/19
5234,Bumetanide Injection,"Hospira, Inc.",844-646-4398,1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1412-04),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: March 2022,,,Demand increase for the drug,Cardiovascular,Current,,
5235,Bumetanide Injection,"Hospira, Inc.",844-646-4398,2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1412-10),Revised,11/18/21,Limited Supply Available. Next Delivery: December 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Cardiovascular,Current,,
5236,Bumetanide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 4 mL vial (NDC 0641-6008-10)",Revised,10/12/21,Inventory is currently available.,Additional lots will be scheduled for manufacturing. Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5237,Bumetanide Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 10 mL vial (NDC 0641-6007-10)",Revised,10/12/21,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing and available in the October  - November 2021 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5238,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,0.5 mg 100 Tablets (NDC 14539-700-01),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5239,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,0.5 mg 500 Tablets (NDC 14539-700-05),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5240,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,0.5 mg 1000 Tablets (NDC 14539-700-10),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5241,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,1 mg 100 Tablets (NDC 14539-701-01),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5242,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,1 mg 500 Tablets (NDC 14539-701-05),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5243,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,1 mg 1000 Tablets (NDC 14539-701-10),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5244,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,2 mg 100 Tablets (NDC 14539-702-01),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5245,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,2 mg 500 Tablets (NDC 14539-702-05),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5246,Bumetanide Tablets,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,2 mg 1000 Tablets (NDC 14539-702-10),New,2/18/21,,,,,Renal,To be Discontinued,2/18/21,2/18/21
5247,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-461-57),Revised,11/23/21,Backordered.  Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5248,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-463-57),Revised,11/23/21,Backordered.  Next release January 2022.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5249,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.25% (25 mg per 10 mL) (2.5 mg per mL) SDV (NDC 63323-468-17),Revised,11/23/21,Backordered.  Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5250,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI .25% (75 mg per 30 mL) (2.5 mg per mL) SDV (NDC 63323-468-37),Revised,11/23/21,Backordered.  Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5251,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (50 mg per 10 mL) (5 mg per mL) SDV (NDC 63323-462-17),Revised,11/23/21,Backordered.  Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5252,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) SDV (NDC 63323-462-37),Revised,11/23/21,Backordered.  Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5253,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) Sterile-Pak, SDV (NDC 63323-462-31)",Revised,11/23/21,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
5254,Bupivacaine Hydrochloride and Epinephrine Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.75% (225 mg per 30 mL) (7.5 mg per mL)  SDV  (NDC 63323-460-37),Revised,11/23/21,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5255,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-01),Revised,11/18/21,Next Delivery and Estimated Recovery: April 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5256,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-17),Revised,11/18/21,Next Delivery and Estimated Recovery: April 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5257,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9043-01),Revised,11/18/21,Next Delivery and Estimated Recovery: April 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5258,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-01),Revised,11/18/21,Next Delivery and Estimated Recovery: April 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5259,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-17),Revised,11/18/21,Next Delivery and Estimated Recovery: April 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5260,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9046-01),Revised,11/18/21,Next Delivery and Estimated Recovery: April 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5261,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-10)",Revised,11/18/21,Limited Supply Available. Next Delivery: February 2022; Estimated Recovery: March 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5262,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-30)",Revised,11/18/21,Limited Supply Available. Next Delivery: December 2021; Estimated Recovery: January 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5263,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-10)",Revised,11/18/21,Limited Supply Available. Next Delivery: April 2022; Estimated Recovery: May 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5264,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-29)",Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5265,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1752-50)",Revised,11/18/21,Next Delivery: December 2021; Estimated Recovery: April 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5266,Bupivacaine Hydrochloride and Epinephrine Injection,"Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1755-50)",Revised,11/18/21,Next Delivery: December 2021; Estimated Recovery: May 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
5267,Bupivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 10 mL Single Dose Vials (NDC 55150-167-10),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5268,Bupivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 30 mL Single Dose Vials (NDC 55150-168-30),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5269,Bupivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 10 mL Single Dose Vials (NDC 55150-169-10),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5270,Bupivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-170-30),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5271,Bupivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 10 mL Single Dose Vials (NDC 55150-171-10),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5272,Bupivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 30 mL Single Dose Vials (NDC 55150-172-30),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5273,Bupivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 50 mL Multiple Dose Vials (NDC 55150-249-50),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5274,Bupivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 50 mL Multiple Dose Vials (NDC 55150-250-50),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5275,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-01),Revised,11/18/21,Next Delivery: January 2022; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia,Current,,
5276,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-02),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia,Current,,
5277,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1160-01),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia,Current,,
5278,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-01),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Anesthesia,Current,,
5279,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-02),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Anesthesia,Current,,
5280,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1163-01),Revised,11/18/21,Available,,,Other,Anesthesia,Current,,
5281,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,75 mg/10 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-01),Revised,11/18/21,Available,,,Other,Anesthesia,Current,,
5282,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,225 mg/30 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-02),Revised,11/18/21,Available,,,Other,Anesthesia,Current,,
5283,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409-3613-01),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia,Current,,
5284,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 25 mg/10 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-10),Revised,11/18/21,Next Delivery: December 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia,Current,,
5285,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 75 mg/30 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-30),Revised,11/18/21,Limited Supply Available. Next Delivery: December 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia,Current,,
5286,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1587-50),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia,Current,,
5287,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-10),Revised,11/18/21,Next Delivery: December 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia,Current,,
5288,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-29),Revised,11/18/21,Next Delivery: December 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia,Current,,
5289,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1610-50),Revised,11/18/21,Limited Supply Available. Next Delivery: April 2022; Estimated Recovery: August 2022,,,Demand increase for the drug,Anesthesia,Current,,
5290,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 75 mg/10 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-10),Revised,11/18/21,Available,,,Other,Anesthesia,Current,,
5291,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine 225 mg/30 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-29),Revised,11/18/21,Limited Supply Available.,,,Demand increase for the drug,Anesthesia,Current,,
5292,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-465-57),Revised,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5293,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.5% (250 mg per 50 mL) (5 mg per mL)                    MDV (NDC 63323-467-57),Revised,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5294,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (25 mg per 10 mL) (2.5 mg per mL) MPF,         SDV (NDC 63323-464-17)",Revised,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5295,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-37)",Revised,11/23/21,Backordered. Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5296,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF,             Sterile-Pak, SDV (NDC 63323-464-31)",Revised,11/23/21,Backordered.  Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5297,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (50 mg per 10 mL) (5 mg per mL)  MPF,                 SDV  (NDC 63323-466-17)",Revised,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5298,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF,                 SDV (NDC 63323-466-37)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5299,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF,                Sterile-Pak, SDV (NDC 63323-466-31)",Revised,11/23/21,Backordered. Next release not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
5300,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (75 mg per 10 mL) (7.5 mg per mL) MPF,             SDV (NDC 63323-472-17)",Revised,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5301,Bupivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (225 mg per 30 mL) (7.5 mg per mL) MPF,     SDV (NDC 63323-472-37)",Revised,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
5302,Bupivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,Marcaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose); Glass Ampul (NDC 00409- 1761-02),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: January 2022,,,Demand increase for the drug,Anesthesia,Current,,
5303,Bupivacaine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"Bupivacaine Spinal, USP (7.5 mg/mL in 8.25% dextrose) 2 mL Single Dose Ampule (10 x 2 mL)(NDC 36000-092-10)",Reverified,11/23/21,Stocked out - recovery TBD,SPINAL 0.75% - Sterile Hyperbaric Solution for Spinal Anesthesia,,Manufacturing Delay,Anesthesia,Current,,
5304,Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 5 mL single-dose ampules (NDC 59923-717-05),Reverified,5/19/21,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
5305,Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 10 mL single-dose ampules (NDC 59923-719-10),Reverified,5/19/21,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
5306,Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 5 mL single-dose ampules (NDC 59923-718-05),Reverified,5/19/21,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
5307,Bupivacaine Hydrochloride Injection,"Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 10 mL single-dose ampules (NDC 59923-720-10),Reverified,5/19/21,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
5308,Bupivacaine Hydrochloride Injection,"Huons Co., Ltd",+82-2-854-4700 or via email intbiz@huons.com,"HCl 0.75% & Dextrose 8.25%, Injectable spinal (NDC 73293-0002)",New,6/21/21,Available,"Drug Product is distributed by HUONS USA, please contact Tel : (949)656-6751 or E-mail: jmchoi@huonsglobal.com for supply related inquires.",,,Anesthesia,Current,,
5309,Busulfan Injection,American Regent/Luitpold,800-645-1706,6 mg/mL  (NDC 0517-0920-08),New,8/6/21,,,,,Hematology,To be Discontinued,8/6/21,8/6/21
5310,Busulfan Injection,Apotex Corp.,800-706-5575,6mg/mL (NDCs 60505-6177-0 and 60505-6177-8),New,10/15/21,,,,,Hematology,To be Discontinued,10/15/21,10/15/21
5311,Calcitriol Injection 1MCG/ML,Akorn Pharmaceuticals,800-932-5676,"Calcitriol Injection USP, 1 mcg/mL, 1 mL ampule  (NDC 17478-931-01)",Revised,10/6/21,,,Available,,Endocrinology/Metabolism,Resolved,10/6/21,
5312,Calcium Disodium Versenate Injection,Bausch Health,800-321-4576,1000 mg/5 mL (200 mg/mL) (NDC 99207-240-05),Reverified,10/25/21,Not currently available. Estimated Shortage duration TBD,,,Requirements related to complying with good manufacturing practices,Other,Current,,
5313,Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 mg calcium gluconate per 10 mL (100 mg/mL), single dose vial (NDC 63323-360-01, 1 vial; NDC 63323-360-19, 25 vials)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
5314,Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5,000 mg calcium gluconate per 50 mL (100 mg/mL), single dose vial (NDC 63323-360-03, 1 vial; NDC 63323-360-59, 25 vials)",Revised,11/23/21,Available,Check wholesaler for inventory,,Demand increase for the drug,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
5315,Calcium Gluconate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10,000 mg calcium gluconate per 100 mL (100 mg/mL), pharmacy bulk package vial (NDC 63323-360-05, 1 vial; NDC 63323-360-61, 20 vials)",Revised,11/23/21,Backordered. Next release January 2022,Check wholesaler inventory,,Demand increase for the drug,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
5316,Calcium Gluconate Injection,HQ Specialty Pharma,888-493-0861,1000 mg/50 mL (20 mg/mL) single-dose bag (NDC 44567-620-24),Revised,6/22/21,Available,Marketed by WG Critical Care,,,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
5317,Calcium Gluconate Injection,HQ Specialty Pharma,888-493-0861,2000 mg/100 mL (20 mg/mL) single-dose bag (NDC 44567-621-24),Revised,6/22/21,Available,Marketed by WG Critical Care,,,Cardiovascular;Endocrinology/Metabolism;Gastroenterology;Other;Pediatric;Pulmonary/Allergy,Current,,
5318,Capreomycin Injection,Akorn Pharmaceuticals,800-932-5676,"Capastat Sulfate (Capreomycin for Injection USP) Eq to 1 g Capreomycin activity, 10mL (NDC 17478-080-50)",Revised,5/5/21,,,,,Anti-Infective,To be Discontinued,5/5/21,5/5/21
5319,Captopril Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,12.5mg; 25mg; 50mg; 100mg (NDC 0378-3007-10; 0378-3007-01; 0378-3012-10; 0378-3012-01; 0378-3017-10; 0378-3017-01; 0378-3022-01),New,8/9/21,,Discontinuation of the manufacture of the drug,,,Cardiovascular,To be Discontinued,8/9/21,8/9/21
5320,Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 25mg/15mg 100s Tabs (NDC 00378-0081-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,8/9/21,8/9/21
5321,Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 25mg/25mg 100s Tabs (NDC 00378-0083-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,8/9/21,8/9/21
5322,Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 50mg/15mg 100s Tabs (NDC 00378-0084-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,8/9/21,8/9/21
5323,Captopril/Hydrochlorothiazide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Captopril/HCTZ 50mg/25mg 100s Tabs (NDC 00378-0086-01),New,8/9/21,,,,,Cardiovascular,To be Discontinued,8/9/21,8/9/21
5324,"Carbidopa, Levodopa and Entacapone, Tablets",Wockhardt,800-346-6854,"50/12.5/200 mg, Bottle of 100 Tablets (NDC 64679-0782-04)",New,3/3/21,,The discontinuation of the product was a result of a business decision.,,,Neurology,To be Discontinued,3/3/21,3/3/21
5325,"Carbidopa, Levodopa and Entacapone, Tablets",Wockhardt,800-346-6854,"75/18.75/200 mg, Bottle of 100 Tablets (NDC 64679-0783-04)",New,3/3/21,,The discontinuation of the product was a result of a business decision.,,,Neurology,To be Discontinued,3/3/21,3/3/21
5326,"Carbidopa, Levodopa and Entacapone, Tablets",Wockhardt,800-346-6854,"100/25/200 mg, Bottle of 100 Tablets (NDC64679-0784-04)",New,3/3/21,,The discontinuation of the product was a result of a business decision.,,,Neurology,To be Discontinued,3/3/21,3/3/21
5327,"Carbidopa, Levodopa and Entacapone, Tablets",Wockhardt,800-346-6854,"125/31.25/200 mg, Bottle of 100 Tablets (NDC 64679-0785-04)",New,3/3/21,,The discontinuation of the product was a result of a business decision.,,,Neurology,To be Discontinued,3/3/21,3/3/21
5328,"Carbidopa, Levodopa and Entacapone, Tablets",Wockhardt,800-346-6854,"150/37.5/200 mg, Bottle of 100 Tablets (NDC 64679-0786-04)",New,3/3/21,,The discontinuation of the product was a result of a business decision.,,,Neurology,To be Discontinued,3/3/21,3/3/21
5329,"Carbidopa, Levodopa and Entacapone, Tablets",Wockhardt,800-346-6854,"200/50/200 mg, Bottle of 100 Tablets (NDC 64679-0787-04)",New,3/3/21,,The discontinuation of the product was a result of a business decision.,,,Neurology,To be Discontinued,3/3/21,3/3/21
5330,Carboplatin Injection,Ingenus Pharmaceuticals LLC,866-321-5031,450 mg/45 mL (NDC 50742-448-45),New,4/7/21,,Discontinued manufacturing due to lack of commercial viability in the market,,,Oncology,To be Discontinued,4/7/21,4/7/21
5331,Carboplatin Injection,Ingenus Pharmaceuticals LLC,866-321-5031,600 mg/60 mL (10 mg/mL)(NDC 50742-447-60),New,4/7/21,,Discontinued manufacturing due to lack of commercial viability in the market,,,Oncology,To be Discontinued,4/7/21,4/7/21
5332,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose,"Chiesi USA, Inc.",888-466-6505 x6511,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose (NDC 10122-326-10),New,3/20/18,,The decision to discontinue the 0.2 mg/mL in 5% Dextrose formulation was business related.  Other formulations of Cardene IV remain available.,,,Cardiovascular,To be Discontinued,3/20/18,3/20/18
5333,"Carisoprodol, Aspirin, and Codeine Phosphate Tablets USP",Ingenus Pharmaceuticals LLC,866-321-5031,200 mg/325 mg/16 mg (NDC 50742-256-01),New,9/1/20,,,,,Musculoskeletal,To be Discontinued,9/1/20,9/1/20
5334,Caspofungin Acetate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,50 mg (NDC 67457-831-50),New,7/23/20,,,,,Anti-Infective;Pediatric,To be Discontinued,7/23/20,7/23/20
5335,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single-dose ADD-Vantage Vial (NDC 00409-2585-01,Reverified,11/18/21,Available,,,Other,Anti-Infective,Current,,
5336,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 1 g (25 vials) (NDC 60505-6142-05),Reverified,10/27/21,Available,,,,Anti-Infective,Current,,
5337,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,10g 10 vials (NDC 25021-102-99),Reverified,10/22/21,Available,,,,Anti-Infective,Current,,
5338,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,500mg 25 vials (NDC 25021-100-10),Reverified,10/22/21,Available,,,,Anti-Infective,Current,,
5339,Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 2 gram/50 mL in DUPLEX Catalog 3105-11 (NDC 00264-3105-11),Reverified,7/15/21,Product on allocation to contracted customers,,,Other,Anti-Infective,Current,,
5340,Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 1 gram/50 mL in DUPLEX Catalog 3103-11 (NDC 0264-3103-11),Reverified,7/15/21,Product on allocation to contracted customers,,,Other,Anti-Infective,Current,,
5341,Cefazolin Injection,WG Critical Care,888-493-0861,500mg SDV (NDC 44567-706-25),Reverified,8/31/21,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
5342,Cefazolin Injection,WG Critical Care,888-493-0861,1g SDV (NDC 44567-707-25),Reverified,8/31/21,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
5343,Cefazolin Injection,WG Critical Care,888-493-0861,10g PBP (NDC 44567-708-10),Reverified,8/31/21,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
5344,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single Dose Glass Fliptop Vial (NDC 00409-0805-01),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
5345,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single Dose Glass Fliptop Vial (NDC 00409-0805-01),Revised,10/2/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/2/20,10/2/20
5346,Cefazolin Injection,"Hospira, Inc.",844-646-4398,10 g Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-0806-01),Revised,10/2/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/2/20,10/2/20
5347,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9923-90),Reverified,10/12/21,Inventory is currently available,Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
5348,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9924-90),Reverified,10/12/21,Inventory is currently available,Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
5349,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 mg/ 100 mL vial (NDC 0143-9983-03),Reverified,10/12/21,Inventory is currently available,Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
5350,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 500 mg (NDC 0781-3450-95),Reverified,11/16/21,Available,,,,Anti-Infective,Current,,
5351,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 1 g (NDC 0781-3451-96),Reverified,11/16/21,Available,,,,Anti-Infective,Current,,
5352,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 10 g (NDC 0781-3452-95),Reverified,11/16/21,Available,,,,Anti-Infective,Current,,
5353,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 10 g (10 vials) (NDC 60505-6143-04),Reverified,10/27/21,Available,,,,Anti-Infective,Current,,
5354,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,1g 25 vials (NDC 25021-101-10),Reverified,10/22/21,Available,,,,Anti-Infective,Current,,
5355,Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 1 gram/50 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3503)(NDC 0338-3503-41)",Reverified,11/23/21,Available,,,,Anti-Infective,Current,,
5356,Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 2 gram/100 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3508)(NDC 0338-3508-41)",Reverified,11/23/21,Available,,,,Anti-Infective,Current,,
5357,Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,100 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1100-1),Reverified,11/18/21,Available,,,,Anti-Infective,Current,,
5358,Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,300 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1300-1),Reverified,11/18/21,Available,,,,Anti-Infective,Current,,
5359,Cefdinir Capsules,Sandoz,800-525-8747,300 mg capsules  (NDC 0781-2176-60),New,7/9/20,,,,,Anti-Infective,To be Discontinued,7/9/20,7/9/20
5360,Cefdinir Powder for Suspension,Sandoz,800-525-8747,125 mg/5 mL (NDCs 0781-6077-46 and 0781-6077-61),New,10/29/21,,,,,Anti-Infective,To be Discontinued,10/29/21,10/29/21
5361,Cefdinir Powder for Suspension,Sandoz,800-525-8747,250 mg/5 mL (NDCs 0781-6078-46 and 0781-6078-61),New,10/29/21,,,,,Anti-Infective,To be Discontinued,10/29/21,10/29/21
5362,Cefotaxime Sodium Injection,"SteriMax, Inc.",800-881-3550,"2g/vial, (NDC 21586-012-2)",Reverified,10/14/21,Available,"SteriMax in conjunction with FDA has initiated a temporary importation of Cefotaxime sodium for Injection, BP into the U.S. market to address drug shortage. To place an order, please contact Direct Success at Distribution@DSuccess.com or 1-877-404-3338.",,Other,Anti-Infective;Pediatric,Current,,
5363,Cefotaxime Sodium Injection,"SteriMax, Inc.",800-881-3550,"1g/vial, (NDC 21586-011-2)",Reverified,10/14/21,Available,"SteriMax in conjunction with FDA has initiated a temporary importation of Cefotaxime sodium for Injection, BP into the U.S. market to address drug shortage. To place an order, please contact Direct Success at Distribution@DSuccess.com or 1-877-404-3338.",,Other,Anti-Infective;Pediatric,Current,,
5364,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9930-10),Reverified,10/12/21,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
5365,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9931-25),Reverified,10/12/21,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
5366,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2 g/ 10 mL vial (NDC 0143-9933-25),Reverified,10/12/21,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
5367,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 g/ 100 mL vial (NDC 0143-9935-01),Reverified,10/12/21,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
5368,Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,1 gram/50 mL in DUPLEX (NDC 00264-3173-11),Reverified,5/19/21,Product not available; Expected recovery: December 2021,,,Other,Anti-Infective,Current,,
5369,Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,2 gram/50 mL in DUPLEX (NDC 00264-3175-11),Reverified,5/19/21,Product not available; Expected recovery: December 2021,,,Other,Anti-Infective,Current,,
5370,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,1 g SDV (NDC 63323-0385-10),Reverified,11/23/21,Available,Check wholesalers for inventory,,Manufacturing delay,Anti-Infective,Current,,
5371,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,2 g SDV (NDC 63323-0386-20),Reverified,11/23/21,Available,Check wholesalers for inventory,,Manufacturing delay,Anti-Infective,Current,,
5372,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 g PBP (NDC 63323-0396-61),Reverified,11/23/21,No release date available at this time.,,,Manufacturing delay,Anti-Infective,Current,,
5373,Cefotetan Disodium Injection,"Teligent Pharma, Inc.",856-697-1441,Cefotan 2g Vial 10 (NDC 52565-0053-10),Reverified,10/13/21,Discontinued,,,,Anti-Infective,Current,,
5374,Cefotetan Disodium Injection,"Teligent Pharma, Inc.",856-697-1441,Cefotan 2g Vial 10 (NDC 52565-0053-10),New,3/25/21,,Business decision to discontinue manufacture of the product,,,Anti-Infective,To be Discontinued,3/25/21,3/25/21
5375,Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1g vial (NDC 0143-9878-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5376,Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2g vial (NDC 0143-9877-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5377,Cefoxitin for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10g vial (NDC 0143-9876-10),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5378,Cefoxitin for Injection,Apotex Corp.,800-706-5575,1 g (25 vials) (NDC 60505-0759-05),Revised,11/18/21,,,,,Anti-Infective,Resolved,11/18/21,
5379,Cefoxitin for Injection,Apotex Corp.,800-706-5575,10 g (10 vials) (NDC 60505-0761-04),Revised,11/18/21,,,,,Anti-Infective,Resolved,11/18/21,
5380,Cefoxitin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,1 g per vial; SDV; (NDC 63323-341-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5381,Cefoxitin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,2 grams per vial; SDV; (NDC 63323-342-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5382,Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"10 g, package of 10 vials (NDC 25021-111-99)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5383,Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"1 g, package of 10 vials (NDC 25021-109-10)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5384,Cefoxitin for Injection,Sagent Pharmaceuticals,866-625-1618,"2 g, package of 10 vials (NDC 25021-110-20)",Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5385,Cefoxitin for Injection,WG Critical Care,888-493-0861,1 g (NDC 44567-245-25),Revised,11/18/21,Available,,Available,,Anti-Infective,Resolved,11/18/21,
5386,Cefoxitin for Injection,WG Critical Care,888-493-0861,2 g (NDC 44567-246-25),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5387,Cefoxitin for Injection,WG Critical Care,888-493-0861,10 g (NDC 44567-247-10),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5388,Cefoxitin for Injection,B. Braun Medical Inc.,800-227-2862,Cefoxitin Injection 2 gram/50 mL in DUPLEX Catalog 3125-11 (NDC NDC 00264-3125-11),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5389,Cefoxitin for Injection,B. Braun Medical Inc.,800-227-2862,Cefoxitin Injection 1 gram/50 mL in DUPLEX Catalog 3123-11 (NDC 0264-3123-11),Revised,11/18/21,,,Available,,Anti-Infective,Resolved,11/18/21,
5390,Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 1g Bag 24 x 50mL (NDC 24987-0412-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
5391,Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 2g Bag 24 x 50mL (NDC 24987-0413-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
5392,"Ceftazidime and Avibactam (AVYCAZ®) for Injection, 2 grams/0.5 grams",Allergan Sales LLC,800-678-1605,"2 g/1, .5 g/1 powder for solution 1 Single-use vials (NDC 0456-2700-01)",Revised,2/8/21,The product is available through direct distribution from the manufacturer. Please contact your wholesaler or customer service.,,,Regulatory delay,Anti-Infective,Current,,
5393,"Ceftazidime and Avibactam (AVYCAZ®) for Injection, 2 grams/0.5 grams",Allergan Sales LLC,800-678-1605,"2 g/1, .5 g/1 powder for solution Carton containing 10 vials  (NDC 0456-2700-10)",Revised,2/8/21,The product is available through direct distribution from the manufacturer.  Please contact your wholesaler or customer service.,,,Regulatory delay,Anti-Infective,Current,,
5394,Ceftolozane and Tazobactam (Zerbaxa) Injection,Merck Sharp & Dohme Corp.,800-672-6372,Supplied in single-dose vials containing ceftolozane 1 g (equivalent to 1.147 g of ceftolozane sulfate) and tazobactam 0.5 g (equivalent to 0.537 g of tazobactam sodium) per vial. Vials are supplied in cartons containing 10 vials (NDC 67919-030-01),Reverified,11/15/21,"unavailable, resupply expected approximately December 2021",,,Requirements related to complying with good manufacturing practices,Anti-Infective,Current,,
5395,Cefuroxime Sodium (Zinacef) Injection,"Teligent Pharma, Inc.",856-697-1441,Cefuroxime Sodium (Zinacef) Premix Sol Frozen 1.5g Bag 24 x 50mL (NDC 24987-0425-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
5396,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 1000 count (NDC 0555-0033-05)",Reverified,11/8/21,Available,This product is on allocation.,,,Neurology;Psychiatry,Current,,
5397,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count (NDC 0555-0033-02)",Reverified,11/8/21,Available,This product is on allocation.,,,Neurology;Psychiatry,Current,,
5398,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 count (NDC 0555-0159-02)",Reverified,11/8/21,Available,This product is on allocation.,,,Neurology;Psychiatry,Current,,
5399,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 500 count (NDC 0555-0158-04)",Reverified,11/8/21,Available,This product is on allocation.,,,Neurology;Psychiatry,Current,,
5400,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 500 count (NDC 0555-0159-04)",Reverified,11/8/21,Available,This product is on allocation.,,,Neurology;Psychiatry,Current,,
5401,Chlordiazepoxide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count (NDC 0555-0158-02)",Reverified,11/8/21,Available,This product is on allocation.,,,Neurology;Psychiatry,Current,,
5402,Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"10mg, 100ct (NDC 42806-562-01)",Revised,11/18/21,Available,,,,Neurology;Psychiatry,Current,,
5403,Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"25mg, 100ct (NDC 42806-563-01)",Revised,11/18/21,Available,,,,Neurology;Psychiatry,Current,,
5404,Chlordiazepoxide Hydrochloride Capsules,"Epic Pharma, LLC",888-374-2791,"5mg, 100ct (NDC 42806-564-01)",New,11/18/21,Available,,,,Neurology;Psychiatry,Current,,
5405,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,5 mg (NDC 43547-251-10),New,11/19/19,,"Product discontinuation as per business decision, non-safety related. Distributed by Solco Healthcare U.S., LLC. 
For additional information, please contact : 
Solco Healthcare US
email: chris.keith@solcohealthcare.com",,,Neurology;Psychiatry,To be Discontinued,11/19/19,11/19/19
5406,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,10 mg (NDC 43547-252-10),New,11/19/19,,"Product discontinuation as per business decision, non-safety related. Distributed by Solco Healthcare U.S., LLC. 
For additional information, please contact : 
Solco Healthcare US
email: chris.keith@solcohealthcare.com",,,Neurology;Psychiatry,To be Discontinued,11/19/19,11/19/19
5407,Chloroprocaine Hydrochloride Injection,B. Braun Medical Inc.,800-227-2862,"Clorotekal® (Chloroprocaine HCl Injection, USP) 5mL ampules 50 mg/5 mL (10 mg/mL) Catalog D7055 (NDC 0264-7055-05)",New,5/17/21,Product available,,,Other,Anesthesia,Current,,
5408,Chloroprocaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Nescacaine 1% (300 mg per 30 mL) (10 mg per mL); MDV; (NDC 63323-475-37),Revised,11/23/21,Available,Check wholesaler for inventory,,,Anesthesia,Current,,
5409,Chloroprocaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Nescacaine 2% (600 mg per 30 mL) (20 mg per mL); MDV; (NDC 63323-476-37),Revised,11/23/21,Available,Check wholesaler for inventory,,,Anesthesia,Current,,
5410,Chloroprocaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Nesacaine 2% (400 mg per 20 mL) (20 mg per mL); SDV; (NDC 63323-477-27),Revised,11/23/21,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
5411,Chloroprocaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,Nesacaine 3% (600 mg per 20 mL) (30 mg per mL); SDV; (NDC 63323-478-27),Revised,11/23/21,Backordered. Next release December 2021.,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
5412,Chloroprocaine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% (20 mg/mL), 20 mL vial (NDC 0143-9209-10)",New,5/17/21,Inventory is currently available.,Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
5413,Chloroprocaine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"3% (30 mg/mL), 20 mL vial (NDC 0143-9210-10)",New,5/17/21,This presentation is temporarily on backorder.,Additional lots will be available in the June 2021 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
5414,Cisatracurium Besylate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"10 mg/5 mL Single Dose Vial, Package of 10 vials (NDC 55150-284-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5415,Cisatracurium Besylate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"20 mg / 10 mL Multiple-Dose Vial, Package of 10 vials (ndc 55150-286-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5416,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,200 mg/20 mL (10 mg/mL) Single-dose vials (NDC 0703-2045-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5417,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,20 mg/10 mL (2 mg/mL) Multiple-dose vials (NDC 0703-2056-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5418,Cisatracurium Besylate Injection,Teva Pharmaceuticals,800-545-8800,10 mg/5 mL (2 mg/mL) Single-dose vials (NDC 0703-2033-03),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5419,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,2mg/mL 10 vials (NDC 70069-141-10),Revised,7/27/21,,,,,Anesthesia,Resolved,7/27/21,
5420,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,2mg/ml 10 vials (NDC 70069-161-10),Revised,7/27/21,,,,,Anesthesia,Resolved,7/27/21,
5421,Cisatracurium Besylate Injection,"Somerset Therapeutics, LLC",732-554-1019,10mg/mL 10 vials (NDC 70069-151-10),Revised,7/27/21,,,,,Anesthesia,Resolved,7/27/21,
5422,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,10 mg per 5 mL single dose vial (NDC 71288-712-06),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5423,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,200 mg per 20 mL single dose vial (NDC 71288-713-21),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5424,Cisatracurium Besylate Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,20 mg per 10 mL  multi dose vial (NDC 71288-712-11),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5425,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg (base) per 5 mL (2 mg per mL), Single dose vial, PF, (NDC 63323-416-05)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5426,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 10 mL (2 mg per mL), Multiple dose vial, (NDC 63323-417-10)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5427,Cisatracurium Besylate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL (10 mg per mL), Single dose vial, PF, (NDC 63323-418-20)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5428,Cisatracurium Besylate Injection,Sandoz,800-525-8747,2mg/ml; 5mL (NDC 0781-3150-95),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5429,Cisatracurium Besylate Injection,Sandoz,800-525-8747,2mg/mL; 10mL (NDC 0781-3152-95),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5430,Cisatracurium Besylate Injection,Sandoz,800-525-8747,1-mg/mL; 20mL (NDC 0781-3153-95_,Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5431,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,10mg/5mL (2mg/mL) Single Dose Vial (NDC 00409-1098-02),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5432,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Dose Vial (NDC 00409-1103-01),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5433,Cisatracurium Besylate Injection,"Hospira, Inc.",844-646-4398,20mg/10mL (2mg/mL) Multi-Dose Vial (NDC 00409-1208-01),Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5434,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"2 mg/mL, 5 mL Single-dose vial (NDC 0074-4378-05, 0074-4378-24, 0074-4378-36)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5435,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"2 mg/mL, 10 mL Multiple-dose vial (NDC 0074-4380-10, 0074-4380-79, 0074-4380-81)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5436,Cisatracurium Besylate Injection,Abbvie,800-255-5162,"10 mg/mL, 20 mL Single-dose vial (NDC 0074-4382-20, 0074-4382-91, 0074-4382-93)",Revised,7/27/21,,,Available,,Anesthesia,Resolved,7/27/21,
5437,Cleocin-T 1%,Pfizer Pharmaceuticals,800-533-4535,Topical solution 1 x 60 pledgets (NDC 0009-3116-14),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
5438,Cleocin-T 1%,Pfizer Pharmaceuticals,800-533-4535,Topical solution 1 x 60 mL applicator bottle (NDC 0009-3116-02),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
5439,Cleocin-T 1%,Pfizer Pharmaceuticals,800-533-4535,Topical gel 1 x 60 g tube (NDC 0009-3331-01),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
5440,Cleocin-T 1%,Pfizer Pharmaceuticals,800-533-4535,Topical gel 1 x 30 g tube (NDC 0009-3331-02),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
5441,"Clindamycin and Benzoyl Peroxide Gel, 1%/5%","Tolmar Pharmaceuticals, Inc.",877-986-5627,45g jar (NDC 0781-7263-68); 35g pump (NDC 0781-7275-43); 50g jar (NDC 0781-7287-50); 50g pump (NDC 0781-7291-46),New,9/30/21,,"A business decision was made to discontinue manufacture of the drug product. Distributed by: Sandoz, Inc.. Sandoz Customer Service Number: 1-800-525-8747",,,Dermatology,To be Discontinued,9/30/21,9/30/21
5442,Clindamycin Injection,"Mylan Institutional, a Viatris company",800-796-9526,6 mL/vial (NDC 67457-816-06),New,10/23/20,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/23/20,10/23/20
5443,Clindamycin Injection,"Mylan Institutional, a Viatris company",800-796-9526,"150 mg/1 mL; 4 mL in 1 vial, Single dose; 25 vial/carton (NDC 67457-815-04)",New,1/8/21,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,1/8/21,1/8/21
5444,Clindamycin Injection,"Mylan Institutional, a Viatris company",800-796-9526,300 mg/ 2 mL; Solution in Single Dose Vials (containing preservatives) (NDC 67457-814-02),New,6/1/21,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,6/1/21,6/1/21
5445,"Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%","Tolmar Pharmaceuticals, Inc.",877-986-5627,45 g tube (NDC 0781-7161-19),New,9/30/21,,"A business decision was made to discontinue manufacture of the drug product. Distributed by: Sandoz, Inc.. Sandoz Customer Service Number: 1-800-525-8747",,,Dermatology,To be Discontinued,9/30/21,9/30/21
5446,Clindamycin Phosphate Topical Solution 1%,"Teligent Pharma, Inc.",856-697-1441,30mL (NDC 52565-018-29),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5447,Clindamycin Phosphate Topical Solution 1%,"Teligent Pharma, Inc.",856-697-1441,60mL (NDC 52565-018-59),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5448,Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-039-15),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5449,Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-039-30),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5450,Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,45g (NDC 52565-039-45),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5451,Clobetasol Propionate Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-039-60),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5452,Clobetasol Propionate Topical Foam,Ingenus Pharmaceuticals LLC,866-321-5031,0.05% (NDCs 50742-304-01 and 50742-304-50),New,11/16/21,,,,,Dermatology,To be Discontinued,11/16/21,11/16/21
5453,Clobetasol Propionate Topical Solution 0.05%,"Tolmar Pharmaceuticals, Inc.",877-986-5627,25 mL (NDC 63646-500-25),New,12/8/20,,,,,Dermatology,To be Discontinued,12/8/20,12/8/20
5454,"Clobetasol Propionate Topical Solution, 0.05%","Tolmar Pharmaceuticals, Inc.",877-986-5627,25 mL bottle (NDC 63646-500-25),New,11/1/21,,,,,Dermatology,To be Discontinued,11/1/21,11/1/21
5455,"Clobetasol Propionate Topical Solution, 0.05%","Tolmar Pharmaceuticals, Inc.",877-986-5627,50 mL bottle (NDC 63646-500-50),New,11/1/21,,,,,Dermatology,To be Discontinued,11/1/21,11/1/21
5456,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg  (90s)(NDC 0378-1910-77),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
5457,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg (100s)(NDC 0378-1910-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
5458,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg (1000s)(NDC 0378-1910-10),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
5459,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (90s)(NDC 0378-1912-77),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
5460,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (100s)(NDC 0378-1912-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
5461,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (1000s)(NDC 0378-1912-10),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
5462,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 2mg (100s)(NDC 0378-1914-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
5463,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 2mg (500s)(NDC 0378-1914-05),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
5464,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 0185-0063-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5465,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 0185-0063-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5466,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 1000 count bottle (NDC 0185-0063-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5467,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 0781-8018-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5468,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 0781-8018-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5469,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 1000 count bottle (NDC 0781-8018-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5470,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 16714-752-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5471,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 16714-752-02)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5472,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 16714-469-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5473,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 16714-469-02)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5474,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 100 count bottle (NDC 0185-0064-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5475,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 500 count bottle (NDC 0185-0064-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5476,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 1000 count bottle (NDC 0185-0064-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5477,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 100 count bottle (NDC 0781-5567-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5478,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 500 count bottle (NDC 0781-5567-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5479,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 1000 count bottle (NDC 0781-5567-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
5480,Clonidine Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,0.1 mg tablets (NDC 0597-0006-01),New,1/6/21,,,,,Cardiovascular,To be Discontinued,1/6/21,1/6/21
5481,Clonidine Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,0.2 mg tablets (NDC 0597-0007-01),New,1/6/21,,,,,Cardiovascular,To be Discontinued,1/6/21,1/6/21
5482,Clonidine Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,0.3 mg tablets (NDC 0597-0011-01),New,1/6/21,,,,,Cardiovascular,To be Discontinued,1/6/21,1/6/21
5483,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"12.5 mg tablet, 100 CT Bottle (NDC 18860-101-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5484,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablets, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-102-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5485,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablet, 100  CT bottle (NDC 18860-102-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5486,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-104-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5487,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-105-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5488,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 100 CT Bottle (NDC 18860-105-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5489,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-106-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5490,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablets, 100 CT Bottle (NDC 18860-106-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5491,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg Tablet, 100 CT Bottle (NDC 18860-104-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
5492,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BK0/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON-PVC. (NDC 24571-113-06)",Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5493,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK0/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-108-06)",Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5494,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK4/0/1.2 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (DC 24571-114-06)",Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5495,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-105-06)",Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5496,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK2/3.5 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-103-06)",Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5497,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol BGK2/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-102-06)",Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5498,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,"PrismaSol B22GK4/0 Replacement Solution for Continuous Renal Replacement Therapy, NON PVC. (NDC 24571-111-06)",Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5499,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,PHOXILLUM BK4/2.5 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-116-06),Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5500,Continuous Renal Replacement Therapy (CRRT) Solutions,Baxter Healthcare,888-229-0001,PHOXILLUM B22K4/0 Replacement Solution for Continuous Renal Replacement Therapy (NDC 24571-117-06),Reverified,11/23/21,Available on allocation,,,,Renal,Current,,
5501,Cortisone Acetate Tablets,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg, bottles of 100 (NDC 0143-9700-01)",Reverified,11/2/21,Currently Unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient,Endocrinology/Metabolism;Rheumatology,Current,,
5502,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,"CYCLOMYDRIL 0.2%, 1% 2ML (NDC 0065-0359-02)",New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
5503,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,"CYCLOMYDRIL 0.2%, 1% 5ML (NDC 0065-0359-05)",New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
5504,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 0.5% 15ML (NDC 0065-0395-15),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
5505,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 1% 2ML (NDC 0065-0396-02),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
5506,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 1% 5ML (NDC 0065-0396-05),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
5507,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 2ML (NDC 0065-0397-02),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
5508,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 5ML (NDC 0065-0397-05),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
5509,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOGYL 2% 15ML (NDC 0065-0397-15),New,11/9/20,Available,,,Shortage of an active ingredient,Ophthalmology,Current,,
5510,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOPENTOLATE HCL 1% 15ML (NDC 61314-396-01),New,11/9/20,Available,"Product distributed by Sandoz. Company Contact Information:
800-525-8747",,Shortage of an active ingredient,Ophthalmology,Current,,
5511,Cyclopentolate Ophthalmic Solution,Alcon,800-268-4574,CYCLOPENTOLATE HCL 1% 2ML (NDC 61314-396-03),New,11/9/20,Available,"Product distributed by Sandoz. Company Contact Information:
800-525-8747",,Shortage of an active ingredient,Ophthalmology,Current,,
5512,Cyclopentolate Ophthalmic Solution,Bausch & Lomb Incorporated,800-321-4576,"Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, 2 mL bottle (NDC 24208-735-01) and 15 mL bottle (NDC 24208-735-06)",Revised,6/24/21,On backorder. Estimated availability: Mid-September 2021,"Distributed by Bausch + Lomb, a division of Bausch Health US, LLC – 1-800-321-4576",,Other,Ophthalmology,Current,,
5513,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 15mL 1 Bottle (NDC 17478-097-12)",Revised,6/24/21,On backorder. Estimated availability: September 2021,,,Other,Ophthalmology,Current,,
5514,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 2mL, 1 Bottle (NDC 17478-097-02)",Revised,6/24/21,On backorder. Estimated availability: September 2021,,,Other,Ophthalmology,Current,,
5515,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl 2% Oph Sol 20mg/mL, 5mL 1 Bottle/EA (NDC 17478-097-10)",Revised,6/24/21,On backorder. Estimated availability: September 2021,,,Other,Ophthalmology,Current,,
5516,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl Opht Sol 1% 10mg/mL, 2mL, 1 Bottle (NDC 17478-100-02)",Revised,6/24/21,On backorder. Estimated availability: August 2021,,,Other,Ophthalmology,Current,,
5517,Cyclopentolate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cyclopentolate HCl Ophth 1% 10mg/mL, 15mL, 1 Bottle (NDC 17478-100-12)",Revised,6/24/21,On backorder. Estimated availability: August 2021,,,Other,Ophthalmology,Current,,
5518,Cysteamine Hydrochloride Ophthalmic Solution,"Leadiant Biosciences, Inc.",866-634-2765,"0.44%, 15 mL bottle (NDC 54482-020-01)",Revised,12/21/20,In shortage; Estimated shortage duration:  Unknown,"Delay in manufacturing. For more information please contact 1-866-634-2765, Leadiant@tmac.com, or go to  www.leadiant.com",,Other,Ophthalmology,Current,,
5519,Cysteine Hydrochloride Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154 or 230,Elcys (Cysteine Hydrochloride injection) 500mg/10ml Single-dose vials (NDC 51754-1007-1) Packaged as 10 per carton (NDC 51754-1007-3),Revised,9/3/19,,,Available,,Other;Pediatric,Resolved,9/3/19,
5520,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"2 g/20 mL (100 mg/mL), vial (NDC 67457-452-20)",New,5/21/21,,,,,Oncology;Pediatric,To be Discontinued,5/21/21,5/21/21
5521,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"100 mg/5 mL (20 mg/mL), vial (NDC 67457-455-52)",New,5/21/21,,,,,Oncology;Pediatric,To be Discontinued,5/21/21,5/21/21
5522,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"1000 mg/50 mL (20 mg/mL), vial (NDC 67457-454-50)",New,5/21/21,,,,,Oncology;Pediatric,To be Discontinued,5/21/21,5/21/21
5523,Cytarabine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 g/20 mL (100 mg/mL), single dose vial (NDC 63323-120-20)",New,9/24/21,Backordered.  Next release October 2021.,Manufacturing delay.  Check wholesaler inventory,,Other,Oncology;Pediatric,Current,,
5524,Cytarabine Injection,"Hospira, Inc.",844-646-4398,"100 mg/5 mL (20 mg/mL), single dose vial (NDC 61703-305-38)",Revised,11/18/21,Available,,,Other,Oncology;Pediatric,Current,,
5525,Cytarabine Injection,"Hospira, Inc.",844-646-4398,"2 g/20 mL (100 mg/mL), single dose vial (NDC 61703-319-22)",Revised,11/18/21,Limited Supply Available. Next Delivery: December 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Oncology;Pediatric,Current,,
5526,Cytarabine Injection,"Hospira, Inc.",844-646-4398,"500 mg/25 mL (20 mg/mL), multiple dose vial (NDC 61703-304-36)",Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: January 2022,,,Demand increase for the drug,Oncology;Pediatric,Current,,
5527,Cytarabine Injection,"Hospira, Inc.",844-646-4398,"1,000 mg/50 mL (20 mg/mL), pharmacy bulk vial (NDC 61703-303-46)",Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Oncology;Pediatric,Current,,
5528,Cytarabine Injection,"Meitheal Pharmaceuticals, Inc.",844-824-8426,"2 g/20 mL (100 mg/mL), single dose vial (NDC 71288-109-20)",New,9/24/21,"Currently, no inventory",Manufacturing delay,,Other,Oncology;Pediatric,Current,,
5529,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"2 g/20 mL (100 mg/mL), single dose vial (NDC 67457-452-20)",Reverified,11/10/21,Unavailable,,,,Oncology;Pediatric,Current,,
5530,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"100 mg/5 mL (20 mg/mL), single dose vial (NDC 67457-455-52)",Reverified,11/10/21,Unavailable,,,,Oncology;Pediatric,Current,,
5531,Cytarabine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"1000 mg/50 mL (20 mg/mL), pharmacy bulk vial (NDC 67457-454-50)",Reverified,11/10/21,Unavailable,,,,Oncology;Pediatric,Current,,
5532,Cytotec (Misoprostol) Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 120 (NDC 0025-1451-20),New,6/11/21,,Discontinuation of the manufacture of the drug.,,,Gastroenterology,To be Discontinued,6/11/21,
5533,"Dacarbazine for Injection, USP","Hospira, Inc.",844-646-4398,200 mg Single Dose ONCO-TAIN™ Glass Fliptop Vial (NDC 61703-0327-22),New,1/14/21,,Discontinuation of the manufacture of the drug,,,Oncology,To be Discontinued,1/14/21,1/14/21
5534,Dacarbazine Injection,Teva Pharmaceuticals,800-545-8800,200 mg 10x20mL (NDC 00703-5075-03),New,10/20/21,Limited quantities are available,,,Other,Oncology,Current,,
5535,Dacarbazine Injection,Teva Pharmaceuticals,800-545-8800,200 mg 1x20mL (NDC 00703-5075-01),New,10/20/21,Limited quantities are available,,,Other,Oncology,Current,,
5536,Dacarbazine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per vial, Single Dose Amber Vial (NDC 63323-127-10)",Reverified,11/23/21,Backordered. Next release November 2021.,,,Manufacturing delay,Oncology,Current,,
5537,Dacarbazine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per vial, Single Dose Amber Vial (NDC 63323-128-20)",Reverified,11/23/21,Backordered. Next release November 2021.,,,Manufacturing delay,Oncology,Current,,
5538,Dacarbazine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,200 mg/vial (NDC 0143-9245-10),Revised,10/27/21,This presentation is temporarily on backorder.,Additional lots will be available in the beginning of November 2021.  Product will be made available as it is released.,,Demand increase for the drug,Oncology,Current,,
5539,Daptomycin Injection,Merck Sharp & Dohme Corp.,800-672-6372,500 mg (NDC 67919-011-01),New,10/8/21,,,,,Anti-Infective,To be Discontinued,10/8/21,10/8/21
5540,Darifenacin Hydrobromide Tablets,Teva Pharmaceuticals,800-545-8800,"Extended release, 7.5 mg, 90 count bottle (NDC 0591-4375-19)",New,6/17/20,,Discontinuance of Manufacturing,,,Urology,To be Discontinued,6/17/20,6/17/20
5541,Darifenacin Hydrobromide Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 30 count bottle (NDC: 0591-4380-30)",New,6/17/20,,Discontinuance of Manufacturing,,,Urology,To be Discontinued,6/17/20,6/17/20
5542,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of 30 (NDC 0430-0171-15)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
5543,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of  90 (NDC 0430-0171-23)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
5544,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg , 337500 TABLETS in 1 DRUM (NDC 0430-0171-00)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
5545,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 15 mg, Bottle of 7 (NDC 0430-0171-96)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
5546,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg Bottle of 30 (NDC 0430-0170-15)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
5547,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg Bottle of  90 (NDC 0430-0170-23)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
5548,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg, 337500 TABLETS in 1 DRUM (NDC 0430-0170-00)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
5549,Darifenacin Hydrobromide Tablets,Allergan,800-678-1605,"Extended-Release Tablet, 7.5 mg, Bottle of 7 (NDC 0430-0170-96)",New,6/4/20,,Allergan has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,6/4/20,6/4/20
5550,Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir (Viekira XR) Tablets,Abbvie,800-255-5162,"200mg; 8.33mg; 50mg; 33.33 tablets, (NDC 0074-0063-28)",New,5/22/18,,"Estimated product availability until January 1, 2019. The product discontinuation is voluntary.",,,Antiviral,To be Discontinued,5/22/18,5/22/18
5551,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,180 mg/1 (NDC 00093-3516-56),New,7/20/20,,Teva had evaluated the market and made a business decision to discontinue the product.,,,Hematology,To be Discontinued,7/20/20,7/20/20
5552,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,90 mg/1 (NDC 00093-3517-56),New,7/20/20,,Teva had evaluated the market and made a business decision to discontinue the product.,,,Hematology,To be Discontinued,7/20/20,7/20/20
5553,Deferasirox Tablets,Teva Pharmaceuticals,800-545-8800,360 mg/1 (NDC 00093-3515-56),New,7/20/20,,Teva had evaluated the market and made a business decision to discontinue the product.,,,Hematology,To be Discontinued,7/20/20,7/20/20
5554,"Deferoxamine Mesylate for Injection, USP","ApoPharma USA, Inc.",866-931-0740,"500 mg per vial, Single use vial, Carton of 4 vials (NDC 52609-4505-6)",Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
5555,"Deferoxamine Mesylate for Injection, USP","ApoPharma USA, Inc.",866-931-0740,"2 g per vial, Single use vial, Carton of 4 vials (NDC 52609-4504-6)",Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
5556,Desmopressin Acetate Nasal Spray,Ferring,888-337-7464,"1.5 mg/mL, (NDC 0053-6871-00)",Revised,5/14/21,Unavailable,,,Other,Hematology,Current,,
5557,Desmopressin Acetate Nasal Spray,Apotex Corp.,800-706-5575,10 mcg/0.1mL (NDC 60505-0815-0),Reverified,6/24/21,Available,,,,Hematology,Current,,
5558,Desmopressin Acetate Nasal Spray,Ferring,888-337-7464,10 mcg/0.1mL (NDCs 55566-2500-0 and 69918-501-05),New,5/14/21,Unavailable,,,Other,Hematology,Current,,
5559,Desogestrel and Ethinyl Estradiol Tablets (ORTHO-CEPT),Janssen Pharmaceuticals,800-526-7736,ORTHO-CEPT (NDC 50458-196-15),Revised,10/8/14,,Product will be delisted. Last distribution March 2015.,,Discontinuation of the manufacture of the drug.,,To Be Discontinued,10/8/14,
5560,Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection SDV [4 mg / 1 ml] 25PK (NDC 67457-423-12),Reverified,11/29/21,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5561,Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [20 mg / 5 ml] 25PK (NDC 67457-422-54),Reverified,11/29/21,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5562,Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [120 mg / 30 ml] 25 PK (NDC 67457-421-30),Reverified,11/29/21,Intermittent supply,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5563,Dexamethasone Sodium Phosphate Injection,"Mylan Institutional, a Viatris company",800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [100 mg / 10 ml] 10PK (NDC 67457-420-10),Reverified,11/29/21,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5564,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,4 mg/1 mL SDV (NDC 55150-237-01),Revised,11/5/21,Backordered — next shipment TBD,Sporadic availability expected.,,Delay in shipping of the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5565,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,20 mg/5 mL MDV  (NDC 55150-238-05),Revised,11/5/21,Backordered — next shipment TBD,Sporadic availability expected.,,Delay in shipping of the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5566,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,120 mg/30 mL MDV (NDC 55150-239-30),Revised,11/5/21,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5567,Dexamethasone Sodium Phosphate Injection,"Somerset Therapeutics, LLC",732-554-1019,"Dexamethasone Sodium Phosphate Injection USP, 10 mg/mL, 1 mL Single Dose Vial (Preservative Free)(NDC 70069-021-25)",Reverified,5/19/21,Currently in Stock (we have capacity constraint but product available at this time). Estimated Release Dates: Released Product Available,,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5568,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,20 mg per 5 mL (4 mg per mL); MDV;  Amber vial (NDC 63323-165-05),Revised,11/23/21,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5569,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mg per 10 mL (10 mg per mL); MDV;  Amber Vial (NDC 63323-516-10),Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5570,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,120 mg per 30 mL (4 mg per mL); MDV; Amber Vial (NDC 63323-165-30),Revised,11/23/21,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5571,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,4 mg per mL (4 mg per mL); SDV; Amber Vial (NDC 63323-165-01),Revised,11/23/21,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5572,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mg per mL (10 mg per mL); SDV; Preservative Free; Amber Vial (NDC 63323-506-01),Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5573,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6145-25)",Reverified,10/12/21,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5574,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 5 mL vial (NDC 0641-6146-25)",Reverified,10/12/21,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5575,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-0367-25)",Reverified,10/12/21,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5576,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-106-10)",Revised,11/23/21,8 month expiry (7/2022 expiry) dating available by request.,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5577,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose Simplist syringe, preservative free (NDC 76045-109-10)",Revised,11/23/21,8 month expiry (7/2022 expiry) dating available by request.,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5578,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,10 mg/1 mL SDV (NDC 55150-304-25),Revised,11/5/21,Currently on backorder - next shipment anticipated early Nov,Check wholesalers for inventory,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5579,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,100 mg/10 mL MDV (contains preservative)(NDC 55150-305-10),Revised,11/5/21,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
5580,Dexmedetomidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mcg/mL, 2 mL vial (NDC 0143-9532-25)",Reverified,10/12/21,Inventory is currently available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
5581,Dexmedetomidine Injection,Amneal Pharmaceutical,866-525-7270,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single-dose bottle (NDC 70121-1388-8 box of 20; NDC 70121-1388-1 individual)",New,4/6/21,Available,,,,Anesthesia,Current,,
5582,Dexmedetomidine Injection,Amneal Pharmaceutical,866-525-7270,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single-dose bottle (NDC 70121-1389-7 box of 10; NDC 70121-1389-1 individual)",New,4/6/21,Available,,,,Anesthesia,Current,,
5583,Dexmedetomidine Injection,Gland Pharma Limited,866-733-3952,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 43598-976-58)",Reverified,11/5/21,Inventory available,Marketed by Dr. Reddy’s Laboratories Inc. Check wholesalers for inventory.,,,Anesthesia,Current,,
5584,Dexmedetomidine Injection,Gland Pharma Limited,866-733-3952,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 43598-975-58)",Reverified,11/5/21,Inventory available,Marketed by Dr. Reddy’s Laboratories Inc. Check wholesalers for inventory..,,,Anesthesia,Current,,
5585,Dexmedetomidine Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"200mcg/50mL, single dose bag (NDC 55150-296-10)",Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5586,Dexmedetomidine Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"400mcg/100mL, single dose bag (NDC 55150-297-10)",Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5587,Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"0.2 mg / 50 ml (Solution in Single Use Vials/Bottles), 20PK (NDC 67457-924-50)",Revised,11/29/21,Available,,,Demand increase for the drug,Anesthesia,Current,,
5588,Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"0.4 mg / 100 ml (Solution in Single Use Vials/Bottles), 10PK (NDC 67457-925-10)",Revised,11/29/21,Available,,,Demand increase for the drug,,Current,,
5589,Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"200 mcg/50 mL (4 mcg/mL), 50 mL single dose vial, box of 25 (NDC 42023-186-20)",Reverified,11/3/21,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,
5590,Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"400 mcg/100 mL (4 mcg/mL), 100 mL single dose vial, box of 10 (NDC 42023-187-10)",Reverified,11/3/21,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,
5591,Dexmedetomidine Injection,Accord Healthcare Inc.,"866-941-7875, option 2","200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 16729-239-93)",Revised,9/13/21,Available,,,,Anesthesia,Current,,
5592,Dexmedetomidine Injection,Accord Healthcare Inc.,"866-941-7875, option 2","200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 16729-432-93), Novaplus",Revised,9/13/21,Available,,,,Anesthesia,Current,,
5593,Dexmedetomidine Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 55150-209-02)",Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5594,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 24 (NDC 0338-9555-24)",Reverified,11/23/21,Available,,,,Anesthesia,Current,,
5595,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 12 (NDC 0338-9557-12)",Reverified,11/23/21,Available,,,,Anesthesia,Current,,
5596,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 24 (NDC 43066-555-24), Novaplus",Reverified,11/23/21,Available,,,,Anesthesia,Current,,
5597,Dexmedetomidine Injection,Baxter Healthcare,888-229-0001,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bag, box of 12 (NDC 43066-557-12), Novaplus",Reverified,11/23/21,Available,,,,Anesthesia,Current,,
5598,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 63323-671-20)",Reverified,11/23/21,Backordered. Next release date not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5599,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 25 (NDC 63323-671-50)",Reverified,11/23/21,5 month expiry (4/2022 expiry) dating available by request.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5600,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 63323-671-00)",Reverified,11/23/21,Backordered. Next release date not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5601,Dexmedetomidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 63323-421-02)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
5602,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"400 mcg/4 mL (100 mcg/mL), multi-dose vial, box of 4 (NDC 44567-600-04)",Reverified,8/31/21,Available,Distributed by WG Critical Care. Please contact WG Critical Care at 888-493-0861.,,Demand increase for the drug,Anesthesia,Current,,
5603,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"1000 mcg/10 mL (100 mcg/mL), multi-dose vial, box of 4 (NDC 44567-601-04)",Reverified,8/31/21,Available,Distributed by WG Critical Care. Please contact WG Critical Care at 888-493-0861.,,Demand increase for the drug,Anesthesia,Current,,
5604,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"200 mcg/50 mL (4 mcg/mL), single dose bag, box of 24 (NDC 44567-602-24)",Reverified,8/31/21,Available,Distributed by WG Critical Care. Please contact WG Critical Care at 888-493-0861.,,Demand increase for the drug,Anesthesia,Current,,
5605,Dexmedetomidine Injection,HQ Specialty Pharma,201-857-8290,"400 mcg/100 mL (4 mcg/mL), box of 24 (NDC 44567-603-24)",Reverified,8/31/21,Available,Distributed by WG Critical Care. Please contact WG Critical Care at 888-493-0861.,,Demand increase for the drug,Anesthesia,Current,,
5606,Dexmedetomidine Injection,Jiangsu Hengrui Medicine Co. Ltd.,Athenex: 855-273-0154,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 70860-605-03)",Reverified,11/5/21,Available,"Distributed by Athenex. To order, contact Athenex at 855-273-0154.",,Demand increase for the drug,Anesthesia,Current,,
5607,Dexmedetomidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 67457-251-02)",Revised,11/29/21,Short dated stock (4/2022 expiry) available by request. Additional manufacturer in progress.,,,Demand increase for the drug,Anesthesia,Current,,
5608,Dexmedetomidine Injection,Par Pharmaceutical,800-828-9393,"100 mcg/mL, 2 mL single dose vial, box of 25 (NDC 42023-146-25)",Reverified,11/3/21,Par Product Available – Please Check Wholesalers,,,,Anesthesia,Current,,
5609,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"80 mcg/20 mL (4 mcg/mL) in 0.9% sodium chloride, single dose vial, box of 10 (NDC 0409-1660-20)",Reverified,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,,Anesthesia,Current,,
5610,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"200 mcg/50 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 20 (NDC 0409-1660-50)",Reverified,11/18/21,Available,,,Demand increase for the drug,Anesthesia,Current,,
5611,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"400 mcg/100 mL (4 mcg/mL) in 0.9% sodium chloride, single dose bottle, box of 10 (NDC 0409-1660-10)",Reverified,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery; July 2022,,,Demand increase for the drug,Anesthesia,Current,,
5612,Dexmedetomidine Injection,Pfizer Pharmaceuticals,844-646-4398,"200 mcg/2 mL (100 mcg/mL), single dose vial, box of 25 (NDC 0409-1638-02)",Reverified,11/18/21,Available,,,Demand increase for the drug,Anesthesia,Current,,
5613,Dexmedetomidine Injection,Slayback Pharma,844-566-2505,"4 mcg/mL in 0.9% sodium chloride, 50 mL single dose bottle, box of 20 (NDC 71225-126-05)",Revised,5/20/21,Available,,,Demand increase for the drug,Anesthesia,Current,,
5614,Dexmedetomidine Injection,Slayback Pharma,844-566-2505,"4 mcg/mL in 0.9% sodium chloride, 100 mL single dose bottle, box of 10 (NDC 71225-126-06)",Revised,5/20/21,Available,,,Demand increase for the drug,Anesthesia,Current,,
5615,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100s (NDC 0378-1070-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
5616,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100s (NDC 0378-1071-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
5617,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-1072-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
5618,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container.  Product code 2B0062Q  (NDC 0338-0017-02)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5619,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container.  Product code 2B0063Q  (NDC 0338-0017-03)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5620,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 1000 mL VIAFLEX Plastic Container. Product code 2B0064X  (NDC 0338-0017-04)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5621,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL AVIVA Container.  Product code 6E0062 (NDC 0338-6346-02)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5622,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL AVIVA Container. Product code 6E0063  (NDC 0338-6346-03)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5623,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL (NDC 0409-7922-02),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5624,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,500 mL (NDC 0409-7922-03),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5625,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,1000 mL (NDC 0409-7922-09),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5626,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL VisIV™ Container (NDC 0409-7922-25),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5627,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL (NDC 0409-7922-53),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5628,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,500 mL (NDC 0409-7922-55),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5629,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,150 mL (NDC 0409-7922-61),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5630,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,50 mL VisIV™ Container (NDC 0409-7923-06),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5631,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,100 mL VisIV™ Container (NDC 0409-7923-11),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5632,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,50 mL (NDC 0409-7923-13),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5633,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"25 mL, Quad Pack (NDC 0409-7923-20)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5634,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,100 mL (NDC 0409-7923-23),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5635,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL, Quad Pack (NDC 0409-7923-36)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5636,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL, Quad Pack (NDC 0409-7923-37)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5637,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, 25 mL, in VIAFLEX Plastic Container. Quad Pack.  Product code 2B0080  (NDC 0338-0017-10)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5638,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, in VIAFLEX Plastic Container.  Single Pack. Product code EZPB0041 (NDC 0338-9147-30)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5639,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, in VIAFLO container Product codes:  UE0062D (250mL, NDC 0338-0062-30); UE0063D (500mL, NDC 0338-0066-20); UE0064D (1000mL, NDC 0338-0070-10)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
5640,Diclofenac Sodium Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg (NDC 0378-0355-01),New,4/4/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction;Rheumatology,To be Discontinued,4/4/18,4/4/18
5641,Diclofenac Sodium Topical Solution,"Teligent Pharma, Inc.",856-697-1441,1.5% 60mL bottle (NDC 52565-002-59),New,2/18/21,,Long-term back order with no date of return; Discontinuation of the manufacture of the drug,,,Analgesia/Addiction,To be Discontinued,2/18/21,2/18/21
5642,Diclofenac Sodium Topical Solution,"Teligent Pharma, Inc.",856-697-1441,1.5% 150mL bottle (NDC 51565-002-05),New,2/18/21,,Long-term back order with no date of return; Discontinuation of the manufacture of the drug,,,Analgesia/Addiction,To be Discontinued,2/18/21,2/18/21
5643,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 200 mg, 30 count bottles (NDC 0555-0588-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
5644,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 250 mg, 30 count bottles (NDC 0555-0589-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
5645,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 400 mg, 30 count bottles (NDC 0555-0590-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
5646,"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-063-15),New,7/6/21,,,,,Dermatology,To be Discontinued,7/6/21,7/6/21
5647,"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-063-30),New,7/6/21,,,,,Dermatology,To be Discontinued,7/6/21,7/6/21
5648,"Diflorasone Diacetate Ointment, 0.05%","Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-063-60),New,7/6/21,,,,,Dermatology,To be Discontinued,7/6/21,7/6/21
5649,Difluprednate (Durezol) Ophthalmic Emulsion,Novartis,888-669-6682,0.05% 5mL in 8mL bottle (NDC 0065-9204-07),Revised,10/15/19,,,,,Ophthalmology,Resolved,10/15/19,
5650,Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Adult (500mcg in 2ml) Ampule (NDC 0515-260-10),Revised,10/6/21,Available,,,Delay in shipping of the drug,Cardiovascular,Current,,
5651,Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Adult (500mcg in 2ml) vial (NDC 70515-261-10),Revised,10/6/21,Available,,,,Cardiovascular,Current,,
5652,Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Pediatric (100mcg in 1ml) ampoule (NDC 70515-262-10),Revised,10/6/21,Available,,,,Cardiovascular,Current,,
5653,Digoxin Injection,Covis Pharma,913-661-3814,Lanoxin (digoxin) Injection Pediatric (100mcg in 1ml) vial (NDC 70515-263-10),Revised,10/6/21,Available,,,,Cardiovascular,Current,,
5654,Digoxin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"250 mcg/mL, 2 mL  (NDC 0641-1410-35)",New,6/4/21,This presentation is on backorder.,Product recovery is undetermined at this time.,,Other,Cardiovascular,Current,,
5655,Digoxin Injection,Sandoz,800-525-8747,500mcg/2 mL; 10 ampules (NDC 0781-3059-95),Reverified,11/16/21,Available; Intermittent Backorder,,,Demand increase for the drug,Cardiovascular,Current,,
5656,Diltiazem Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1171-02),New,6/8/21,,,,,Cardiovascular,To be Discontinued,6/8/21,6/8/21
5657,Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,25 mg/5mL vial (NDC 70860-301-05),Reverified,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
5658,Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,50 mg/10mL vial (NDC 70860-301-10),Reverified,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
5659,Diltiazem Hydrochloride Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,125 mg/25mL vial (NDC 70860-301-25),Reverified,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
5660,Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 5 mL vial  (NDC 0641-6013-10)",Revised,10/12/21,Inventory is currently available.,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5661,Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial (NDC 0641-6014-10)",Revised,10/12/21,Inventory is currently available,Additional lots are scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5662,Diltiazem Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 30 mL vial (NDC 0641-6015-10)",Revised,10/12/21,Inventory is currently available.,Additional lots will be scheduled for manufacturing.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5663,Diltiazem Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg; Single Dose ADD-Vantage Vial (NDC 00409-4350-03),Reverified,11/18/21,Available,,,Other,Cardiovascular,Current,,
5664,Diltiazem Hydrochloride Injection,"Hospira, Inc.",844-646-4398,25 mg/5 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1171-01),Revised,3/23/21,,,,,Cardiovascular,To be Discontinued,3/23/21,3/23/21
5665,Diltiazem Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1171-02),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
5666,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 10 mL, 10 vials (NDC 17478-0937-10)",Revised,2/12/21,On backorder. Expected release: April 2021,,,,Cardiovascular,Current,,
5667,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 1 vial (NDC 17478-0937-25)",Revised,2/12/21,Available,,,,Cardiovascular,Current,,
5668,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 10 vials (NDC 17478-0937-26)",Revised,2/12/21,Discontinued,,,,Cardiovascular,Current,,
5669,Diltiazem Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 5 mL, 10 vials (NDC 17478-0937-05)",Revised,2/12/21,Available,,,,Cardiovascular,Current,,
5670,Dimercaprol (Bal in Oil) Injection,Akorn Pharmaceuticals,800-932-5676,"3 mL (100 mg/mL) ampules, box of 10 (NDC 17478-526-03)",Revised,6/29/21,,,Available,,Hematology;Other,Resolved,6/29/21,
5671,"Diphenhydramine Hydrochloride Injection, USP",Pfizer Pharmaceuticals,800-533-4535,50 mg/mL Carpuject™ Luer Lock Glass Syringe (NDC 00409-2290-31),New,12/28/20,,Discontinuation of the manufacture of the drug,,,Pulmonary/Allergy,To be Discontinued,12/28/20,12/28/20
5672,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace CR, 100 mg capsules, bottle of 100 (NDC 0025-2732-31)",Reverified,11/18/21,Next Delivery and Estimated Recovery: January 2022,Manufacturing Delay. Please contact Pfizer Customer Service for assistance.,,Other,Cardiovascular,Current,,
5673,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace CR, 150 mg capsules, bottle of 100 (NDC 0025-2742-31)",Reverified,11/18/21,Next Delivery and Estimated Recovery: January 2022,Manufacturing Delay. Please contact Pfizer Customer Service for assistance.,,Other,Cardiovascular,Current,,
5674,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"100 mg capsules, bottle of 100 (NDC 59762-0386-1)",Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: March 2022,Shortage per Manufacturer: Manufacturing delay,,Other,Cardiovascular,Current,,
5675,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"150 mg capsules, bottle of 100 (NDC 59762-0400-1)",Reverified,11/18/21,Next Delivery and Estimated Recovery: February 2022,Greenstone label,,,Cardiovascular,Current,,
5676,Disopyramide Phosphate (Norpace) Capsules,Teva Pharmaceuticals,800-545-8800,"100 mg capsules, bottle of 100 (NDC 0093-3127-01)",Reverified,11/8/21,Available,,,,Cardiovascular,Current,,
5677,Disopyramide Phosphate (Norpace) Capsules,Teva Pharmaceuticals,800-545-8800,"150 mg capsules, bottle of 100 (NDC 0093-3129-01)",Reverified,11/8/21,Available,,,,Cardiovascular,Current,,
5678,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace IR, 100 mg capsules; bottle of 100 (NDC 0025-2752-31)",Reverified,11/18/21,Next Delivery: January 2022; Estimated Recovery: February 2022,Shortage per Manufacturer: Manufacturing delay,,Other,Cardiovascular,Current,,
5679,Disopyramide Phosphate (Norpace) Capsules,Pfizer Pharmaceuticals,800-533-4535,"Norpace IR, 150 mg capsules; bottle of 100 (NDC 0025-2762-31)",Reverified,11/18/21,Next Delivery: January 2022; Estimated Recovery: February 2022,,,,Cardiovascular,Current,,
5680,Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100s (NDC 0378-4140-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
5681,Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100s (NDC 0378-4141-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
5682,Disulfiram Tablets,Teva Pharmaceuticals,800-545-8800,"250 mg, 100 count (NDC 0093-5035-01)",New,11/20/20,,Teva made a business decision to discontinue the product.,,,Analgesia/Addiction,To be Discontinued,11/20/20,11/20/20
5683,Disulfiram Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, 100 count (NDC 0093-5036-01)",New,11/20/20,,Teva made a business decision to discontinue the product.,,,Analgesia/Addiction,To be Discontinued,11/20/20,11/20/20
5684,Dobutamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"250 mg/250 mL (NDC 0338-1073-02) Product code 2B0791, 500 mg/250 mL (NDC 0338-1075-02) Product code 2B0792, 1000 mg/250 mL (NDC 0338-1077-02) Product code 2B0793",Reverified,11/23/21,Available,,,,Cardiovascular;Pediatric;Renal,Current,,
5685,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/250 mL (1 mg/mL); Flexible Container (NDC 00409-2346-32),Revised,11/18/21,Available,,,Other,Cardiovascular;Pediatric;Renal,Current,,
5686,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/250 mL (2 mg/mL); Flexible Container (NDC 00409-2347-32),Revised,11/18/21,Limited Supply Available. Next Delivery: December 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Cardiovascular;Pediatric;Renal,Current,,
5687,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1000 mg/250 mL (4 mg/mL); Flexible Container (NDC 00409-3724-32),Revised,11/18/21,Limited Supply Available. Next Delivery: January 2022; Estimated Recovery: March 2022,,,Other,Cardiovascular;Pediatric;Renal,Current,,
5688,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-20),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular;Pediatric;Renal,Current,,
5689,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/40 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-54),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Cardiovascular;Pediatric;Renal,Current,,
5690,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-01),Revised,11/18/21,Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Cardiovascular;Pediatric;Renal,Current,,
5691,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-02),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Cardiovascular;Pediatric;Renal,Current,,
5692,Docetaxel Injection,Ingenus Pharmaceuticals LLC,866-321-5031,20 mg/2 mL (10 mg/mL)(NDC 50742-428-02),New,4/7/21,,Discontinued manufacturing due to lack of commercial viability in the market,,,Oncology,To be Discontinued,4/7/21,4/7/21
5693,Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4353,125 mcg (0.125 mg) capsules; Bottle of 60 (NDC 59762-0037-2),New,5/21/21,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,5/21/21,5/21/21
5694,Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4353,250 mcg (0.25 mg) capsules; Bottle of 60 (NDC 59762-0038-2),New,5/21/21,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,5/21/21,5/21/21
5695,Dofetilide Capsules,Pfizer Pharmaceuticals,800-533-4535,500 mcg (0.5 mg) capsules; Bottle of 60 (NDC 59762-0039-2),New,5/21/21,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,5/21/21,5/21/21
5696,Dopamine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg/mL, 5 mL vial (NDC 0143-9252-25)",Reverified,10/12/21,This presentation is currently available.,Additional lots are scheduled for manufacturing.   Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5697,Dopamine Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg/mL, 10 mL vial (NDC 0143-9254-25)",Reverified,10/12/21,This presentation is currently available.,Additional lots are scheduled for manufacturing.   Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5698,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"400 mg/250 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-22)",Revised,11/18/21,Available,,,Other,Cardiovascular,Current,,
5699,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"800 mg/500 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-24)",Revised,11/18/21,Next Delivery and Estimated Recovery: February 2022,,,Demand increase for the drug,Cardiovascular,Current,,
5700,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"800 mg/250 mL (3,200 mcg/mL); Flexible Container (NDC 00409-7810-22)",Revised,11/18/21,Next Delivery: March 2022; Estimated Recovery: April 2022,,,Demand increase for the drug,Cardiovascular,Current,,
5701,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/5 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-5820-01),Revised,11/18/21,Available,,,Other,Cardiovascular,Current,,
5702,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,400 mg/10 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9104-20),Revised,11/18/21,Available,,,Other,Cardiovascular,Current,,
5703,Dopamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"800 mcg/mL (250 mL bag) Product code 2B0832 (NDC 0338-1005-02), 800 mcg/mL (500 mL bag)  Product code 2B0833 (NDC 0338-1005-03), 1600 mcg/mL (250 mL bag) Product code 2B0842 (NDC 0338-1007-02), 1600 mcg/mL (500 mL bag) Product code 2B0843 (NDC 0338-1007-03), 3200 mcg/mL (250 mL bag) Product code 2B0846 (NDC 0338-1009-02)",Reverified,11/23/21,Available,,,,Cardiovascular,Current,,
5704,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 17478-605-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5705,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 50383-233-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5706,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt-PF® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 0.2 mL single use, 60 count (NDC 17478-604-30)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5707,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 61314-030-02)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5708,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 24208-486-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5709,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 0591-2482-79)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5710,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride and Timolol Maleate 20 mg and 5 mg/mL, 10 mL (0591-2482-79)",New,4/20/18,,This was a business-related decision to discontinue manufacturing this product.,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
5711,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Aurobindo Pharma,866-850-2876,"Dorzolamide HCl and Timolol Maleate (Cosopt® PF) Ophthalmic Solution 2%/0.5% Preservative Free, 2mL single use container (NDC 65862-0947-60)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5712,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0591-2481-79)",New,4/20/18,,This was a business-related decision to discontinue manufacturing these products,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
5713,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0093-7618-43)",New,4/20/18,,This was a business-related decision to discontinue manufacturing these products,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
5714,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride 22.3 mg/mL, 10 mL (NDC 0591-2481-79)",Revised,4/29/21,,This was a business-related decision to discontinue manufacturing these products,,,Ophthalmology,To be Discontinued,4/29/21,4/29/21
5715,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride 22.3 mg/mL, 10 mL (NDC 0093-7618-43)",Revised,4/29/21,,This was a business-related decision to discontinue manufacturing these products,,,Ophthalmology,To be Discontinued,4/29/21,4/29/21
5716,Dorzolamide Hydrochloride Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 61314-019-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5717,Dorzolamide Hydrochloride Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 50383-232-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5718,Dorzolamide Hydrochloride Ophthalmic Solution,Merck Sharp & Dohme Corp.,800-637-2579,"TRUSOPT® dorzolamide hydrochloride ophthalmic solution 2%, 10 mL in an 18 mL capacity bottle (NDC 0006-3519-36)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5719,Dorzolamide Hydrochloride Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride USP 2%, 10 mL (NDC 24208-485-10)",Revised,5/10/21,,,Available,,Ophthalmology,Resolved,5/10/21,
5720,Doxycycline Hyclate Powder for Suspension,"Hospira, Inc.",844-646-4398,25mg/5mL (NDC 0069-0970-65),New,11/15/21,,,,,Anti-Infective,To be Discontinued,11/15/21,11/15/21
5721,Echothiophate Iodide (Phospholine Iodide) Ophthalmic Solution,Pfizer Pharmaceuticals,800-533-4535,6.25 mg package for 0.125% (NDC 0046-1065-05),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Ophthalmology,Current,,
5722,Efavirenz Tablets,"Mylan Specialty, a Viatris Company",800-796-9526,600 mg (NDC 0378-2233-93),New,11/2/21,,,,,Antiviral,To be Discontinued,11/2/21,11/2/21
5723,Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate (Atripla) Tablets,"Gilead Sciences, LLC",800-445-3235,600 mg; 200 mg; 300 mg (NDC 15584-0101-1),New,2/4/21,,Date of permanent discontinuation of manufacture is July 2021.  Product expected to be available until December 2021.,,,Antiviral,To be Discontinued,2/4/21,2/4/21
5724,Enalaprilat Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2.5mg/2mL, vial (NDC 0143-9786-10)",Revised,10/12/21,This presentation is currently available.,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5725,Enalaprilat Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1.25mg/mL, vial  (NDC 0143-9787-10)",Revised,10/12/21,This presentation is currently available.,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
5726,Enoxaparin Sodium Injection,Teva Pharmaceuticals,800-545-8800,30 mg/0.3mL (NDCs 0703-8530-21 and 0703-8530-23),New,1/28/21,,Product expected to be available until December 2021,,,Hematology,To be Discontinued,1/28/21,1/28/21
5727,Enoxaparin Sodium Injection,Teva Pharmaceuticals,800-545-8800,40 mg/0.4 mL (NDCs 0703-8540-21 and 0703-8540-23),New,1/28/21,,Product expected to be available until October 2021,,,Hematology,To be Discontinued,1/28/21,1/28/21
5728,Enoxaparin Sodium Injection,Teva Pharmaceuticals,800-545-8800,60 mg/0.6 mL (NDCs 0703-8560-21 and 0703-8560-23),New,1/28/21,,Product expected to be available until December 2021,,,Hematology,To be Discontinued,1/28/21,1/28/21
5729,Enoxaparin Sodium Injection,Teva Pharmaceuticals,800-545-8800,80 mg/0.8 mL (NDCs 0703-8680-21 and 0703-8680-23),New,1/28/21,,Product expected to be available until December 2021,,,Hematology,To be Discontinued,1/28/21,1/28/21
5730,Enoxaparin Sodium Injection,Teva Pharmaceuticals,800-545-8800,100 mg/1 mL (NDCs 0703-8580-21 and 0703-8580-23),New,1/28/21,,Product expected to be available until December 2021,,,Hematology,To be Discontinued,1/28/21,1/28/21
5731,Enoxaparin Sodium Injection,Teva Pharmaceuticals,800-545-8800,120 mg/0.8 mL (NDCs 0703-8610-21 and 0703-8610-23),New,1/28/21,,Product expected to be available until August 2021,,,Hematology,To be Discontinued,1/28/21,1/28/21
5732,Enoxaparin Sodium Injection,Teva Pharmaceuticals,800-545-8800,150 mg/1 mL (NDCs 0703-8510-21 and 0703-8510-23),New,1/28/21,,Product expected to be available until December 2021,,,Hematology,To be Discontinued,1/28/21,1/28/21
5733,"Epinephrine Injection, 0.1 mg/mL","Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4933-01) (old NDC 00409-4921-34, pack of 10; NDC 0409-4921-20, individual)",Revised,11/18/21,Next Delivery and Estimated Recovery: TBD,,,Demand increase for the drug,Cardiovascular;Pulmonary/Allergy,Current,,
5734,"Epinephrine Injection, 0.1 mg/mL","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"0.1mg/mL, 10mL, (NDC 76329-3316-1)",Revised,11/2/21,Backorder due to the increase in demands,,,Demand increase for the drug,Cardiovascular;Pulmonary/Allergy,Current,,
5735,"Epinephrine Injection, Auto-Injector","Mylan Specialty, a Viatris Company",800-796-9526,0.3 mg EpiPen® (NDC 49502-500-02); Authorized Generic (NDC 49502-102-02),Reverified,11/29/21,Available,Product is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
5736,"Epinephrine Injection, Auto-Injector","Mylan Specialty, a Viatris Company",800-796-9526,0.15 mg EpiPen® (NDC 49502-501-02); Authorized Generic (NDC 49502-101-02),Reverified,11/29/21,Available,Product is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
5737,"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.15 mg/0.15 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1695-49)",Revised,4/28/21,On allocation to current customers.,,,Manufacturing delays,Pulmonary/Allergy,Current,,
5738,"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.3 mg/0.3 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1694-49)",Reverified,12/14/20,On allocation to current customers.,,,Manufacturing delays,Pulmonary/Allergy,Current,,
5739,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.3 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-023-01)",Reverified,1/27/21,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
5740,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.15 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-022-01)",Reverified,1/27/21,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
5741,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.1 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-021-01)",Reverified,1/27/21,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
5742,"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.3 mg/mL epinephrine injection, USP, auto-injector (NDC 0093-5986-27)",Reverified,11/8/21,Limited inventory on allocation.  Expected recovery mid-November.,,,,Pulmonary/Allergy,Current,,
5743,"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.3 mg single-dose, pre-filled syringes (NDC 0781-3442-20)",Reverified,12/17/19,Available,,,,Pulmonary/Allergy,Current,,
5744,"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.15 mg single-dose, pre-filled syringes (NDC 0781-3448-20)",Reverified,12/17/19,Available,,,,Pulmonary/Allergy,Current,,
5745,"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.15 MG Epinephrine Injection, USP auto-injector (NDC 0093-5985-27)",Reverified,11/8/21,Limited inventory on allocation.  Expected recovery mid-October.,,,,Pulmonary/Allergy,Current,,
5746,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,20 mg/10ml (2 mg/ml)(NDC 0085-1177-01),New,10/21/20,,To be discontinued on or near October 2020.,,,Cardiovascular,To be Discontinued,10/21/20,10/21/20
5747,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,75 mg/100ml (0.75 mg/ml)(NDC 0085-1136-01),New,10/21/20,,To be discontinued on or near October 2020.,,,Cardiovascular,To be Discontinued,10/21/20,10/21/20
5748,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,200 mg/100ml (2 mg/ml)(NDC 0085-1177-02),New,10/21/20,,Discontinued,,,Cardiovascular,To be Discontinued,10/21/20,10/21/20
5749,Ergotamine Tartrate and Caffeine (Cafergot) Tablets,Sandoz,800-525-8747,1mg/100mg (NDC 0781-5405-01),New,7/2/20,,Discontinuation of drug manufacturing,,,Neurology,To be Discontinued,7/2/20,7/2/20
5750,Erlotinib Hydrochloride Tablets,"Astellas Pharma Global Development, Inc.",800-727-7003,25 mg tablets (NDC 50242-062-01),New,9/29/20,,,,,Oncology,To be Discontinued,9/29/20,9/29/20
5751,Erlotinib Hydrochloride Tablets,"Astellas Pharma Global Development, Inc.",800-727-7003,100 mg tablets (NDC 50242-063-01),New,9/29/20,,,,,Oncology,To be Discontinued,9/29/20,9/29/20
5752,Erlotinib Hydrochloride Tablets,"Astellas Pharma Global Development, Inc.",800-727-7003,150 mg tablets (NDC 50242-064-01),New,9/29/20,,,,,Oncology,To be Discontinued,9/29/20,9/29/20
5753,Erythromycin Ethylsuccinate Powder for Suspension,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",200 mg/5 mL  (NDC 0254-1020-47),New,2/8/21,,,,,Anti-Infective,To be Discontinued,2/8/21,2/8/21
5754,Erythromycin Ethylsuccinate Powder for Suspension,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",400 mg/5 mL (NDC 0254-1021-47),New,2/8/21,,,,,Anti-Infective,To be Discontinued,2/8/21,2/8/21
5755,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 3.5 g tube (NDC 17478-070-35),Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5756,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 1 g  tube (unit dose) (NDC17478-070-31),Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5757,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 3.5 g tube (NDC 17478-824-35)(Premier),Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5758,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 1 g  tube (unit dose) (NDC 17478-824-01)(Premier),Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5759,Erythromycin Ophthalmic Ointment,Bausch Health,800-321-4576,3.5 g in 1 Tube (NDC 24208-910-55),Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5760,Erythromycin Ophthalmic Ointment,Bausch Health,800-321-5676,1 g in cartons of 50 (NDC 24208-910-19),Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5761,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"1 gram, 50-count (NDC 00574-4024-50)",Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5762,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"3.5 gram, 1-count (NDC 00574-4024-35)",Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5763,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"3.5 gram, 24-count (NDC 00574-4024-39)",Revised,5/19/21,,,Available,,Ophthalmology,Resolved,5/19/21,
5764,Esomeprazole Sodium for Injection,"Mylan Institutional, a Viatris company",800-796-9526,"40 mg vial, box of 10 (NDC 67457-392-99)",New,9/16/21,,,,,Gastroenterology;Pediatric,To be Discontinued,9/16/21,9/16/21
5765,Estradiol (Alora) Patch,Allergan,800-678-1605,(NDC 0023-5885-12),New,3/24/21,,The company has made a business decision to discontinue the product.,,,Reproductive,To be Discontinued,3/24/21,3/24/21
5766,Estradiol (Alora) Patch,Allergan,800-678-1605,(NDC 0023-5886-15),New,3/24/21,,The company has made a business decision to discontinue the product.,,,Reproductive,To be Discontinued,3/24/21,3/24/21
5767,Estradiol (Alora) Patch,Allergan,800-678-1605,(NDC 0023-5887-17),New,3/24/21,,The company has made a business decision to discontinue the product.,,,Reproductive,To be Discontinued,3/24/21,3/24/21
5768,Estradiol (Alora) Patch,Allergan,800-678-1605,(NDC 0023-5888-11),New,3/24/21,,The company has made a business decision to discontinue the product.,,,Reproductive,To be Discontinued,3/24/21,3/24/21
5769,Ethacrynic Acid Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",25 mg/1 (NDC 49884-276-01),New,12/17/20,,Discontinued due to business reasons,,,Cardiovascular;Renal,To be Discontinued,12/17/20,12/17/20
5770,Ethambutol Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,400 mg  (NDC 0555-0923-02),New,9/28/20,,,,,Anti-Infective,To be Discontinued,9/28/20,9/28/20
5771,Ethambutol Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,400mg  (NDC 0555-0923-02),New,11/5/21,,,,,Anti-Infective,To be Discontinued,11/5/21,11/5/21
5772,Etomidate Injection,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,20 mg/10mL carton of 10 (NDC 23155-160-41),Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5773,Etomidate Injection,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,40 mg/20 mL carton of 10 (NDC 23155-160-42),Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5774,Etomidate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 10 mL vial (NDC 55150-221-10)",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5775,Etomidate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"40 mg/mL, 20 mL vial (NDC 55150-222-20)",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5776,Etomidate Injection,Gland Pharma Limited,833-291-9645,"2 mg/mL, 10 mL vial (NDC 72266-146-10)",Revised,4/22/21,,,Distributed by Fosun Pharma; Available,,Anesthesia,Resolved,4/22/21,4/22/21
5777,Etomidate Injection,Gland Pharma Limited,833-291-9645,"2 mg/mL, 20 mL vial (NDC 72266-147-10)",Revised,4/22/21,,,Distributed by Fosun Pharma; Available,,Anesthesia,Resolved,4/22/21,4/22/21
5778,Etomidate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 0143-9506-10)",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5779,Etomidate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9507-10)",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5780,Etomidate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 10 mL vial (NDC 0143-9310-10), Novaplus",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5781,Etomidate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9311-10), Novaplus",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5782,Etomidate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"2 mg/mL, 10 mL vial (NDC 67457-902-10)",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5783,Etomidate Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"2 mg/mL, 20 mL vial (NDC 67457-903-20)",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5784,Etomidate Injection,Pfizer Pharmaceuticals,800-533-4535,"Amidate, 2 mg/mL, 10 mL vial (NDC 0409-6695-01)",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5785,Etomidate Injection,Pfizer Pharmaceuticals,800-533-4535,"Amidate, 2 mg/mL, 20 mL vial (NDC 0409-6695-02)",Revised,4/22/21,,,Available,,Anesthesia,Resolved,4/22/21,
5786,Etoposide Injection,Accord Healthcare Inc.,866-941-7875,20mg/mL (NDC 16729-262-31),New,2/16/21,,Last lot of this NDC available in the market currently expires in October 2021.,,,Oncology,To be Discontinued,2/16/21,2/16/21
5787,Exenatide (BYDUREON) Extended Release for Injectable Suspension,AstraZeneca,800-236-9933,"BYDUREON® (exenatide extended-release) for injectable suspension, for subcutaneous use;  Single Dose Tray presentation; (2 mg) (NDC 0310-6520-04)",New,4/3/18,,"The planned permanent discontinuance of the Bydureon Single Dose Tray inventory from the U.S. market is September 30, 2018.  There are currently 2 other delivery options for exenatide-extended-release:  the Bydureon® Dual Chamber Pen presentation (NDC 0310-6530-04) and Bydureon® BCise™ (NDC 0310-6540-04).",,,Endocrinology/Metabolism,To be Discontinued,4/3/18,4/3/18
5788,Famotidine Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,"20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 70860-751-02 and 41)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5789,Famotidine Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,"200 mg per 20 mL(10 mg per mL), multiple dose vial with preservatives, (NDC 70860-751-20 and 41)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5790,Famotidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,Famotidine Injection (Solution in Single Dose Vials) [20 mg / 2 ml] 25PK (NDC 67457-433-22),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5791,Famotidine Injection,Baxter Healthcare,888-229-0001,"Famotidine Injection premix, 20mg/50 mL in GALAXY Plastic Container (NDC 0338-5197-41)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5792,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 2 mL vial (NDC 0641-6022-25)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5793,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 4 mL vial (NDC 0641-6023-25)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5794,Famotidine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 20 mL vial (NDC 0641-6021-10)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5795,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 63323-739-12)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5796,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mg per 4 mL (10 mg per mL), mutilple dose vial, (NDC 63323-738-09)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5797,Famotidine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL(10 mg per mL), multiple dose vial, (NDC 63323-738-20)",Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5798,Famotidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,Famotidine Injection (Solution in Multi Dose Vials : Containing Preservatives) [40 mg / 4 ml] 10PK (NDC 67457-448-43),Revisee,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5799,Famotidine Injection,"Mylan Institutional, a Viatris company",800-796-9526,Famotidine Injection (Solution in Multi Dose Vials : Containing Preservatives) [200 mg / 20 ml] 10PK (NDC 67457-457-20),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5800,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 100 Count (NDC 0172-5728-60),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5801,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 1000 Count (NDC 0172-5728-80),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5802,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,20 MG 500 Count (NDC 0172-5728-70),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5803,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,40 MG 100 Count (NDC 0172-5729-60),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5804,Famotidine Tablets,Teva Pharmaceuticals,800-545-8800,40 MG 500 Count (NDC 0172-5729-70),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5805,Famotidine Tablets,Aurobindo Pharma,732-839-9400,20 mg - 100/Bottle (NDC 65862-859-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5806,Famotidine Tablets,Aurobindo Pharma,732-839-9400,40 mg - 100/Bottle (NDC 65862-860-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5807,Famotidine Tablets,Alembic Pharmaceuticals,908-393-9604,20 mg Bottle of 100 counts (NDC 62332-001-31),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5808,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,20 mg Bottle of 1000 counts (NDC 62332-001-91),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5809,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 100 counts (NDC 62332-002-31),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5810,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 500 counts (NDC 62332-002-71),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5811,Famotidine Tablets,Alembic Pharmaceuticals,909-393-9604,40 mg Bottle of 1000 counts (NDC 62332-002-91),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5812,Famotidine Tablets,"Carlsbad Technology, Inc.",,20mg 100 count (NDC 61442-121-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5813,Famotidine Tablets,"Carlsbad Technology, Inc.",,20 mg 1000 count (NDC 61442-121-10),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5814,Famotidine Tablets,"Carlsbad Technology, Inc.",,40 mg 100 count (NDC 61442-122-01),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5815,Famotidine Tablets,"Carlsbad Technology, Inc.",,40 mg 1000 count (NDC 61442-122-10),Revised,11/10/21,,,Available,,Gastroenterology,Resolved,11/10/21,
5816,Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,40 mg (NDC 55111-796-30),New,11/22/21,,,,,Rheumatology,To be Discontinued,11/22/21,11/22/21
5817,Febuxostat Tablets,"Dr. Reddy's Laboratories, Inc.",866-732-3952,80 mg (NDC 55111-797-30),New,11/22/21,,,,,Rheumatology,To be Discontinued,11/22/21,11/22/21
5818,"Fenoldopam Mesylate (Corlopam) Injection, USP","Hospira, Inc.",844-646-4398,20 mg/2 mL (10 mg/mL); Glass Ampul (NDC 00409-2304-02),New,11/16/20,,"Discontinuation of the manufacture of the ampul, equivalent vial available.",,,Cardiovascular,To be Discontinued,11/16/20,11/16/20
5819,"Fenoldopam Mesylate (Corlopam) Injection, USP","Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Glass Ampul (NDC 00409-2304-01),New,11/16/20,,"Discontinuation of the manufacture of the ampul, equivalent vial available.",,,Cardiovascular,To be Discontinued,11/16/20,11/16/20
5820,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,50 mcg per 1 mL (50 mcg per mL) Single Dose Simplist PFS  (NDC 63323-808-11),Reverified,11/23/21,Available,Check wholesalers for inventory,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
5821,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 1 mL vial
(NDC 0641-6247-25)",New,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5822,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 mcg per 20 mL (50 mcg per mL) (0.05 mg per mL)  SDV (NDC 63323-806-20)",Reverified,11/23/21,Backordered. Next release January 2022.,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
5823,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2,500 mcg per 50 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-50)",Reverified,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
5824,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,50 mcg per 1 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-01),Reverified,11/23/21,Available,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
5825,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mcg per 2 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-02),Reverified,11/23/21,Backordered. Next release November 2021.,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
5826,Fentanyl Citrate (Sublimaze) Injection,"Fresenius Kabi USA, LLC",888-386-1300,250 mcg per 5 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-05),Reverified,11/23/21,Available,Check wholesalers for inventory.,,Increase in demand,Analgesia/Addiction;Pediatric,Current,,
5827,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1276-32),Revised,11/18/21,Next Delivery and Estimated Recovery: January 2023,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5828,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-32),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5829,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,250 mcg/5 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-35),Revised,11/18/21,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
5830,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,1000 mcg/20 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-38),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Pediatric,Current,,
5831,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-22),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: May 2022,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5832,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,250 mcg/5 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-25),Revised,11/18/21,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
5833,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,500 mcg/10 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-28),Revised,11/18/21,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
5834,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,"1,000 mcg/20 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-31)",Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: March 2022,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5835,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,"2,500 mcg/50 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-61)",Revised,11/18/21,Limited Supply Available. Next Delivery: December 2021; Estimated Recovery: May 2022,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5836,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 2 mL ampul (NDC 0641-6024-10),Revised,10/12/21,Currently not available,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5837,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 5 mL ampul (NDC 0641-6025-10),Revised,10/12/21,Currently not available,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5838,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL ampul (NDC 0641-6026-05),Revised,10/12/21,Currently not available,Inventory available in vial presentations.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5839,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 2 mL vial
(NDC 0641-6027-25)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5840,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 5 mL vial
(NDC 0641-6028-25)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5841,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL vial (NDC 0641-6029-25),Revised,10/12/21,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing and available in the November - December 2021 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5842,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL  50 mL vial
(NDC 0641-6030-01)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
5843,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule 10 pack (NDC 17478-0030-02),Revised,2/12/21,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
5844,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule; 25 pack (NDC 17478-0030-25),Revised,2/12/21,Discontinued,,,,Analgesia/Addiction;Pediatric,Current,,
5845,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 10 pack (NDC 17478-0030-05),Revised,2/12/21,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
5846,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,20 mL ampule (NDC 17478-0030-20),Revised,2/12/21,Discontinued,,,,Analgesia/Addiction;Pediatric,Current,,
5847,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 25 pack (NDC 17478-0030-55),Revised,2/12/21,Discontinued,,,,Analgesia/Addiction;Pediatric,Current,,
5848,Finasteride Tablets,Mylan Pharmaceuticals Inc.,800-RXMYLAN (1-800-796- 9526),5 mg tablet (NDC 0378-5036-05)(NDC 0378-5036-77)(NDC 0378-5036-93),New,5/23/18,,The discontinuation of this product is a business decision,,,Urology,To be Discontinued,5/23/18,5/23/18
5849,Finasteride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 30 CT (NDC 45963-500-30),New,9/18/20,,"Teva’s Finasteride 5 mg Tablets marketed under NDC 0093-7355-56, NDC 0093-7355-05 & NDC 0093-7355-98 are not affected by this discontinuation.",,,Urology,To be Discontinued,9/18/20,9/18/20
5850,Finasteride Tablets,Teva Pharmaceuticals,-,5 mg 90 CT (NDC 45963-500-08),New,9/18/20,,"Teva’s Finasteride 5 mg Tablets marketed under NDC 0093-7355-56, NDC 0093-7355-05 & NDC 0093-7355-98 are not affected by this discontinuation.",,,Urology,To be Discontinued,9/18/20,9/18/20
5851,Finasteride Tablets,Teva Pharmaceuticals,800-545-8800,"1mg tablet (NDC 45963-600-03, 45963-600-09)",New,9/18/20,,This product discontinuation is a business related decision.,,,Urology,To be Discontinued,9/18/20,9/18/20
5852,Finasteride Tablets,Teva Pharmaceuticals,800-545-8800,5mg tablet (NDC 45963-500-02),New,9/18/20,,This product discontinuation is a business related decision.,,,Urology,To be Discontinued,9/18/20,9/18/20
5853,Floxuridine for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9270-01),Revised,10/12/21,This presentation is temporarily on backorder.,,,Other,Oncology,Current,,
5854,"Floxuridine for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,500 mg per vial (NDC 63323-145-07_,New,9/30/20,,"Discontinued: May 30, 2019",,,Oncology,To be Discontinued,9/30/20,9/30/20
5855,Fludrocortisone Acetate Tablets,Teva Pharmaceuticals,800-545-8800,"0.1 mg, 100 count bottle (NDC 0555-0997-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
5856,Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 100 count bottle (NDC 0115-7033-01)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
5857,Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 500 count bottle (NDC 0115-7033-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
5858,Flumazenil Injection,Mylan,800-796-9526,"0.5 mg in 5 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-447-53)",New,12/16/19,,Expected Discontinuation April 2020,,,Analgesia/Addiction;Neurology;Pediatric,To be Discontinued,12/16/19,12/16/19
5859,Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-054-15),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5860,Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-054-30),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5861,Fluocinonide Gel 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-054-60),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5862,Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,15g (NDC 52565-040-15),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5863,Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,30g (NDC 52565-040-30),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5864,Fluocinonide Ointment 0.05%,"Teligent Pharma, Inc.",856-697-1441,60g (NDC 52565-040-60),New,6/21/21,,Discontinuation of the manufacture of the drug,,,,To be Discontinued,6/21/21,6/21/21
5865,Fluocinonide Topical Solution,Teva Pharmaceuticals,800-545-8800,0.5 mg/mL  (NDC 0472-0829-02),New,8/3/21,,,,,Dermatology,To be Discontinued,8/3/21,8/3/21
5866,Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 1.0 mg 100 sterile strips (NDC 17478-404-01),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,6/4/21,
5867,Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 0.6 mg 300 sterile strips (NDC 17478-403-03),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,6/4/21,
5868,Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 100 Strips per box (ndc 17238-900-11),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,6/4/21,
5869,Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 300 Strips per box (NDC 17238-900-30),Revised,6/4/21,,,Available,,Ophthalmology,Resolved,6/4/21,
5870,Fluorometholone Ophthalmic Ointment,Abbvie,800-678-1605,FML (flourometholone) Ointment 0.1% 1 TUBE in 1 CARTON  3.5 g in 1 TUBE (NDC 0023-0316-04),New,9/13/21,,Discontinuation of the manufacture of the drug,,,Ophthalmology,To be Discontinued,9/13/21,9/13/21
5871,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 100 count bottle (NDC 0781-2823-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
5872,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 1000 count bottle (NDC 0781-2823-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
5873,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 100 count bottle (NDC 0781-2822-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
5874,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 1000 count bottle (NDC 0781-2822-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
5875,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 100 count bottle (NDC 0781-2824-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
5876,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 1000 count bottle (NDC 0781-2824-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
5877,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 30 count bottle (NDC 0781-2824-31)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
5878,Fluoxetine Tablets,Allergan Pharmaceuticals International Limited,1-800-678-1605,"Fluoxetine (Sarafem) Tablets, 10 mg (NDC 0430-0210-14)",New,12/22/20,,Discontinued due to business reasons,,,Reproductive,To be Discontinued,12/22/20,12/22/20
5879,Fluoxetine Tablets,Allergan Pharmaceuticals International Limited,1-800-678-1605,"Fluoxetine (Sarafem) Tablets, 20 mg (NDC 0430-0220-14)",New,12/22/20,,Discontinued due to business reasons,,,Reproductive,To be Discontinued,12/22/20,12/22/20
5880,Fluticasone Inhalational Powder,GlaxoSmithKline,888-825-5249,"100 mcg, 28 blisters (NDC 0173-0602-00)",New,4/23/21,,This product discontinuation is a business-related decision. GSK has ceased distribution of this product. The 60-blister presentation will continue to be available.,,,Pulmonary/Allergy,To be Discontinued,4/23/21,4/23/21
5881,Fluticasone Inhalational Powder,GlaxoSmithKline,888-825-5249,"250 mcg, 28 blisters (NDC 0173-0601-00)",New,4/23/21,,This product discontinuation is a business-related decision. The anticipated date that GSK will cease distribution of the product is approximately July 2021. The 60-blister presentation will continue to be available.,,,Pulmonary/Allergy,To be Discontinued,4/23/21,4/23/21
5882,Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",100 mg. 30’s count (NDC 10370-175-11),Revised,1/15/21,Product available,,,Delay in shipping of the drug,Psychiatry,Current,,
5883,Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",150 mg. 30’s count (NDC 10370-176-11),Revised,1/15/21,On backorder. Estimated availability February 2021,,,Delay in shipping of the drug,Psychiatry,Current,,
5884,Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 100 mg Extended Release Capsules, 30 count (NDC 0228-2848-03)",Reverified,11/8/21,Product is available,,,Requirements related to complying with good manufacturing practices,Psychiatry,Current,,
5885,Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 150 mg Extended Release Capsules, 30 count (NDC 0228-2849-03)",Reverified,11/8/21,Available,,,Requirements related to complying with good manufacturing practices,Psychiatry,Current,,
5886,Fosphenytoin Sodium Injection,"Mylan Institutional, a Viatris company",800-796-9526,"100 mg/2 mL, package of 25 vials (NDC 67457-516-25)",New,9/3/21,,,,,Neurology;Pediatric,To be Discontinued,9/3/21,9/3/21
5887,Fosphenytoin Sodium Injection,"Mylan Institutional, a Viatris company",800-796-9526,"500 mg/10 mL, package of 10 vials (NDC 67457-517-01)",New,8/4/21,,,,,Neurology;Pediatric,To be Discontinued,8/4/21,8/4/21
5888,Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,20 mg/2mL vial (NDC 70860-302-41 and 70860-302-02),New,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
5889,Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,40 mg/4mL vial (NDC 70860-302-42 and 70860-302-04),New,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
5890,Furosemide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,100 mg/10mL vial (NDC 70860-302-43 and 70860-302-10),New,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,,Cardiovascular,Current,,
5891,Furosemide Injection,Gland Pharma Limited,866-625-1618,"2 mL in 1 vial, 25 vials/carton (NDC 25021-311-02)",Reverified,7/16/21,Available,Marketing partner: Sagent Pharmaceuticals,,Demand increase for the drug,Cardiovascular,Current,,
5892,Furosemide Injection,Gland Pharma Limited,866-625-1618,"4 mL in 1 vial, 25 vials/carton (NDC 25021-311-04)",Reverified,7/16/21,Available,Marketing partner: Sagent Pharmaceuticals,,Demand increase for the drug,Cardiovascular,Current,,
5893,Furosemide Injection,Gland Pharma Limited,866-625-1918,"10 mL in 1 vial, 25 vials/carton (NDC 25021-311-10)",Reverified,7/16/21,Available,Marketing partner: Sagent Pharmaceuticals,,Demand increase for the drug,Cardiovascular,Current,,
5894,Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,20 mg/2 mL single-dose vial (NDC 25021-311-02),Reverified,10/22/21,Available,,,,Cardiovascular,Current,,
5895,Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,40 mg/4 mL single-dose vial (NDC25021-311-04),Reverified,10/22/21,Available,,,,Cardiovascular,Current,,
5896,Furosemide Injection,Sagent Pharmaceuticals,866-625-1618,100 mg/10 mL single-dose vial (NDC 25021-311-10),Reverified,10/22/21,Available,,,,Cardiovascular,Current,,
5897,Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,
5898,Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04)",Reverified,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,
5899,Furosemide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Cardiovascular,Current,,
5900,Furosemide Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,20 mg/2 mL single-dose vial (NDC 55150-322-25),Reverified,11/5/21,"Currently on backorder, next shipment TBD",Check wholesalers for inventory,,Delay in shipping of the drug,Cardiovascular,Current,,
5901,Furosemide Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,40 mg/4 mL single-dose vial (NDC 55150-323-25),Reverified,11/5/21,Available,Check wholesalers for inventory,,Delay in shipping of the drug,Cardiovascular,Current,,
5902,Furosemide Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,100 mg/10 mL single-dose vial (NDC 55150-324-25),Reverified,11/5/21,Available,Check wholesalers for inventory,,Delay in shipping of the drug,Cardiovascular,Current,,
5903,Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 10 mL Single Dose Glass Vial (25 x 10 mL) (NDC 36000-284-25)",Reverified,11/23/21,Available,,,,Cardiovascular,Current,,
5904,Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 2 mL Single Dose Glass Vial (25 x 2 mL)(NDC 36000-282-25)",Reverified,11/23/21,Available,,,,Cardiovascular,Current,,
5905,Furosemide Injection,Baxter Healthcare,888-229-0001,"Furosemide Injection, USP, 10 mg/mL - 4 mL Single Dose Glass Vial (25 x 4 mL)(NDC 36000-283-25)",Reverified,11/23/21,Available,,,,Cardiovascular,Current,,
5906,Furosemide Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,20 mg/mL (NDC 23155-473-41),Reverified,10/13/21,Available,,,,Cardiovascular,Current,,
5907,Furosemide Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,40 mg/4mL (NDC 23155-473-42),Reverified,10/13/21,Available,,,,Cardiovascular,Current,,
5908,Furosemide Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,100 mg/10mL (NDC 23155-473-44),Reverified,10/13/21,Available,,,,Cardiovascular,Current,,
5909,Furosemide Injection,"Hospira, Inc.",844-646-4398,20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-02),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,Other,Cardiovascular,Current,,
5910,Furosemide Injection,"Hospira, Inc.",844-646-4398,40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-04),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Cardiovascular,Current,,
5911,Furosemide Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial (NDC 0409-6102-10),Revised,11/18/21,Available,,,Other,Cardiovascular,Current,,
5912,Furosemide Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL; Ansyr Plastic syringe (NDC 0409-1639-10),Revised,11/18/21,Limited Supply Available.,,,Demand increase for the drug,Cardiovascular,Current,,
5913,Furosemide Injection,"Hospira, Inc.",844-646-4398,40 mg/4 mL (10 mg/mL); Ansyr Plastic syringe (NDC 0409-9631-04),Revised,11/18/21,Limited Supply Available.,,,Demand increase for the drug,Cardiovascular,Current,,
5914,Furosemide Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,80mg (NDC 0378-0232-05),New,4/7/21,,,,,Cardiovascular,To be Discontinued,4/7/21,4/7/21
5915,Gemcitabine Hydrochloride Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"200 mg, single dose vial (NDC 67457-464-20)",New,6/26/20,,Expected discontinuation December 2020,,,Oncology,To be Discontinued,6/26/20,6/26/20
5916,Gemcitabine Hydrochloride Injection,Mylan Institutional,800-796-9526,"1 g, single dose vial (NDC 67457-462-01)",New,12/16/19,,Expected Discontinuation March/April 2020,,,Oncology,To be Discontinued,12/16/19,12/16/19
5917,Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 7 Tablets in 1 Blister Pack (NDC 44004-321-07)",Reverified,11/10/21,Estimated recovery to be determined.,License to manufacture and distribute FACTIVE is under legal dispute.,,Other,Anti-Infective,Current,,
5918,Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 5 Tablets in 1 Blister Pack (NDC 44004-321-05)",Reverified,11/10/21,Estimated recovery to be determined.,License to manufacture and distribute FACTIVE is under legal dispute.,,Other,Anti-Infective,Current,,
5919,Gentamicin Sulfate and Prednisolone Acetate Ophthalmic Ointment,Abbvie,800-678-1605,PRED-G- gentamicin sulfate 0.3% and prednisolone acetate 0.6% ointment 1 TUBE in 1 CARTON  3.5 g in 1 TUBE (NDC 0023-0066-04),New,9/13/21,,Discontinuation of the manufacture of the drug,,,Ophthalmology,To be Discontinued,9/13/21,9/13/21
5920,Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"80 mg per 2 mL (40 mg per mL), MDV, (NDC 63323-010-02)",Revised,11/23/21,Backordered. Next release January 2022.,Check wholesaler inventory,,Manufacturing delay,Anti-Infective,Current,,
5921,Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"800 mg per 20 mL (40 mg per mL), MDV, (NDC 63323-010-20)",Revised,11/23/21,Available,Check wholesaler inventory,,,Anti-Infective,Current,,
5922,Gentamicin Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per 2 mL (10 mg per mL), Pediatric SDV, (NDC 63323-173-02)",Revised,11/23/21,Available,Check wholesaler inventory,,Manufacturing delay,Anti-Infective,Current,,
5923,Gentamicin Sulfate Injection,"Hospira, Inc.",844-646-4398,80 mg/2 mL (40 mg/mL); 2 mL Single Dose Glass Fliptop Vial (NDC 00409-1207-03),Revised,11/18/21,Next Delivery: December 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Anti-Infective,Current,,
5924,Gentamicin Sulfate Injection,"Hospira, Inc.",844-646-4398,80 mg/2 mL (40 mg/mL) Single Dose Glass Fliptop Vial NovaPlus (NDC 00409-1207-25),Revised,11/18/21,Available,,,Other,Anti-Infective,Current,,
5925,Glipizide Tablets,Teva Pharmaceuticals,800-545-8800,"5mg tablets (NDC 0591-0460-10), (NDC 0591-0460-05), (NDC 0591-0460-01)",New,5/28/20,,"Teva had evaluated the market and made decision to discontinue the product. No inventory remains for Glipizide 5 mg tablets 100 count NDC: 0591-0460-01. For the remaining presentations, allocations are being made based on customer Rx trends.",,,Endocrinology/Metabolism,To be Discontinued,5/28/20,5/28/20
5926,Glipizide Tablets,Teva Pharmaceuticals,800-545-8800,"10mg tablets, (NDC 0591-0461-10), (NDC 0591-0461-01), (NDC 0591-0461-05)",New,5/28/20,,"Teva had evaluated the market and made decision to discontinue the product. No inventory remains for Glipizide 5 mg tablets 100 count NDC: 0591-0460-01. For the remaining presentations, allocations are being made based on customer Rx trends.",,,Endocrinology/Metabolism,To be Discontinued,5/28/20,5/28/20
5927,Guanfacine Hydrochloride Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,1 mg (NDC 0378-1160-01),Reverified,11/29/21,Unavailable,,,Other,Cardiovascular,Current,,
5928,Guanfacine Hydrochloride Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,2 mg (NDC 0378-1190-01),Reverified,11/29/21,Unavailable,,,Other,Cardiovascular,Current,,
5929,Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1mg tablets 100 count bottle (NDC 0591-0444-01),Revised,11/8/21,Available,,,,Cardiovascular,Current,,
5930,Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2 mg tablets 100 count bottle (NDC 0591-0453-01),Revised,11/8/21,On backorder,Recovery: December 2021,,,Cardiovascular,Current,,
5931,Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,1 mg bottles of 30 (NDC 65162-711-03); 1 mg bottles of 100 (NDC 65162-711-10),Reverified,8/17/20,Available,,,Other,Cardiovascular,Current,,
5932,Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,2 mg bottles of 30 (NDC 65162-713-03); 2 mg bottles of 100 (NDC 65162-713-10); 2 mg bottles of 500 (NDC 65162-713-50),Reverified,8/17/20,Available,,,Other,Cardiovascular,Current,,
5933,Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 1 mg, 100 Count (NDC 42806-048-01)",Reverified,2/23/21,Available,,,Other,Cardiovascular,Current,,
5934,Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 2 mg, 100 Count (NDC 42806-296-01)",Reverified,2/23/21,Available,,,Other,Cardiovascular,Current,,
5935,Guanidine Hydrochloride Tablets,Merck Sharp & Dohme Corp.,800-672-6372,125 mg tablets (NDC 0085-0492-01),New,9/28/20,,To be discontinued on or near October 2020.,,,Neurology,To be Discontinued,9/28/20,9/28/20
5936,Haloperidol Lactate (Haldol) Injection,"Janssen Biotech, Inc.",800-526-7736,"5 mg/mL, 10 ampule in 1 box, > 1 mL in 1 ampule, (NDC 50458-255-01)",New,11/13/20,,Product discontinuation as per business decision,,,Psychiatry,To be Discontinued,11/13/20,11/13/20
5937,Haloperidol Lactate Injection,Patriot Pharmaceuticals,215-325-7676,"5 mg/mL, 10 ampule in 1 box,> 1 mL in 1 ampule, (NDC 10147-0911-1)",New,11/13/20,,Product discontinuation as per business decision,,,Psychiatry,To be Discontinued,11/13/20,11/13/20
5938,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,0.5 mg (NDC 0378-0351-01) and (NDC 0378-0351-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5939,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-0257-01) and (NDC 0378-0257-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5940,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0214-01) and (NDC 0378-0214-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5941,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5 mg (NDC 0378-0327-01) and (NDC 0378-0327-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5942,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-0334-01),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5943,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg (NDC 0378-0355-01),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5944,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 100 CT (NDC 68382-079-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
5945,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 1000 CT (NDC 68382-079-10),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
5946,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 10MG 100 CT (NDC 68382-080-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
5947,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 20MG 100 CT (NDC 68382-081-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
5948,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-13-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5949,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-83-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5950,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count unit dose (NDC 0781-13-9113),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5951,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-13-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5952,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-83-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5953,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5954,Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0781-13-9801),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5955,Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5956,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-13-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5957,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-83-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5958,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-13-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5959,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-83-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5960,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count unit dose (NDC 0781-13-9613),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5961,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-13-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5962,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-83-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5963,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count unit dose (NDC 0781-13-9713),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5964,Haloperidol Tablets,Sandoz,800-525-8747,20 mg 100 count bottle (NDC 0781-83-9301),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
5965,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 2,000 USP units in 1000 mL.  Product code 2B0944  (NDC 0338-0433-04)",Revised,11/23/21,Available,,,Manufacturing Delay,Hematology,Current,,
5966,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 1,000 USP units in 500 mL.  Product code 2B0953 (NDC 0338-0431-03)",Revised,11/23/21,Unavailable,Product code 2B0953 was replaced with code AHB0953U,,Other,Hematology,Current,,
5967,Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc.",844-646-4398,"1,000 Units/500 mL (2 Units/mL); Flexible Container (NDC 00409-7620-03)",Reverified,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: April 2022,,,Demand increase for the drug,Hematology,Current,,
5968,Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc.",844-646-4398,"2,000 Units/1000 mL (2 Units/mL); Flexible Container (NDC 00409-7620-59)",Reverified,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Hematology,Current,,
5969,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection, 1,000 units / 500 mL (2 units / mL) in VIAFLEX Plastic Container.  Product code AHB0953U (NDC 0338-0424-18)",Revised,11/23/21,Available,Product code AHB0953U replaces code 2B0953,,,Hematology,Current,,
5970,Heparin Sodium and Sodium Chloride 0.9% Injection,Sagent Pharmaceuticals,866-625-1618,1000 units/mL 10mL pack 25 (NDC 25021-400-10),Revised,10/22/21,On backorder.,,,Demand increase for the drug,Hematology,Current,,
5971,Heparin Sodium and Sodium Chloride 0.9% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1,000 Units/500 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-77)",Revised,11/23/21,Available,Check wholesaler for inventory,,Other,Hematology,Current,,
5972,Heparin Sodium and Sodium Chloride 0.9% Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2,000 Units/1000 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-10)",Revised,11/23/21,Backordered. Next release January 2022.,Check wholesaler for inventory,,Other,Hematology,Current,,
5973,Histrelin Acetate Implant,"Endo Pharmaceuticals, Inc.",800-462-3636,Vantas 50 mg Implantation Kit (NDC 67979-500-01),Revised,9/21/21,,Endo has made a business decision to discontinue manufacture of this product.,,,Oncology,To be Discontinued,9/21/21,9/21/21
5974,Hydralazine Hydrochloride Injection,American Regent/Luitpold,800-645-1706,20mg/ml SDV ( NDC 0517 - 0901-25 ),Revised,6/29/21,,,Available,,Cardiovascular,Resolved,6/29/21,
5975,Hydralazine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mg per mL, SDV (NDC 63323-614-01)",Revised,6/29/21,,,Available,,Cardiovascular,Resolved,6/29/21,
5976,Hydralazine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"20 mg/mL, 1mL single dose vial  (box of 10) (NDC 17478-934-01)",Revised,6/29/21,,,,,Cardiovascular,Resolved,6/29/21,
5977,Hydralazine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"20 mg/mL, 1mL single dose vial  (box of 25) (NDC 17478-934-15)",Revised,6/29/21,,,,,Cardiovascular,Resolved,6/29/21,
5978,Hydralazine Hydrochloride Injection,"Mylan Institutional, a Viatris company",800-796-9526,20 mg / 1 ml] 25PK (NDC 67457-291-01),Revised,6/29/21,,,,,Cardiovascular,Resolved,6/29/21,
5979,Hydralazine Hydrochloride Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,20 mg/mL per vial (NDC 39822-0500-4),Revised,6/29/21,,,,,Cardiovascular,Resolved,6/29/21,
5980,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg/25 mg (NDC 0378-2025-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
5981,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,12.5 mg/ 20 mg (NDC 0378-2012-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
5982,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/ 12.5 mg (NDC 0378-1012-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
5983,Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution,Perrigo Pharmaceuticals,269-673-8451,Hydrocodone Bitartrate (5 mg/5 mL) and Homatropine Methylbromide (1.5 mg/5 mL)(NDC 0574-1105-16),New,6/5/18,,The discontinuation of this product is a business decision,,,Pediatric;Pulmonary/Allergy,To be Discontinued,6/5/18,6/5/18
5984,Hydrocodone/Homatropine Tablets,Lupin,866-587-4617,5/1.5 mg (NDC 43386-0118-03),New,12/28/20,,This discontinuation is a business decision. We have no plans to re-enter the market at this time.,,,Pulmonary/Allergy,To be Discontinued,12/28/20,12/28/20
5985,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 12 suppositories (NDC 59741-301-12),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
5986,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 24 suppositories (NDC 59741-301-24),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
5987,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 100 suppositories (NDC 59741-301-01),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
5988,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,5 mg tablet; bottle of 50 (NDC 59762-0073-1),Reverified,11/18/21,Available,,,Other,Endocrinology/Metabolism,Current,,
5989,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,10 mg tablet; bottle of 100 (NDC 59762-0074-1),Reverified,11/18/21,Available,,,Other,Endocrinology/Metabolism,Current,,
5990,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,20 mg tablet; bottle of 100 (NDC 59762-0075-1),Reverified,11/18/21,Available,,,Other,Endocrinology/Metabolism,Current,,
5991,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 20 mg tablet; bottle of 100 (NDC 0009-0044-01),Reverified,11/18/21,Available,,,Other,Endocrinology/Metabolism,Current,,
5992,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 5 mg tablet; bottle of 50 (NDC 0009-0012-01),Reverified,11/18/21,Available,,,Other,Endocrinology/Metabolism,Current,,
5993,Hydrocortisone Tablets,Pfizer Pharmaceuticals,800-533-4535,Cortef 10 mg tablet; bottle of 100 (NDC 0009-0031-01),Reverified,11/18/21,Available,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,
5994,Hydrocortisone Tablets,"Vensun Pharmaceuticals, Inc.",855-273-0146,"5 mg, 50 count bottles (NDC 64380-970-25)",Reverified,11/2/21,Available,,,,Endocrinology/Metabolism,Current,,
5995,Hydrocortisone Tablets,"Vensun Pharmaceuticals, Inc.",855-273-0146,"10 mg, 100 count bottles (NDC 64380-971-06)",Reverified,11/2/21,Available,,,,Endocrinology/Metabolism,Current,,
5996,Hydrocortisone Tablets,"Vensun Pharmaceuticals, Inc.",855-273-0146,"20 mg, 100 count bottles (NDC 64380-972-06)",Reverified,11/2/21,Available,,,,Endocrinology/Metabolism,Current,,
5997,Hydrocortisone Tablets,Amneal Pharmaceutical,866-525-7270,100mg/100 count (NDC 00115-1697-01),Reverified,5/24/21,Available,,,,Endocrinology/Metabolism,Current,,
5998,Hydrocortisone Tablets,Amneal Pharmaceutical,866-525-7270,20mg/100 count (NDC 00115-1700-01),Reverified,5/24/21,Available,,,,Endocrinology/Metabolism,Current,,
5999,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.2 mg per 1 mL, prefilled syringe, MicroVault packaging (NDC 76045-121-11)",Revised,11/23/21,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6000,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 2 mg per 1 mL, prefilled syringe, MicroVault packaging (NDC 76045-010-11)",Revised,11/23/21,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6001,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-06)                                                                                           Microvault",Revised,11/23/21,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6002,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-11)                                                                                                                                                                                     Microvault",Revised,11/23/21,Backordered. Next release November 2021.,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6003,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg per 1 mL, Single dose vial, (NDC 63323-852-25)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6004,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-853-25)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6005,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-854-10)",Revised,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6006,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-10)",Revised,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6007,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 5 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-15)",Revised,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6008,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-50)",Revised,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6009,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-05)",Revised,11/23/21,Check wholesalers for inventory,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6010,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-10)                                                                                                                                       Blister pack",Revised,11/23/21,Check wholesalers for inventory,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6011,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 2 mg per 1 mL, prefilled syringe (NDC 76045-010-10)",Revised,11/23/21,Backordered. Next release date not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6012,Hydromorphone Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 4 mg per 1 mL, prefilled syringe (NDC 76045-011-10)",Revised,11/23/21,Backordered. Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6013,Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,10 MG/1ML (NDC0703-0110-03),Reverified,11/8/21,Available,,,,Analgesia/Addiction,Current,,
6014,Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,10 MG/1ML (NDC 0703-0113-03),Reverified,11/8/21,Available,,,,Analgesia/Addiction,Current,,
6015,Hydromorphone Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,10 MG/1 ML (NDC 0703-0018-01),Reverified,11/8/21,Available,,,,Analgesia/Addiction,Current,,
6016,Hydromorphone Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 1 mL vial (NDC 0641-0121-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6017,Hydromorphone Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0641-2341-41)",Reverified,10/12/21,Inventory is currently available.,Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6018,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,0.5 mg/0.5 mL (1 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-05),Reverified,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
6019,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/1 mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-10),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6020,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1312-10),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6021,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1283-31),Reverified,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6022,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1312-30),Reverified,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
6023,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/1 mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1304-31),Reverified,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6024,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/mL); Glass Ampul (NDC 00409-2552-01),Reverified,11/18/21,Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6025,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Glass Ampul (NDC 00409-3356-01),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6026,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/1 mL (4 mg/mL); Glass Ampul (NDC 00409-2540-01),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6027,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3365-01),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6028,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-01),Reverified,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6029,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-05),Reverified,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6030,Hydromorphone Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-50),Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6031,Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 1 mL ampule, 10 count (NDC 17478-0540-01)",Reverified,5/19/21,Available,,,,Analgesia/Addiction,Current,,
6032,Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 5 mL ampule, 10 count (NDC 17478-0540-05)",Reverified,5/19/21,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6033,Hydromorphone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 50 mL vial, 10 count (NDC 17478-0540-50)",Reverified,5/19/21,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6034,Hydroxocobalamin Injection,SERB SA,,"Hydroxocobalamin Injection (Cyanokit) intravenous powder for solution for injection, 5 gram, vial, (NDC 11704-0370-01)",Reverified,11/12/21,Available,Product Is distributed by Meridian Medical Technologies.  Contact number: 1-800-638-8093,Other,Other,Endocrinology/Metabolism,Current,,
6035,Hydroxocobalamin Injection,Teva Pharmaceuticals,800-545-8800,"Hydroxocobalamin Injection 1000MCG/ML, 1X30ML(NDC 0591-2888-30)",Reverified,11/8/21,Available,,,Other,Endocrinology/Metabolism,Current,,
6036,Hydroxychloroquine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,"200 mg, 500 count bottle (NDC 0591-3041-05)",New,12/7/20,,Teva made a business decision to discontinue this product.,,,Anti-Infective;Rheumatology,To be Discontinued,12/7/20,12/7/20
6037,Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,Hydroxyprogesterone Caproate Injection USP 250 mg/1 mL single-dose vial (NDC 55150-309-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6038,Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,"Hydroxyprogesterone Caproate Injection USP 1,250 mg/5 mL multiple-dose vial (NDC 55150-310-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6039,Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,Hydroxyprogesterone Caproate Injection 250 mg/ 1 ml (NDC 71225-105-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6040,Hydroxyprogesterone Caproate Injection,American Regent/Luitpold,800-645-1706,"Hydroxyprogesterone Caproate Injection, USP 250mg/mL 1mL Single Dose Vial (NDC 0517-1767-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6041,Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,"Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml (NDC 71225-104-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6042,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single dose auto-injector 1.1mL for subcutaneous injection: (NDC 64011-247-02),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6043,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6044,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Multi-dose vial 5mL for intramuscular injection: (NDC 64011-243-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6045,Hydroxyprogesterone Caproate Injection,Prasco Laboratories,866-525-0688,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
6046,Hydroxypropyl (Lacrisert) Cellulose Ophthalmic Insert,"Bausch Health Americas, Inc.",800-321-4576,"Lacrisert, 5 mg per ophthalmic insert, 60 unit dose blister pack (NDC 24208-800-60)",Revised,9/8/21,"Unavailable, Resupply expected February 2022",,,Other,Ophthalmology,Current,,
6047,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,100 mg 100 count (NDC 0555-0324-02),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6048,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 100 count (NDC 0555-0323-02),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6049,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 500 count (NDC 0555-0323-04),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6050,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 100 count (NDC 0555-0302-02),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6051,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 500 count (NDC 0555-0302-04),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6052,Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 100 count (NDC 0185-0674-01),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6053,Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 500 count (NDC 0185-0674-05),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6054,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 100ct (NDC 00115-1803-01),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6055,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 500ct (NDC 00115-1803-02),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6056,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 100ct (NDC 00115-1804-01),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6057,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 500ct (NDC 00115-1804-02),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6058,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 100 count (NDC 14539-674-01),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6059,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 500 count (NDC 14539-674-05),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6060,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 100 count (NDC 14539-675-01),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6061,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 500 count (NDC 14539-675-05),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6062,Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 25 mg Capsules; 100 count bottle (NDC 0069-5410-66),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6063,Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 50 mg Capsules; 100 count bottle (NDC 0069-5420-66),Revised,2/17/21,,,,,Psychiatry,Resolved,2/17/21,
6064,Imipenem and Cilastatin for Injection,Merck Sharp & Dohme Corp.,800-672-6372,500 mg  imipenem  equivalent  and  500 mg  cilastatin  equivalent  and  20 mg  sodium bicarbonate as a buffer in trays of 25 vials (NDC 0006-3516-59),Reverified,11/15/21,Product is available,"For additional information, please contact: Merck National Service Center at 1-800-672-6372",,Demand increase for the drug,Anti-Infective,Current,,
6065,Imipenem and Cilastatin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"250 mg/250 mg per vial, single dose vial, sterile powder (NDC 63323-349-25)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Delay in shipping of the drug,Anti-Infective,Current,,
6066,Imipenem and Cilastatin for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg/500 mg per vial, single dose vial, sterile powder (NDC  63323-322-25)",Reverified,11/23/21,Available,Check wholesaler for inventory,,Delay in shipping of the drug,Anti-Infective,Current,,
6067,Indinavir (CRIXIVAN) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,200 mg capsules (NDC 0006-0571-43),New,9/21/20,,,,,Antiviral,To be Discontinued,9/21/20,9/21/20
6068,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 100s (NDC 0378-0143-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6069,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 1000s (NDC 0378-0143-10)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6070,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100s (NDC 0378-0147-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6071,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 500s (NDC 0378-0147-05)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6072,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent (NDC 0085-4350-01)",New,4/23/21,,To be discontinued on or near March 2022,,,Antiviral,To be Discontinued,4/23/21,4/23/21
6073,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent (NDC 0085-4351-01)",New,4/23/21,,To be discontinued on or near March 2022,,,Antiviral,To be Discontinued,4/23/21,4/23/21
6074,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Powder for Injection (Interferon alfa-2b), 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01)",New,4/23/21,,To be discontinued on or near March 2022,,,Antiviral,To be Discontinued,4/23/21,4/23/21
6075,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Solution for Injection (Interferon alfa-2b), 18 million IU multidose vial (22.8 million IU per 3.8 mL per vial); boxes containing 1 vial of INTRON A Solution for Injection (NDC 0085-1168-01)",New,4/23/21,,To be discontinued on or near July 2021,,,Antiviral,To be Discontinued,4/23/21,4/23/21
6076,"Interferon alfa-2b, Recombinant for Injection",Merck Sharp & Dohme Corp.,800-672-6372,"INTRON A Solution for Injection (Interferon alfa-2b), 25 million IU multidose vial (32 million IU per 3.2 mL per vial); boxes containing 1 vial of INTRON A Solution for Injection (NDC 0085-1133-01)",New,4/23/21,,To be discontinued on or near June 2021,,,Antiviral,To be Discontinued,4/23/21,4/23/21
6077,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 41% (Isovue 200), 10x50mL vial, (NDC 0270-1314-30)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6078,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 41% (Isovue 200M), 10x20mL vial, (NDC 0270-1411-25)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6079,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250),  10x150mL bottle, (NDC 0270-1317-09)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6080,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250),  10x50mL bottle, (NDC 0270-1317-05)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6081,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 51% (IsoVue 250 PBP),  10x200mL bottle, (NDC 0270-1317-41)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6082,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300), 10x75mL bottle, (NDC 0270-1315-47)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6083,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300 PBP), 6x500mL bottle, (NDC 0270-1315-98)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6084,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 61% (IsoVue 300 PBP), 10x200mL bottle, (NDC 0270-1315-41)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6085,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 76% (IsoVue 370 PBP), 6x500mL bottle, (NDC 0270-1316-98)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6086,Iopamidol (Isovue) Injection,Bracco Diagnostics,877-272-2269,"Iopamidol Injection 76% (IsoVue 370 PBP), 10x200mL bottle, (NDC 0270-1316-41)",New,7/1/21,,Bracco continues to manufacture/provide customers with a variety of ISOVUE products.,,,Medical Imaging,To be Discontinued,7/1/21,7/1/21
6087,Ipratropium Bromide Inhalation Solution,Teva Pharmaceuticals,800-545-8800,"0.5 mg/2.5 mL  (NDCs 0591-3798-30, 0591-3798-60, and 0591-3798-83)",New,12/15/20,,,,,Pulmonary/Allergy,To be Discontinued,12/15/20,12/15/20
6088,Isoniazid Injection,Sandoz,800-525-8747,10 mL (100 mg/mL) Multiple dose vial (NDC 0781-3056-70),Reverified,11/16/21,Unavailable. Estimated recovery: TBD,,,Requirements related to complying with good manufacturing practices,Anti-Infective,Current,,
6089,Isoniazid Tablets,Teva Pharmaceuticals,800-545-8800,300 mg 1000 count (NDC 0555-0071-05),New,10/27/20,,Teva made a business decision to discontinue the 1000 count presentation. The other presentations of Isoniazid Tablets product remain active.,,,Anti-Infective,To be Discontinued,10/27/20,10/27/20
6090,Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg/mL, 5 mL vial (NDC 0143-9509-10)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,,Anesthesia,Current,,
6091,Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 10 mL vial (NDC 0143-9508-10)",Revised,10/12/21,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing in the October - November 2021 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
6092,Ketamine Injection,Par Pharmaceutical,201-802-4000,"10 mg/mL, 20 mL MDV (NDC 42023-113-10)",Revised,7/7/21,Product Available – Please Check Wholesalers for Availability,,,,Anesthesia,Current,,
6093,Ketamine Injection,Par Pharmaceutical,201-802-4000,"100 mg/mL, 5 mL MDV (NDC 42023-115-10)",Revised,7/7/21,Product Available – Please Check Wholesalers for Availability,,,,Anesthesia,Current,,
6094,Ketamine Injection,Par Pharmaceutical,201-802-4000,"50 mg/mL, 10 mL MDV (NDC 42023-114-10)",Revised,7/7/21,Product Available – Please Check Wholesalers for Availability,,,Demand increase for the drug,Anesthesia,Current,,
6095,Ketamine Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,200 mg / 20 mL (NDC 67457-181-20),Reverified,11/5/21,Available,Mylan label; Sporadic availability expected.,,,Anesthesia,Current,,
6096,Ketamine Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,500 mg / 10 mL (NDC 67457-001-10),Reverified,11/5/21,Currently on backorder - next shipment anticipated in November,Sporadic availability expected.,,,Anesthesia,Current,,
6097,Ketamine Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1000 mg / 10 mL (NDC 67457-108-10),Reverified,11/5/21,Currently on backorder - next shipment anticipated in November,Mylan label; Sporadic availability expected.,,,Anesthesia,Current,,
6098,Ketamine Injection,"Hospira, Inc.",844-646-4398,500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05),Revised,11/18/21,Limited Supply Available. Next Delivery: April 2022; Estimated Recovery: August 2022,,,Demand increase for the drug,Anesthesia,Current,,
6099,Ketamine Injection,"Hospira, Inc.",844-646-4398,500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10),Revised,11/18/21,Next Delivery and Estimated Recovery: February 2023,,,Demand increase for the drug,Anesthesia,Current,,
6100,Ketoprofen Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"200 mg Extended-Release Capsules, bottle of 100 (NDC 0378-8200-01)",Reverified,11/29/21,Available,,,Other,Analgesia/Addiction;Rheumatology,Current,12/23/16,
6101,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0093-3193-01)",Reverified,11/8/21,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
6102,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"75 mg, 100 count bottle (NDC 0093-3195-01)",Reverified,11/8/21,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
6103,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"75 mg, 500 count bottle (NDC 0093-3195-05)",Reverified,11/8/21,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
6104,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 23155-020-10)",New,11/25/19,,Avet is no longer marketing the 25 mg strength,,,Analgesia/Addiction;Rheumatology,To be Discontinued,11/25/19,11/25/19
6105,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 69336-127-10)",Revised,1/19/21,Available,"Marketed by Sterling Knight Pharmaceuticals, LLC. Contact information: 662-661-3232.",,,Analgesia/Addiction;Rheumatology,Current,,
6106,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 69336-127-11)",Revised,1/19/21,Available,"Marketed by Sterling Knight Pharmaceuticals, LLC. Contact information: 662-661-3232.",,,Analgesia/Addiction;Rheumatology,Current,,
6107,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 23155-020-01)",Revised,1/19/21,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
6108,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 23155-020-10)",Revised,1/19/21,Unavailable - Discontinuation of the manufacture of the drug,,,,Analgesia/Addiction;Rheumatology,Current,,
6109,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 23155-020-01)",New,11/25/19,,Avet is no longer marketing the 25 mg strength,,,Analgesia/Addiction;Rheumatology,To be Discontinued,11/25/19,11/25/19
6110,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"50 mg, 100 count bottle (NDC 23155-021-01)",Revised,1/19/21,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
6111,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"75 mg, 100 count bottle (NDC 23155-022-01)",Revised,1/19/21,Available,,,,Analgesia/Addiction;Rheumatology,Current,,
6112,Ketorolac Tromethamine Injection,Gland Pharma Limited,609-250-7990,"30 mg/mL, 1 mL vial (NDC 72266-118-25)",Reverified,11/5/21,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Demand increase for the drug,Analgesia/Addiction,Current,,
6113,Ketorolac Tromethamine Injection,Gland Pharma Limited,609-250-7990,"30 mg/mL, 2 mL vial (NDC 72266-119-25)",Reverified,11/5/21,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Analgesia/Addiction,Current,,
6114,Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 30 mg/ mL.  Single dose glass flip top vial - 25 units per carton (NDC 0338-0072-25)",Reverified,11/23/21,Limited Supply,FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container),,Demand increase for the drug,Analgesia/Addiction,Current,,
6115,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"15 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-107-10)",Revised,11/23/21,Backordered. Next release January 2022.,Check wholesaler for inventory,,,Analgesia/Addiction,Current,,
6116,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose, Simplist Syringe, (NDC 76045-104-10)",Revised,11/23/21,Available,Check wholesaler for inventory,,,Analgesia/Addiction,Current,,
6117,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"60 mg per 2 mL, Single Dose, Simplist Syringe, (NDC 76045-105-20)",Revised,11/23/21,Available,Check wholesaler for inventory,,,Analgesia/Addiction,Current,,
6118,Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 15 mg/mL. Single dose glass flip top vial. 10 units per carton (NDC 0338-0069-10)",Reverified,11/23/21,Limited Supply,FOR INTRAVENOUS AND INTRAMUSCULAR USE. 15 mg/mL (1 mL fill volume/ 2 mL container),,,Analgesia/Addiction,Current,,
6119,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"15 mg/mL, 1 mL vial (NDC 0641-6041-25)",Reverified,10/12/21,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
6120,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 1 mL vial (NDC 0641-6042-25)",Reverified,10/12/21,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
6121,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 2 mL vial (NDC 0641-6043-25)",Reverified,10/12/21,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
6122,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,15 mg/mL vial (NDC 70860-700-01 and 70860-700-02),Reverified,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Demand increase for the drug,Analgesia/Addiction,Current,,
6123,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,30 mg/mL vial (NDC 70860-701-01 and 70860-701-03),Reverified,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Demand increase for the drug,Analgesia/Addiction,Current,,
6124,Ketorolac Tromethamine Injection,Gland Pharma Limited,855-273-0154,60 mg/mL vial (NDC 70860-701-02 and 70860-701-04),Reverified,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Demand increase for the drug,Analgesia/Addiction,Current,,
6125,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 15MG/ML 25X1ML (NDC 25021-700-01),Reverified,10/22/21,Backordered. Estimated availability TBD,,,Manufacturing delays,Analgesia/Addiction,Current,,
6126,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X2ML (NDC 25021-701-02),Reverified,10/22/21,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,
6127,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X1ML (NDC 25021-701-01),Reverified,10/22/21,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,
6128,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-2287-23),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6129,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-31),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6130,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,60 mg/2 mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-61),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6131,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,15 mg/mL (15 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3793-01),Reverified,11/18/21,Next Delivery: December 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6132,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3795-01),Reverified,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6133,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,60 mg/2 mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3796-01),Reverified,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6134,Ketorolac Tromethamine Injection,Virtus Pharmaceuticals,888-843-3593,30MG/ML (NDC 69543-0386-25),New,3/26/18,Available,,,Other,Analgesia/Addiction,Current,,
6135,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"15 mg per mL, Single Dose Amber Vial, (NDC 63323-161-01)",Revised,11/23/21,Backordered. Next release not available at this time.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
6136,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-01)",Revised,11/23/21,Backordered.  Next release December 2021.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
6137,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-02)",Revised,11/23/21,Backordered.  Next release December 2021.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
6138,Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection,Sun Pharmaceutical Industries Inc.,800-221-7554,5 Vial Kit (NDC 45567-0030-1),Revised,11/16/21,Currently unavailable. Distribution is anticipated in late December 2021 to early January 2022.,Issues that led the shortage have been addressed but the timing for complete market recovery is unknown at this time.,,Other,Medical Imaging,Current,,
6139,Lamivudine and Tenofovir Disoproxil Fumarate Tablets,"Celltrion, Inc.",201-988-4615,300 mg; 300 mg (NDC 72606-002-01),New,9/1/21,,,,,Antiviral,To be Discontinued,9/1/21,9/1/21
6140,Lamivudine and Zidovudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine and Zidovudine Tablets 150mg and 300mg (NDC 0378-5180-91),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
6141,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 100mg (NDC 0378-5168-93),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
6142,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 150mg (NDC 0378-5169-91),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
6143,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 300mg (NDC 0378-5170-93),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
6144,Lanoxin (digoxin) Tablets,Concordia Pharmaceuticals Inc.,866-243-5382,Lanoxin (digoxin) 187.5 mcg (0.1875 mg) tablets; 100-count bottles (NDC 59212-245-55),New,5/22/18,,"A business decision was made to discontinue manufacture and supply of the Lanoxin 187.5 mcg (0.1875 mg) strength tablets.  All existing lots on the market are good through expiry. The anticipated final date of availability for sale is June 30, 2018 (NDC 59212-245-55).",,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
6145,Letermovir (Prevymis) Injection,Merck Sharp & Dohme Corp.,800-672-6372,480 mg injection (NDC 0006-5004-01),Revised,9/14/21,,,Available,,Antiviral,Resolved,9/14/21,9/14/21
6146,Letermovir (Prevymis) Injection,Merck Sharp & Dohme Corp.,800-672-6372,240 mg injection (NDC 0006-5003-01),Revised,9/14/21,,,Available,,Antiviral,Resolved,9/14/21,9/14/21
6147,Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,"100mg/vial, 20mL (NDC 0703-5140-01)",Reverified,11/8/21,Backordered – Estimated date of availability TBD,,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
6148,Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,350mg/vial 30mL (NDC 0703-5145-01),Reverified,11/8/21,Backordered – Estimated date of availability TBD,,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
6149,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mg SDV (NDC 63323-710-50),Revised,11/23/21,Available,Check Wholesaler Inventory,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
6150,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,500 mg SDV (NDC 63323-711-00),Revised,11/23/21,Backordered. Next release December 2021.,Check Wholesaler Inventory,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
6151,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,50 mg vial (NDC 25021-813-10),Revised,10/22/21,Backordered. Estimated availability December 2021,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
6152,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,100mg vial (NDC 25021-814-30),Revised,10/22/21,Available,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
6153,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,200mg vial (NDC 25021-815-30),Revised,10/22/21,Available.,,,,Oncology;Pediatric,Current,9/25/13,
6154,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,350mg vial (NDC 25021-816-30),Revised,10/22/21,Available.,,,,Oncology;Pediatric,Current,9/25/13,
6155,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,500mg vial (NDC 25021-828-50),Revised,10/22/21,Available,,,Manufacturing delay,Oncology;Pediatric,Current,,
6156,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg, 10 mL vial (NDC 0143-9555-01)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
6157,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg, 20 mL vial (NDC 0143-9554-01)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
6158,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"200 mg, 30 mL vial (NDC 0143-9553-01)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
6159,Leucovorin Calcium Lyophilized Powder for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"350 mg, 50 mL vial (NDC 0143-9552-01)",Revised,10/12/21,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing in the October - November 2021 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
6160,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-10)",Revised,11/23/21,Backordered. Next release January 2022.,Check Wholesaler Inventory,,Manufacturing Delay,Oncology;Pediatric,Current,,
6161,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-50)",Revised,11/23/21,Backordered. Next release January 2022.,Check Wholesaler Inventory,,Manufacturing Delay,Oncology;Pediatric,Current,,
6162,Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,100 mg vial (NDC 67457-528-10),Reverified,11/29/21,Intermittent Supply,,,Demand increase for the drug,Oncology;Pediatric,Current,,
6163,Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,200 mg vial (NDC 67457-529-20),Reverified,11/29/21,Intermittent Supply,,,Demand increase for the drug,Oncology;Pediatric,Current,,
6164,Leucovorin Calcium Lyophilized Powder for Injection,"Mylan Institutional, a Viatris company",800-796-9526,350 mg vial (NDC 67457-530-35),Reverified,11/29/21,Intermittent Supply,,,Demand increase for the drug,Oncology;Pediatric,Current,,
6165,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-4273,Eligard 22.5 mg (NDC 62935-223-05),Reverified,7/29/21,Available,Call customer service: 1-877-ELIGARD,,,Endocrinology/Metabolism;Oncology,Current,,
6166,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-4273,Eligard 30 mg (NDC 62935-303-30),Reverified,7/29/21,Available,Call customer service: 1-877-ELIGARD,,,Endocrinology/Metabolism;Oncology,Current,,
6167,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Eligard 45 mg (NDC 62935-453-45),Reverified,7/29/21,Available,Call customer service: 1-877-ELIGARD,,,Endocrinology/Metabolism;Oncology,Current,,
6168,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Fensolvi 45 mg (NDC 62935-153-50),Reverified,7/29/21,Available,Call customer service: 1-888-FENSOLVI,,,Endocrinology/Metabolism;Oncology,Current,,
6169,Leuprolide Acetate Injection,"Tolmar Pharmaceuticals, Inc.",877-354-2473,Eligard 7.5 mg Kit (NDC 62935-753-75),Reverified,7/29/21,Available,Call customer service: 1-877-ELIGARD,,,Endocrinology/Metabolism;Oncology,Current,,
6170,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 3 Months, 30mg (NDC 0074-9694-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6171,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 3 Months 22.5 mg PDS Kit (NDC 0074-3346-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6172,Leuprolide Acetate Injection,Abbvie,800-621-1020,Lupron Depot 6 Months 45mg PDS Kit (NDC 0074-3473-03),Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6173,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 1 Month 7.5 mg PDS Kit (NDC 0074-3642-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6174,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 4 Months 30 mg PDS Kit (NDC 0074-3683-03)",Revised,11/8/21,Not Available; Next replenishment anticipated January 2022,,,Other,Endocrinology/Metabolism;Oncology,Current,,
6175,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 1 Month 3.75 mg PDS Kit (NDC 0074-3641-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6176,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot, 3 Months 11.25 mg PDS Kit (NDC 0074-3663-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6177,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 11.25 mg PDS Kit (NDC 0074-2282-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6178,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 15 mg PDS Kit (NDC 0074-2440-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6179,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 1 Month 7.5 mg PDS Kit (NDC 0074-2108-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6180,Leuprolide Acetate Injection,Abbvie,800-621-1020,"Lupron Depot PED, 3 Months, 11.25mg (NDC 0074-3779-03)",Revised,11/8/21,Available,,,,Endocrinology/Metabolism;Oncology,Current,,
6181,"Levetiracetam Extended-Release Oral Tablets, USP",Apotex Corp.,800-706-5575,Levetiracetam Extended-Release Tablets 500 mg (60 ct. bottle)(NDC 60505-3280-06),Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6182,"Levetiracetam Extended-Release Oral Tablets, USP",Apotex Corp.,800-706-5575,Levetiracetam Extended-Release Tablets 750 mg (60 ct. bottle)(NDC 60505-3517-06),Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6183,"Levetiracetam Extended-Release Oral Tablets, USP",Sun Pharmaceutical Industries Inc.,800-818-4555,500mg tablet 60 count bottle (NDC 4733557386),Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6184,"Levetiracetam Extended-Release Oral Tablets, USP",Sun Pharmaceutical Industries Inc.,800-818-4555,750mg tablet 60 count bottle (NDC 4733557686),Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6185,"Levetiracetam Extended-Release Oral Tablets, USP",Lupin,866-587-4617,500mg  60 count bottle (NDC 68180-117-07),Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6186,"Levetiracetam Extended-Release Oral Tablets, USP",Lupin,866-587-4617,750mg 60 count bottle (NDC 68180-118-07),Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6187,"Levetiracetam Extended-Release Oral Tablets, USP",UCB Inc.,844-599-2273,500mg extended-release (NDC 50474-598-66),Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6188,"Levetiracetam Extended-Release Oral Tablets, USP",UCB Inc.,844-599-2273,750mg extended-release (NDC 50474-599-66),Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6189,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 500mg, 60’s (NDC 43547-0345-06)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6190,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 500mg, 500’s (NDC 43547-0345-50)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6191,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 750mg, 60’s (NDC 43547-0346-06)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6192,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 750mg, 500’s (NDC 43547-0346-50)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6193,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,844-599-2273,"250MG, (NDC 50474-594-40)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6194,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,844-599-2273,"500MG, (NDC 50474-595-40)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6195,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,844-599-2273,"750MG, (NDC 50474-596-40)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6196,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,844-599-2273,"1000MG, (NDC 50474-597-66)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6197,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"250mg, 120 count (NDC 65862024508)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6198,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"500mg , 120 count (NDC 65862024608)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6199,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"1000mg, 60 count (NDC 65862031560)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6200,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"750mg, 120 count (NDC 65862024708)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6201,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 90 Count Bottes (68180-112-09)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6202,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 120 Count Bottes (68180-112-16)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6203,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 500 Count Bottes (68180-112-02)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6204,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 90 Count Bottes (68180-113-09)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6205,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 90 Count Bottes (68180-114-09)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6206,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 500 Count Bottes (68180-114-02)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6207,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 120 Count Bottes (68180-113-16)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6208,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 500 Count Bottes (68180-113-02)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6209,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 120 Count Bottes (68180-114-16)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6210,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 1000 mg – 60 Count Bottes (68180-115-07)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6211,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"250mg, 120 count (NDC 31722053612)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6212,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"250mg, 500 count (NDC 31722053605)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6213,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"500mg, 120 count (NDC 31722053712)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6214,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"500mg, 500 count (NDC 31722053705)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6215,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"750mg, 120 count (NDC 31722053812)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6216,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"750mg, 500 count (NDC 31722053805)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6217,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 250mg – 120’s (NDC 43547-0221-15)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6218,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 500mg – 120’s (NDC 43547-0222-15)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6219,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 500mg – 1000’s (NDC 43547-0222-11)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6220,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 750mg – 120’s (NDC 43547-0223-15)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6221,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 1000mg – 60’s (NDC 43547-0224-06)",Revised,3/16/21,,,Long-term backorder for all skus. No estimated release date at this time.,,Neurology,Resolved,3/16/21,
6222,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 250 mg, 120 count (NDC 0378-5613-78)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6223,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 250 mg, 500 count (NDC 0378-5613-05)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6224,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 500 mg, 500 count (NDC 0378-5615-05)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6225,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 500 mg, 120 count (NDC 0378-5615-78)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6226,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 750 mg, 120 count (NDC 0378-5617-78)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6227,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 750 mg, 500 count (NDC 0378-5617-05)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6228,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 1000 mg, 60 count (NDC 0378-5619-91)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6229,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"250mg, 120 count bottle (NDC 13668-014-12)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6230,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"500mg, 120 count bottle (NDC 13668-015-12)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6231,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"750 mg, 120 count bottle (NDC 13668-016-12)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6232,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"750 mg, 500 count bottle (NDC 13668-016-05)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6233,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"1000 mg, 60 count bottle (NDC 13668-017-60)",Revised,3/16/21,,,,,Neurology,Resolved,3/16/21,
6234,Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 5 mL (NDC 0591-3012-26)",New,4/27/18,,This was a business-related decision to discontinue manufacturing these products,,,Anesthesia,To be Discontinued,4/27/18,4/27/18
6235,Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 30 mL (NDC 0591-3012-30)",New,4/27/18,,This was a business-related decision to discontinue manufacturing these products,,,Anesthesia,To be Discontinued,4/27/18,4/27/18
6236,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/500 mL (4mg/mL) in VIAFLEX Plus container. Product code 2B0973 (NDC 0338-0409-03)",Reverified,11/23/21,Available,,,Demand increase for the drug,Cardiovascular,Current,,
6237,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/250 mL (8mg/mL) in VIAFLEX Plus container. Product code 2B0962 (NDC 0338-0411-02)",Reverified,11/23/21,Available,,,,Cardiovascular,Current,,
6238,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.8% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5982 (NDC 00264-9598-20),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,
6239,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5942 (NDC 00264-9594-20),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,
6240,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 500mL Excel Plastic container P5941 (NDC 00264-9594-10),Reverified,5/6/21,Product available,,,Other,Cardiovascular,Current,,
6241,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 2 mL Ampoule (NDC 55150-158-72),Revised,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6242,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 5 mL Ampoule (NDC 55150-159-74),Revised,11/5/21,Available,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6243,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 2 mL Ampoule (NDC 55150-160-72),Revised,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6244,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 2 mL Single Dose Vial (NDC 55150-161-02),Revised,11/5/21,Currently on backorder - next shipment anticipated early Nov,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6245,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 5 mL Single Dose Vial (NDC 55150-162-05),Revised,11/5/21,Currently on backorder - next shipment anticipated in November,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6246,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 30 mL Single Dose Vial (NDC 55150-163-30),Revised,11/5/21,Available,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6247,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 2 mL Single Dose Vial (NDC 55150-164-02),Revised,11/5/21,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6248,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 5 mL Single Dose Vial (NDC 55150-165-05),Revised,11/5/21,Available,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6249,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57)",Reverified,11/23/21,Not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6250,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6251,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02)",Reverified,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6252,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10)",Reverified,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6253,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27)",Reverified,11/23/21,Backordered. Next release November 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6254,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57)",Reverified,11/23/21,Backordered. Next release November 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6255,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6256,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80)",Reverified,11/23/21,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6257,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89)",Reverified,11/23/21,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6258,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57)",Reverified,11/23/21,Backordered. Next release November 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6259,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6260,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); Ansyr Plastic Syringe (NDC 0409-9137-05),Revised,11/18/21,Available,,,Other,Anesthesia;Pediatric,Current,,
6261,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,20 mg/2 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-32),Revised,11/18/21,Available,,,Other,Anesthesia;Pediatric,Current,,
6262,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"200 mg/20 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-01, pack of 25; NDC 0409-4276-16, individual)",Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: October 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6263,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,300 mg/30 mL (1%; 10 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4279-02),Revised,11/18/21,Next Delivery: March 2022; Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6264,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"500 mg/50 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-02; NDC 0409-4276-17, individual)",Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: April 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6265,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,40 mg/2 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-01),Revised,11/18/21,Next Delivery: May 2022; Estimated Recovery: June 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6266,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-02),Revised,11/18/21,Next Delivery: January 2022; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6267,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4904-34),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: January 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6268,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/5 mL (2%; 20 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4903-34),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
6269,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/5 mL (2%; 20 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-2066-05),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: May 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6270,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-01, pack of 25; NDC 0409-4277-16, individual)",Revised,11/18/21,Next Delivery: January 2022; Estimated Recovery: January 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6271,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"1,000 mg/50 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-02)",Revised,11/18/21,Next Delivery: March 2022; Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6272,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,200 mg/5 mL (4%; 40 mg/mL); Glass Ampul (NDC 0409-4283-01),Revised,11/18/21,Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6273,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,Xylocaine Cardiac 100 mg/5 mL (2%; 20 mg/mL); Ansyr Plastic Syringe (NDC 0409-1323-05),Revised,11/18/21,Next Delivery: January 2022; Estimated Recovery: December 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
6274,Lidocaine Hydrochloride (Xylocaine) Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"2%, 5mL Luer-Jet Prefilled Syringe (NDC 76329-3390-1)
(old NDC 0548-3390-00)",Reverified,11/2/21,Available,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6275,Lidocaine Hydrochloride (Xylocaine) Injection,American Regent/Luitpold,800-645-1706,"1%, 50 mL vial package of 25 (NDC 00517-0625-25)",Reverified,3/30/21,Unavailable-No product available for release. No plan to manufacture.,"American Regent/Luitpold has discontinued manufacturing Lidocaine HCl Injection, USP",,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
6276,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6277,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6278,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6279,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6280,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6281,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6282,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57)",Reverified,11/23/21,Backordred. Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6283,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10)
discontinued",Reverified,11/23/21,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6284,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued",Reverified,11/23/21,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6285,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50)-NDC discontinued",Reverified,11/23/21,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6286,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27)",Reverified,11/23/21,Backordered. Next release November 2021.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6287,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07)",Reverified,11/23/21,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6288,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97)",Reverified,11/23/21,Backordered. Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6289,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (0.5%; 5 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4275-01),Revised,11/18/21,Unavailable. Next Delivery and Estimated Recovery: January 2022,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
6290,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/2 mL (5%; 50 mg/mL) and 7.5% Dextrose; Glass Ampul (NDC 0409-4712-01),Revised,11/18/21,Unavailable. Next Delivery: September 2022; Estimated Recovery: December 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
6291,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (0.5%; 5 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4278-01),Revised,11/18/21,Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6292,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-02),Revised,11/18/21,Available,,,Other,Anesthesia;Pediatric,Current,,
6293,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31)",Reverified,11/23/21,Not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6294,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 10 mL Multi Dose Vial (NDC 55150-251-10),Revised,11/5/21,Currently on backorder - next shipment TBD,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6295,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 20 mL Multi Dose Vial (NDC 55150-252-20),Revised,11/5/21,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6296,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 10 mL Multi Dose Vial (NDC 55150-254-10),Revised,11/5/21,Currently on backorder - next shipment anticipated end of Nov,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6297,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 20 mL Multi Dose Vial (NDC 55150-255-20),Revised,11/5/21,Currently on backorder - next shipment anticipated end of Nov,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6298,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 5 mL vial, Preservative Free (NDC 0143-9595-25)",Revised,10/12/21,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing in the October - November 2021 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
6299,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 5 mL vial, Preservative Free (NDC 0143-9594-25)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
6300,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 50 mL vial, Preserved (NDC 0143-9577-10)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
6301,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 50 mL vial, Preserved (NDC 0143-9575-10)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
6302,Lidocaine Hydrochloride (Xylocaine) Injection,"Spectra Medical Devices, Inc.",978-657-0889 ext. 5231,1% 5 mL ampule (NDC 65282-1605-1),New,6/14/18,"Currently available, in stock Production is ongoing",,,Other,Anesthesia,Current,,
6303,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,300 mg/20 mL (1.5%; 15 mg/mL); Glass Ampul (NDC 0409-4776-01),Revised,11/18/21,Available,,,Other,Anesthesia;Pediatric,Current,,
6304,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% MDV 1000mg/50mL (NDC 55150-256-50),Revised,11/5/21,Currently on backorder - next shipment anticipated end of Nov,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6305,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"0.5% w/EPI 1:100,000; 1.8 mL Carpule (NDC 00409-0996-01)",Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
6306,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"2.5 g/50 mL (0.5%; 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3177-01)",Reverified,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6307,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"200 mg/20 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-01)",Reverified,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: March 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6308,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"300 mg/30 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-02)",Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: January 2023,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6309,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"500 mg/50 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3178-03)",Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6310,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"75 mg/5 mL (1.5%; 1:200,000); Glass Ampul (NDC 0409-1209-01)",Reverified,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6311,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"450 mg/30 mL (1.5%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3181-01)",Reverified,11/18/21,Next Delivery and Estimated Recovery: July 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6312,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-01)",Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6313,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"600 mg/30 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-02)",Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6314,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"1 g/50 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-03)",Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: September 2022,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6315,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3183-01)",Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
6316,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"2% w/EPI 1:50,000; 1.8mL syringe (NDC 00409-7263-01)",Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
6317,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 100 mg MDV (NDC 63323-0482-17)",Reverified,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
6318,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 100mg SDV, MPF (NDC 63323-0487-17)",Reverified,11/23/21,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
6319,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-0488-17)",Reverified,11/23/21,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
6320,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-0489-17)",Reverified,11/23/21,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
6321,Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 5mcg tablets (NDC 0378-3611-01),New,3/28/18,,The discontinuation of this product is a business decision,,,Endocrinology/Metabolism,To be Discontinued,3/28/18,3/28/18
6322,Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 25mcg tablets (NDC 0378-3612-01),New,3/28/18,,The discontinuation of this product is a business decision,,,Endocrinology/Metabolism,To be Discontinued,3/28/18,3/28/18
6323,Lipid Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (20 grams per 100 mL) (NDC 63323--820-00)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6324,Lipid Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (50 grams per 250 mL) (NDC 63323--820-74)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6325,Lipid Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Smoflipid injectable emulsion, USP, 20% (0.2 grams per mL) (100 grams per 500 mL) (NDC 63323-820-50)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6326,Lipid Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Smoflipid injectable emulsion, USP, 20%, PBP (0.2 grams per mL) (200 grams per 1000 mL) (NDC 63323-820-10)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6327,Lipid Injection,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 100 mL, Product Code EADB9520, (NDC 0338-954-005)",Revised,11/23/21,Available,NDC 0338-954-005,,,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6328,Lipid Injection,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 1000 mL, Product Code EADB9524, (NDC 0338-954-008)",Revised,11/23/21,Available,NDC 0338-954-008,,,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6329,Lipid Injection,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 250 mL, Product Code EADB9521, (NDC 0338-954-006)",Revised,11/23/21,Available,NDC 0338-954-006,,,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6330,Lipid Injection,Baxter Healthcare,888-229-0001,"Clinolipid 20% (Lipid Injectable Emulsion, USP) 500 mL, Product Code EADB9523, (NDC 0338-954-007)",Revised,11/23/21,Available,NDC 0338-954-007,,,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6331,Lipid Injection,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 100 mL, Product Code 2B6061, (NDC 0338-051-958)",Revised,11/23/21,"Limited Supply, on Allocation; Recovery Q4",NDC 0338-051-958. Fresenius is the NDA holder and Baxter is the distributor.,,Demand Increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6332,Lipid Injection,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 250 mL, Product Code 2B6062, (NDC 0338-051-909)",Revised,11/23/21,"Limited Supply on Allocation, Recovery Q4",NDC 0338-051-909. Fresenius is the NDA holder and Baxter is the distributor.,,Demand Increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6333,Lipid Injection,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 1000 mL, Pharmacy Bulk Package, Product Code 2B6064, (NDC 0338-051-914)",New,10/26/21,Limited Supply on Allocation,NDC 0338-051-914. Fresenius is the NDA holder and Baxter is the distributor.,,Demand Increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6334,Lipid Injection,Baxter Healthcare,888-229-0001,"Intralipid 20% IV Fat Emulsion, 500 mL, Product Code 2B6063, (NDC 0338-051-913)",New,10/26/21,Limited Supply on Allocation,NDC 0338-051-913. Fresenius is the NDA holder and Baxter is the distributor.,,Demand Increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6335,Lipid Injection,Baxter Healthcare,888-229-0001,"Intralipid 30% IV Fat Emulsion, 500 mL, Pharmacy Bulk Package, Product Code 2B6065, (NDC 0338-052-013)",New,10/26/21,Limited Supply on Allocation,NDC 0338-052-013. Fresenius is the NDA holder and Baxter is the distributor.,,Demand Increase,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6336,Lipid Injection,B. Braun Medical Inc.,800-227-2862,"Nutrilipid (20% IV Fat Emulsion) in 1,000mL Bag Catalog S4600 (NDC 00264-4460-00)",New,10/27/21,"Product available, on allocation to contracted customers",,,Other,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6337,Lipid Injection,B. Braun Medical Inc.,800-227-2862,Nutrilipid (20% IV Fat Emulsion) in 500mL Bag Catalog S4601 (NDC 0264-4460-10),New,10/27/21,"Product on back order, next release expected end Nov 2021",,,Other,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6338,Lipid Injection,B. Braun Medical Inc.,800-227-2862,Nutrilipid (20% IV Fat Emulsion) in 250mL Bag Catalog S4603 (NDC 00264-4460-30),New,10/27/21,"Product available, on allocation to contracted customers",,,Other,Endocrinology/Metabolism;Gastroenterology;Total Parenteral Nutrition,Current,,
6339,Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2.5 mg (NDC 0378-2072-01); 5 mg (NDC 0378-2073-01); 5 mg (NDC 0378-2073-10); 10 mg (NDC 0378-2074-01); 10 mg (NDC 0378-2074-10); 20 mg (NDC 0378-2075-01); 20 mg (NDC 0378-2075-10); 30 mg (NDC 0378-2077-01); 40 mg (NDC 0378-2076-01; 40 mg (NDC 0378-2076-05),New,4/11/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,4/11/18,4/11/18
6340,Lithium Oral Solution,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,8 mEq/5 mL 500 mL bottle (NDC 0054-3527-63),Reverified,11/5/21,"Unavailable, Estimated Shortage: TBD",,,Shortage of an active ingredient,Psychiatry,Current,,
6341,Lorazepam Injection,"Hospira, Inc.",844-646-4398,4 mg/mL; Carpuject Luer Lock Glass Syringe (NDC 00409-1539-31),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Neurology,Current,,
6342,Lorazepam Injection,"Hospira, Inc.",844-646-4398,2 mg/mL; Carpuject Luer Lock Glass Syringe  (NDC 00409-1985-30),Reverified,11/18/21,Available,,,Other,Neurology,Current,,
6343,Lorazepam Injection,"Hospira, Inc.",844-646-4398,2 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6778-02),Reverified,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Neurology,Current,,
6344,Lorazepam Injection,"Hospira, Inc.",844-646-4398,4 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6779-02),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Neurology,Current,,
6345,Lorazepam Injection,"Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-6780-02),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Neurology,Current,,
6346,Lorazepam Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"LORAZEPAM INJECTION, USP, C IV [2 mg/ mL](NDC 76329-8261-1)",Reverified,11/2/21,Available,,,Other,Neurology,Current,,
6347,Lorazepam Injection,Akorn Pharmaceuticals,800-932-5676,Lorazepam Injection 2 mg/mL (NDC 17478-040-01),Reverified,5/19/21,Available,,,Demand increase for the drug,Neurology,Current,,
6348,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 1 mL vial (NDC 0641-6001-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
6349,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 10 mL vial (NDC 0641-6000-10)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
6350,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 1 mL vial (NDC 0641-6003-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
6351,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 10 mL vial ((NDC 0641-6002-10)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
6352,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 1 mL vial (NDC 0641-6044-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
6353,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 10 mL vial (NDC 0641-6046-10)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
6354,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 1 mL vial (NDC 0641-6045-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
6355,Lorazepam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 10 mL vial (NDC 0641-6002-10)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
6356,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 1000 count bottle (NDC 0527-1394-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
6357,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 1000 count bottle (NDC 0527-1395-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
6358,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 1000 count bottle (NDC 0527-1396-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
6359,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 1000 count bottle (NDC 0527-1397-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
6360,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 100 count bottle (NDC 0527-1394-01)",Revised,6/21/21,Available,,,,Psychiatry,Current,,
6361,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 1000 count bottle (NDC 0527-1394-10)",Revised,6/21/21,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
6362,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 100 count bottle (NDC 0527-1395-01)",Revised,6/21/21,Available,,,,Psychiatry,Current,,
6363,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 1000 count bottle (NDC 0527-1395-10)",Revised,6/21/21,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
6364,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 100 count bottle (NDC 0527-1396-01)",Revised,6/21/21,Available,,,Other,Psychiatry,Current,,
6365,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 1000 count bottle (NDC 0527-1396-10)",Revised,6/21/21,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
6366,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 100 count bottle (NDC 0527-1397-01)",Revised,6/21/21,Available,,,,Psychiatry,Current,,
6367,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 1000 count bottle (NDC 0527-1397-10)",Revised,6/21/21,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
6368,Loxapine Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"5 mg, 100 count bottle (NDC 0378-7005-01)",Reverified,11/29/21,Unavailable,,,Other,Psychiatry,Current,,
6369,Loxapine Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"10 mg, 100 count bottle (NDC 0378-7010-01)",Reverified,11/29/21,Unavailable,,,Other,Psychiatry,Current,,
6370,Loxapine Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"25 mg, 100 count bottle (NDC 0378-7025-01)",Reverified,11/29/21,Unavailable,,,Other,Psychiatry,Current,,
6371,Loxapine Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"50 mg, 100 count bottle (NDC 0378-7050-01)",Reverified,11/29/21,Unavailable,,,Other,Psychiatry,Current,,
6372,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count bottle (NDC 0591-0369-01)",Revised,11/8/21,Available,,,,Psychiatry,Current,,
6373,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count bottle (NDC 0591-0370-01)",Revised,11/8/21,Recovery: Feb 2022,January 2022 recovery,,Other,Psychiatry,Current,,
6374,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 count bottle (NDC 0591-0371-01)",Revised,11/8/21,Available,,,,Psychiatry,Current,,
6375,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0591-0372-01)",Revised,11/8/21,Available,,,,Psychiatry,Current,,
6376,Mannitol Injection,"Fresenius Kabi USA, LLC",888-386-1300,25% (12.5 grams per 50 mL)(250 mg per mL) Single dose vial (NDC 63323-024-25),Reverified,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Renal,Current,,
6377,Mannitol Injection,"Hospira, Inc.",844-646-4398,12.5 g/50 mL (25%); Single Dose Glass Fliptop Vial (NDC 0409-4031-01),Revised,11/18/21,Limited Supply Available. Next Delivery: December 2021; Estimated Recovery: June 2022,,,Demand increase for the drug,Renal,Current,,
6378,Mannitol Injection,Baxter Healthcare,888-229-0001,"10% OSMITROL Injection (10% Mannitol Injection, USP) 500 mL Viaflex Plastic Container Product Code 2D5613Q (NDC 0338-0535-03)",New,9/29/21,Available,,,,Renal,Current,,
6379,Mannitol Injection,Baxter Healthcare,888-229-0001,"20% OSMITROL Injection (20% Mannitol Injection, USP) 500 mL Viaflex Plastic Container Product Code 2D5633Q (NDC 0338-0357-03); 250 mL Viaflex Plastic Container Product Code 2D5632Q (NDC 0338-0357-02)",New,9/29/21,Available,,,,Renal,Current,,
6380,Mannitol Injection,"ICU Medical, Inc.",877-946-7747,"20% Mannitol Injection, USP 500 mL (Legacy Hospira NDC 0409-7715-03)(ICU Medical NDC 0990-7715-03)",Revised,11/10/21,On allocation,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Renal,Current,,
6381,Mannitol Injection,"ICU Medical, Inc.",877-946-7747,"20% Mannitol Injection, USP 250 mL (Legacy Hospira NDC 0409-7715-02)(ICU Medical NDC 0990-7715-02)",Revised,11/10/21,On allocation,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Renal,Current,,
6382,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,718-276-8607,"12.5mg tablets, 100 count (NDC 42806-012-01)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
6383,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"12.5mg tablets, 1000 count (NDC 42806-012-10)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
6384,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 100 count (NDC 42806-014-01)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
6385,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 1000 count (NDC 42806-014-10)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
6386,"Medroxyprogesterone Acetate (Depo-Provera) Injection, Suspension",Pfizer Pharmaceuticals,800-533-4535,"400 mg/mL, 1 carton containing one 2.5 mL vial (NDC 0009-0626-01)",New,10/27/20,,Discontinuation of the manufacturing of the drug.,,,Reproductive,To be Discontinued,10/27/20,10/27/20
6387,Meloxicam Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,7.5 mg tablets (NDCs 0597-0029-01 and 0597-0029-94),New,11/1/21,,,,,Analgesia/Addiction,To be Discontinued,11/1/21,11/1/21
6388,Meloxicam Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,15 mg tablets (NDCs 0597-0030-01 and 0597-0030-56),New,11/1/21,,,,,Analgesia/Addiction,To be Discontinued,11/1/21,11/1/21
6389,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine) 1% (500 mg per 50 mL), (10 mg per mL), MDV, (NDC 63323-0283-57)",Revised,11/23/21,Available,Check wholesaler inventory,,,Anesthesia,Current,,
6390,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine) 2% (1,000 mg per 50 mL), (20 mg per mL), MDV, (NDC 63323-0296-57)",Revised,11/23/21,Available,Check wholesaler inventory,,,Anesthesia,Current,,
6391,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 1% (300 mg per 30 mL), (10 mg per mL), SDV, (NDC 63323-0260-37)",Revised,11/23/21,Available,Check wholesaler inventory,,,Anesthesia,Current,,
6392,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 1.5% (450 mg per 30 mL), (15 mg per mL), SDV, (NDC 63323-0293-37)",Revised,11/23/21,Available,,,Manufacturing delay,Anesthesia,Current,,
6393,Mepivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"(Polocaine MPF) 2% (400 mg per 20 mL), (20 mg per mL), SDV, (NDC 63323-0294-27)",Revised,11/23/21,Backordered. Next release December 2021.,,,Manufacturing delay,Anesthesia,Current,,
6394,Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,300 mg/30 mL (10 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1036-30),Reverified,11/18/21,Next Delivery and estimated recovery: May 2022,Shortage per manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
6395,Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,400 mg/20 mL (20 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1067-20),Reverified,11/18/21,Next Delivery and estimated recovery: April 2022,Shortage per manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
6396,Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,450 mg/30 mL (15 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-1041-30),Reverified,11/18/21,Next Delivery and estimated recovery: June 2022,Shortage per manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
6397,Mepivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 0409-1038-50),Reverified,11/18/21,Available,,,Other,Anesthesia,Current,,
6398,Mesalamine (CANASA®)  Suppositories,Allergan,800-678-1605,"1 gm, Rectal Suppositories, 42 suppositories in 1 box (NDC 58914-501-42)",New,7/30/20,,"Additional products remain available:   
NDC 58914-501-56 (30 suppositories in 1 box); NDC 58914-501-33 (3 suppositories in 1 box); NDC 59762-0118-3",,,Gastroenterology,To be Discontinued,7/30/20,7/30/20
6399,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,750mg tablets (NDC 2037-577-10) and (NDC 62037-577-01 ),New,6/24/20,,Teva made a business decision to discontinue the product.,,,Endocrinology/Metabolism,To be Discontinued,6/24/20,6/24/20
6400,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,500mg tablets (NDC 62037-571-01) and (NDC 62037-571-10),New,6/24/20,,Teva made a business decision to discontinue the product.,,,Endocrinology/Metabolism,To be Discontinued,6/24/20,6/24/20
6401,Methadone Hydrochloride Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Methadone Hydrochloride Injection (Solution in Multi Dose Vials) [200 mg / 20 ml](NDC 67457-217-20),Revised,6/8/21,,,Available,,Analgesia/Addiction;Anesthesia,Resolved,6/8/21,
6402,Methadone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Methadone Hydrochloride Injection USP, 200 mg/20 mL (10 mg/mL) , 20 mL multidose vials (NDC 17478-380-20)",Revised,6/8/21,,,Available,,Analgesia/Addiction;Anesthesia,Resolved,6/8/21,
6403,Methimazole Tablets,Pfizer Pharmaceuticals,800-533-4535,Tapazole 5 mg tablets; bottle of 100 (NDC 60793-104-01),New,11/5/21,,Discontinuation of the manufacture of the drug.,,,Endocrinology/Metabolism,To be Discontinued,11/5/21,11/5/21
6404,Methimazole Tablets,Pfizer Pharmaceuticals,800-533-4535,Tapazole 10 mg tablets; bottle of 100 (NDC 60793-105-01),New,11/5/21,,Discontinuation of the manufacture of the drug.,,,Endocrinology/Metabolism,To be Discontinued,11/5/21,11/5/21
6405,"Methocarbamol Tablet, USP","Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",750 mg tablets (NDC 52244-449-10),New,10/27/20,,,,,Analgesia/Addiction,To be Discontinued,10/27/20,10/27/20
6406,Methohexital Sodium (Brevital) Injection,Par Pharmaceutical,800-828-9393,"500 mg/vial, 50 mL multiple dose vial, box of 1 (NDC 42023-105-01)",Revised,11/15/21,,,Available,,Anesthesia,Resolved,11/15/21,
6407,Methoxsalen Capsules,Teva Pharmaceuticals,800-545-8800,10mg  (NDC 45963-325-50),New,3/22/21,,,,,Dermatology,To be Discontinued,3/22/21,3/22/21
6408,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 100s (16729-03-001),Revised,2/5/21,Limited availability,,,API procurement delay,Cardiovascular,Current,,
6409,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 500s (16729-03-016),Revised,2/5/21,Limited availability,,,API procurement delay,Cardiovascular,Current,,
6410,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 100s (16729-03-101),Revised,2/5/21,Limited availability,,,API procurement delay,Cardiovascular,Current,,
6411,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 500s (16729-03-116),Revised,2/5/21,Limited availability,,,API procurement delay,Cardiovascular,Current,,
6412,Methyldopa Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,250 mg (NDC 0378-0611-01),Revised,10/8/21,,,,,Cardiovascular,To be Discontinued,10/8/21,10/8/21
6413,Methyldopa Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,500 mg (NDC 0378-0421-01),Revised,10/8/21,,,,,Cardiovascular,To be Discontinued,10/8/21,10/8/21
6414,Methylprednisolone Tablets,Teva Pharmaceuticals,800-545-8800,4 mg tablets (NDC 0591-0790-01),New,12/5/19,,,,,Neurology,To be Discontinued,12/5/19,12/5/19
6415,"Metoclopramide Injection, USP",Heritage Pharma,855-228-9470,10mg/2mL (NDC 23155-240-41),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
6416,Metoclopramide Tablets,Par Pharmaceutical,800-828-9393,"10 mg, 500S (NDC 49884-0689-01",New,7/6/21,,Discontinued due to business reasons.,,,Gastroenterology,To be Discontinued,7/6/21,7/6/21
6417,Metoclopramide Tablets,Par Pharmaceutical,800-828-9393,"10 mg, 500S (NDC 49884-0689-05)",New,7/6/21,,Discontinued due to business reasons.,,,Gastroenterology,To be Discontinued,7/6/21,7/6/21
6418,Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,50 mg tablets (NDCs 0591-0462-01 and 0591-0462-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,12/16/19,12/16/19
6419,Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,100 mg tablets (NDCs 0591-0463-01 and 0591-0463-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,12/16/19,12/16/19
6420,Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,250 mg tablets 1 x 100 bottle (NDC 0025-1831-31),New,10/20/20,,Discontinuation of the manufacture of the drug.,,,,To be Discontinued,10/20/20,10/20/20
6421,Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,250 mg tablets 1 x 50 bottle (NDC 0025-1831-50),New,10/20/20,,Discontinuation of the manufacture of the drug.,,,,To be Discontinued,10/20/20,10/20/20
6422,Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets 1 x 100 bottle (NDC 0025-1821-31),New,10/13/21,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/13/21,10/13/21
6423,Metronidazole (Flagyl) Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets 1 x 50 bottle (NDC 0025-1821-50),New,10/13/21,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/13/21,10/13/21
6424,Midazolam Injection,Akorn Pharmaceuticals,800-932-5676,10 ML Vial - Pack of 10 (NDC 17478-0524-10),Revised,10/22/21,Available,,,,Anesthesia;Neurology,Current,,
6425,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6426,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 2 mL prefilled syringe, 24 count (NDC 76045-0001-20)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6427,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6428,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6429,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6430,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6431,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 1 mL prefilled syringe, 24 count (NDC 76045-0002-10)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6432,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6433,Midazolam Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg/mL, 5 mL vial, 10 count (NDC 63323-0412-05)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6434,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 10 mL vial, 10 count (NDC 00641-6056-10)",Reverified,10/12/21,Available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6435,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 2 mL vial, 25 count (NDC 00641-6057-25)",Reverified,10/12/21,Available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6436,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1 mg/mL, 5 mL vial, 10 count (NDC 0641-6059-25)",Reverified,10/12/21,Available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6437,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 1 mL vial, 25 count (NDC 00641-6061-25)",Reverified,10/12/21,Available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6438,Midazolam Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial, 10 count (NDC 00641-6060-10)",Reverified,10/12/21,Available,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6439,Midazolam Injection,"Hospira, Inc.",844-646-4398,2 mg/2mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-17),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: October 2022,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6440,Midazolam Injection,"Hospira, Inc.",844-646-7398,5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-05),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6441,Midazolam Injection,"Hospira, Inc.",844-646-4398,5 mg/mL (5 mg/mL)  Single Dose Glass Fliptop Vial (NDC 00409-2308-01),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6442,Midazolam Injection,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-05),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: February 2022,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6443,Midazolam Injection,"Hospira, Inc.",844-646-4398,10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2308-02),Revised,11/18/21,Available,,,Other,Anesthesia;Neurology,Current,,
6444,Midazolam Injection,"Hospira, Inc.",844-646-4398,25 mg/5 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-03),Revised,11/18/21,Available,,,Other,Anesthesia;Neurology,Current,,
6445,Midazolam Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,50 mg/10mL vial (NDC 23155-601-42),Revised,10/13/21,Available,,,Other,Anesthesia;Neurology,Current,,
6446,Midazolam Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,25 mg/5mL vial (NDC 23155-601-41),Revised,10/13/21,Available,,,Other,Anesthesia;Neurology,Current,,
6447,Midazolam Injection,Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals,855-228-9470,2 mg/2mL vial (NDC 23155-600-41),Revised,10/13/21,Available; On allocation due to increased demand,,,Other,Anesthesia;Neurology,Current,,
6448,Midazolam Injection,"Hospira, Inc.",844-646-4398,10 mg/10 mL (1 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2587-05),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6449,Midazolam Injection,"Hospira, Inc.",844-646-4398,2 mg/2 mL (1 mg/mL) CARPUJECT™ Luer Lock Glass Syringe (NDC 00409-2306-62),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Neurology,Current,,
6450,Midazolam Injection,"Hospira, Inc.",844-646-4398,5 mg/mL CARPUJECT™ Luer Lock Glass Syringe (NDC 00409-2307-60),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Neurology,Current,,
6451,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,50 mg per 10 mL Multi-Dose Vial (NDC 70860-601-10),Reverified,11/5/21,Available,"Marketing partner: Athenex Pharmaceutical Division, LLC.",,Demand increase for the drug,Anesthesia;Neurology,Current,,
6452,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,25 mg per 5 mL Multi-Dose Vial (NDC 70860-601-05),Reverified,11/5/21,Available,"Marketing partner: Athenex Pharmaceutical Division, LLC.",,Demand increase for the drug,Anesthesia;Neurology,Current,,
6453,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,25 mg per 5 mL Multi-Dose Vial (NDC 47781-589-17),Reverified,11/5/21,No stock available,Marketing partner: Alvogen Inc.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6454,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,50 mg per 10 mL Multi-Dose Vial (NDC 47781-589-91),Reverified,11/5/21,Available,Marketing partner: Alvogen Inc.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6455,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,2 mg per 2 mL Single Dose Vial (NDC 70860-600-02),Reverified,11/5/21,Available,"Marketing partner: Athenex Pharmaceutical Division, LLC.",,Demand increase for the drug,Anesthesia;Neurology,Current,,
6456,Midazolam Injection,Gland Pharma Limited,Athenex: 855-273-0154; Alvogen: 973-532-7840,2 mg per 2 mL Single Dose Vial (NDC 47781-588-68),Reverified,11/5/21,Available,Marketing partner: Alvogen Inc.,,Demand increase for the drug,Anesthesia;Neurology,Current,,
6457,Miglitol Tablets,"Hospira, Inc.",844-646-4398,25 mg (NDC 0009-5012-01),New,11/17/20,,,,,Endocrinology/Metabolism,To be Discontinued,11/17/20,11/17/20
6458,Miglitol Tablets,"Hospira, Inc.",844-646-4398,50 mg (NDC 0009-5013-01),New,11/17/20,,,,,Endocrinology/Metabolism,To be Discontinued,11/17/20,11/17/20
6459,Miglitol Tablets,"Hospira, Inc.",844-646-4398,100 mg (NDC 0009-5014-01),New,11/17/20,,,,,Endocrinology/Metabolism,To be Discontinued,11/17/20,11/17/20
6460,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,15mg tablets (NDC 0591-2469-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
6461,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,30mg tablets (NDC 0591-2470-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
6462,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,45mg tablets (NDC 0591-2471-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
6463,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 100 (NDC 59762-5008-2),Reverified,11/18/21,Next Delivery: December 2021; Estimated Recovery: April 2022,,,Demand increase for the drug,Gastroenterology,Current,,
6464,Misoprostol Tablets,Lupin,800-466-1450,100-mcg tablets Bottles of 60 (NDC 43386-160-06),Revised,4/30/21,Available,,,Other,Gastroenterology,Current,,
6465,Misoprostol Tablets,Lupin,800-466-1450,100-mcg tablets Bottles of 120 (NDC 43386-160-12),Revised,4/30/21,Available,,,Other,Gastroenterology,Current,,
6466,Misoprostol Tablets,Lupin,800-466-1450,200-mcg tablets Bottles of 60 (NDC 43386-161-06),Revised,4/30/21,Available,,,Other,Gastroenterology,Current,,
6467,Misoprostol Tablets,Lupin,800-466-1450,200-mcg tablets Bottles of 100 (NDC 43386-161-01),Revised,4/30/21,Available,,,Other,Gastroenterology,Current,,
6468,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 60 (NDC 59762-5007-1),Reverified,11/18/21,Next Delivery: November 2021; Esimtated Recovery: January 2022,,,Other,Gastroenterology,Current,,
6469,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 120 (NDC 59762-5007-2),Reverified,11/18/21,Next Delivery and Estimated Recovery: March 2022,,,Other,Gastroenterology,Current,,
6470,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 60 (NDC 59762-5008-1),Reverified,11/18/21,Next Delivery and Estimated Recovery: January 2022,,,Other,Gastroenterology,Current,,
6471,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; 10x10 blister (NDC 0025-1451-34),Reverified,11/18/21,Available,,,Other,Gastroenterology,Current,,
6472,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,100 mcg tablets; Bottle of 60 (NDC 0025-1451-60),Reverified,11/18/21,Available,,,Demand increase for the drug,Gastroenterology,Current,,
6473,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 100 (NDC 0025-1461-31),Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Gastroenterology,Current,,
6474,Misoprostol Tablets,Pfizer Pharmaceuticals,800-533-4535,200 mcg tablets; Bottle of 60 (NDC 0025-1461-60),Reverified,11/18/21,Next Delivery and Estimated Recovery: TBD,,,Demand increase for the drug,Gastroenterology,Current,,
6475,Mometasone Furoate Monohydrate Nasal Spray,Merck Sharp & Dohme Corp.,800-672-6372,50 mcg (NDC 0085-1288-01),New,6/9/21,,,,,Pulmonary/Allergy,To be Discontinued,6/9/21,6/9/21
6476,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,4 mg  (NDCs 0093-7424-98 and 0093-7424-56),New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,7/28/20,7/28/20
6477,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,5 mg  (NDCs 0093-7425-98 and 0093-7425-56),New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,7/28/20,7/28/20
6478,Montelukast Sodium Chewable Tablet,Teva Pharmaceuticals,800-545-8800,"10 mg (NDCs 0093-7426-10, 0093-7426-56, and 0093-7426-98)",New,7/28/20,,,,,Pulmonary/Allergy,To be Discontinued,7/28/20,7/28/20
6479,Montelukast Sodium Chewable Tablet,Sandoz,800-525-8747,"4 mg  (NDCs 0781-5554-05, 0781-5554-06, 0781-5554-13, 0781-5554-31, 0781-5554-64, 0781-5554-92)",New,10/12/21,,,,,Pulmonary/Allergy,To be Discontinued,10/12/21,10/12/21
6480,Montelukast Sodium Chewable Tablet,Sandoz,800-525-8747,"5 mg  (NDCs 0781-5555-05, 0781-5555-06, 0781-5555-13, 0781-5555-31, 0781-5555-64, 0781-5555-92)",New,10/12/21,,,,,Pulmonary/Allergy,To be Discontinued,10/12/21,10/12/21
6481,Montelukast Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-5201-93),New,3/20/18,,The discontinuation of this product is a business decision,,,Pediatric;Pulmonary/Allergy,To be Discontinued,3/20/18,3/20/18
6482,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-2658-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6483,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, 100s (NDC 0378-2659-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6484,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"60 mg, 100s (NDC 0378-2660-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6485,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100s (NDC 0378-2661-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6486,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg, 100s (NDC 0378-2662-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
6487,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-452-01)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6488,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-454-01)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6489,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 1 mL, Single dose vial, (NDC 63323-455-01)",Revised,11/23/21,7 month expiry (6/2022 expiry) dating available by request.,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6490,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"8 mg per 1 mL, Single dose vial, (NDC 63323-458-01)",Revised,11/23/21,7 month expiry (6/2022 expiry) dating available by request.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
6491,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose vial, (NDC 63323-451-01)",Revised,11/23/21,Backordered. Next release January 2022.,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6492,Morphine Sulfate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,Morphine Sulfate 1 mg/mL 30 mg in 30 mL PUMP-JET®  SUITABLE FOR USE WITH COMPATIBLE I.V. INFUSION PUMPS (NDC 76329-1911-1),Reverified,11/2/21,Available,,,,Analgesia/Addiction,Current,,
6493,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6125-25)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6494,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"8 mg/mL, 1 mL vial (NDC 0641-6126-25)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6495,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-6127-25)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6496,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,250 mg/10 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1135-02),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6497,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,2 mg/mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1890-01),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: December 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
6498,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,2 mg/mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1890-11),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6499,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,4 mg/mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1891-01),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: December 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
6500,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,4 mg/mL (4 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1891-11),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6501,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,8 mg/mL (8 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1892-01),Revised,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6502,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,8 mg/mL (8 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1892-11),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6503,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1893-01),Revised,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6504,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1893-11),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction,Current,,
6505,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,5 mg/10 mL (0.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3814-12),Revised,11/18/21,Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6506,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,10 mg/10 mL (1 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3815-12),Revised,11/18/21,Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6507,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,"1,000 mg/20 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-03)",Revised,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6508,Morphine Sulfate Injection,"Hospira, Inc.",844-646-4398,"2,500 mg/50 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-05)",Revised,11/18/21,Available,,,Other,Analgesia/Addiction,Current,,
6509,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-10)",Revised,11/23/21,Check wholesalers for inventory,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6510,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single-use prefilled syringe (NDC 76045-005-10)",Revised,11/23/21,Check wholesalers for inventory,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6511,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 1 mL, Single-use prefilled syringe (NDC 76045-006-10)",Revised,11/23/21,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6512,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"8 mg per 1 mL, Single-use prefilled syringe (NDC 76045-007-10)",Revised,11/23/21,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6513,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single-use prefilled syringe (NDC 76045-008-10)",Revised,11/23/21,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
6514,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 1 mg/mL, 10 mL ampul (NDC 0641-6019-10)",Revised,10/12/21,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing in the October - November 2021 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6515,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 0.5 mg/mL, 10 mL ampul (NDC 0641-6020-10)",Revised,10/12/21,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing in the October - November 2021 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6516,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 10 mg/mL, 20 mL ampul (NDC 0641-6039-01)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6517,Morphine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 25 mg/mL, 20 mL ampul (NDC 0641-6040-01)",Revised,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
6518,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single-use prefilled syringe, micro vault packaging (NDC 76045-004-11)",Revised,11/23/21,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6519,Morphine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single-use prefilled syringe, micro vault packaging (NDC 76045-005-11)",Revised,11/23/21,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
6520,Moxifloxacin (Moxeza) Ophthalmic Solution,Novartis,888-669-6682,"5mg/mL, 3mL in 1 bottle, (NDC 0065-0006-03)",New,7/2/21,,Novartis Pharmaceuticals has made a business decision to permanently discontinue Moxeza (moxifloxacin hydrochloride) Solution 5mg/mL.,,,Ophthalmology,To be Discontinued,7/2/21,7/2/21
6521,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 10 mL Single Dose Dual Glass Fliptop Vials (NDC 61703-0434-82),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6522,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 2 x 50 mL Pharmacy Bulk Package Dual Glass Fliptop Vials (NDC 61703-0422-83),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6523,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Pediatric; Single Dose Glass Fliptop Vial (NDC 61703-0421-53),Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6524,Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1)",Reverified,11/16/21,Limited supply on allocation,"Drug Product is distributed by Baxter Healthcare, please contact 888-229-0001 for supply related inquires.  For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition",,Demand increase for the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6525,Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Adult, Multiple Vitamins for Injection. Single dose package. (NDC 54643-5649-1)",Reverified,11/16/21,Limited supply on allocation,"Drug Product is distributed by Baxter Healthcare, please contact 888-229-0001 for supply related inquires.  For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition",,Demand increase for the drug,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6526,Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Adult, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5650-2)",Reverified,11/16/21,Stocked out; Recovery TBD,"Drug Product is distributed by Baxter Healthcare, please contact 888-229-0001 for supply related inquires.  For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition",,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6527,Multi-Vitamin Infusion (Adult and Pediatric),Sandoz,800-525-8747,"INFUVITE Pediatric, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5647-0)",Reverified,11/16/21,Stocked out; Recovery TBD,"Drug Product is distributed by Baxter Healthcare, please contact 888-229-0001 for supply related inquires.  For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition",,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6528,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,20 mg (100 ct) (NDC 50742-178-01),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
6529,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,20 mg (1000 ct) (NDC 50742-178-10 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
6530,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,40 mg (100 ct) (NDC 50742-179-01 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
6531,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,40 mg (1000 ct) (NDC 50742-179-10 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
6532,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,80 mg (100 ct) (NDC 50742-180-01 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
6533,Nadolol Tablets,Ingenus Pharmaceuticals LLC,866-321-5031,80 mg (1000 ct) (NDC 50742-180-10 ),New,9/11/20,,Product Discontinuation,,,Cardiovascular,To be Discontinued,9/11/20,9/11/20
6534,Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,1 g; Single Dose Vial (Powder)(NDC 0409-3713-01),New,10/20/21,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/20/21,10/20/21
6535,Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,2 g; Single Dose Vial (Powder)(NDC 0409-3714-01),New,10/20/21,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/20/21,10/20/21
6536,Nafcillin Injection,Pfizer Pharmaceuticals,800-533-4535,10 g per Pharmacy Bulk Package; Pharmacy Bulk Vial (Powder)(NDC 0409-3715-01),New,10/20/21,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,10/20/21,10/20/21
6537,Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-3124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
6538,Nafcillin Sodium Injection,Sandoz,800-525-8747,2 gram vial packaged in 10s (NDC 0781-3125-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
6539,Nafcillin Sodium Injection,Sandoz,800-525-8747,Pharmacy Bulk Package bottle (NDC 0781-3126-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
6540,Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-9124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
6541,Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9224-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
6542,Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9225-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
6543,Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3128-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
6544,Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3129-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
6545,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 1 mL Glass Ampul (NDC 00409-1463-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,6/28/21,
6546,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/mL; 1 mL Glass Ampul (NDC 00409-1465-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,6/28/21,
6547,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1464-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,6/28/21,
6548,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (20 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1467-01),Revised,6/28/21,,,Available,,Analgesia/Addiction,Resolved,6/28/21,
6549,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,50 mg 100 Tablets (NDC 0093-7178-01),Revised,11/17/21,Estimated availability in 4Q 2021 to 1Q 2022,,,Regulatory delay,Psychiatry,Current,,
6550,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,100 mg 60 Tablets (NDC 0093-1024-06),Revised,11/17/21,Estimated availability in 4Q 2021 to 1Q 2022,,,Regulatory delay,Psychiatry,Current,,
6551,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,150 mg 60 Tablets (NDC 0093-7113-06),Revised,11/17/21,Estimated availability in 4Q 2021 to 1Q 2022,,,Regulatory delay,Psychiatry,Current,,
6552,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,200 mg 60 Tablets (NDC 0093-1025-06),Revised,11/17/21,Estimated availability in 4Q 2021 to 1Q 2022,,,Regulatory delay,Psychiatry,Current,,
6553,Nefazodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,250 mg 60 Tablets (NDC 0093-1026-06),Revised,11/17/21,Estimated availability in 4Q 2021 to 1Q 2022,,,Regulatory delay,Psychiatry,Current,,
6554,"Neomycin Sulfate, Polymyxin B Sulfate and Hydrocortisone Acetate Cream",Pfizer Pharmaceuticals,800-533-4535,"CORTISPORIN (neomycin sulfate, polymyxin b sulfate and hydrocortisone acetate cream); Tube of 7.5 g cream (NDC 61570-032-75)",New,3/9/21,,Discontinuation of the manufacture of the drug.,,,Dermatology,To be Discontinued,3/9/21,3/9/21
6555,"Neomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone Ointment",Pfizer Pharmaceuticals,800-533-4535,"Cortisporin (neomycin sulfate, polymyxin b sulfate, bacitracin zinc and hydrocortisone ointment); Tube of 1/2 oz ointment with applicator tip (NDC 61570-031-50)",New,3/9/21,,Discontinuation of the manufacture of the drug.,,,Dermatology,To be Discontinued,3/9/21,3/9/21
6556,Nesiritide Powder (NATRECOR) for Injection,Janssen Pharmaceuticals,800-526-7736,1.5 mg (NDC 65847-205-25),New,2/5/18,,Discontinuation of the manufacture of the drug,,,Cardiovascular,To be Discontinued,2/5/18,2/5/18
6557,Nevirapine (Viramune) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,200 mg tablets (NDC 0597-0046-60),New,5/29/20,,,,,Antiviral,To be Discontinued,5/29/20,5/29/20
6558,Nevirapine Oral Suspension,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,50mg/5mL (NDC 0597-0047-24),New,10/1/21,,,,,Antiviral,To be Discontinued,10/1/21,10/1/21
6559,Nizatidine Capsules,Teva Pharmaceuticals,800-545-8800,"300 mg, 30 count bottle (NDC 0591-3138-30)",Revised,11/8/21,Supply Interruption. Relaunch Mar-Apr 2022,,,Other,Gastroenterology,Current,3/27/20,
6560,Nizatidine Capsules,Teva Pharmaceuticals,800-545-8800,"150 mg, 60 count bottle (NDC 0591-3137-60)",Revised,11/8/21,Supply Interruption. Relaunch Mar-Apr 2022,,,Other,Gastroenterology,Current,3/27/20,
6561,Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"300 mg, 30 count bottle (NDC 68462-0426-30)",New,3/27/20,Unavailable,This was a business-related decision to discontinue manufacturing these products.,,,Gastroenterology,Current,3/27/20,
6562,Nizatidine Capsules,Glenmark Pharmaceuticals,201-331-4282,"150 mg, 60 count bottle (NDC 68462-0425-60)",New,3/27/20,Unavailable,This was a business-related decision to discontinue manufacturing these products.,,,Gastroenterology,Current,3/27/20,
6563,Norethindrone (NOR QD) Tablets,Allergan,800-678-1605,"Nor QD, 0.35 mg norethindrone, Tablets, (NDC  52544-235-28)",New,2/23/18,,"An authorized generic of the product is currently available as Nora-BE, NDC 52544-629-28.",,,Reproductive,To be Discontinued,2/23/18,2/23/18
6564,Norethindrone Acetate/Ethinyl Estradiol (Femhrt) Tablets,Allergan,800-678-1605,Femhrt (NDC 0430-0145-14),New,3/24/21,,The company has made a business decision to discontinue the product.,,,Reproductive,To be Discontinued,3/24/21,3/24/21
6565,Norethindrone Acetate/Ethinyl Estradiol/Ferrous Fumarate Kit,Allergan,800-678-1605,Tilia Fe (NDC 51862-284-03),New,3/24/21,,The company has made a business decision to discontinue the product.,,,Reproductive,To be Discontinued,3/24/21,3/24/21
6566,Norethindrone Acetate/Ethinyl Estradiol/Ferrous Fumarate Kit,Allergan,800-678-1605,ESTROSTEP Fe (NDC 0430-0005-31),New,3/24/21,,The company has made a business decision to discontinue the product.,,,Reproductive,To be Discontinued,3/24/21,3/24/21
6567,Norethindrone/Ethinyl Estradiol Kit,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",(NDC 0603-7521-17),New,12/17/20,,Discontinued due to business reasons,,,Reproductive,To be Discontinued,12/17/20,12/17/20
6568,Norethindrone/Ethinyl Estradiol Kit,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",(NDC 0603-7521-49),New,12/17/20,,Discontinued due to business reasons,,,Reproductive,To be Discontinued,12/17/20,12/17/20
6569,Norethindrone/Ethinyl Estradiol Kit,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",(NDC 0603-7525-17),New,12/17/20,,Discontinued due to business reasons,,,Reproductive,To be Discontinued,12/17/20,12/17/20
6570,Norethindrone/Ethinyl Estradiol Kit,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",(NDC 0603-7525-49),New,12/17/20,,Discontinued due to business reasons,,,Reproductive,To be Discontinued,12/17/20,12/17/20
6571,Nystatin and Triamcinolone Acetonide Topical Cream,Sandoz,800-525-8747,"100,000 units per gram; 0.1%  (NDCs 0168-0081-15, 0168-0081-30, and 0168-0081-60)",New,4/21/21,,,,,Dermatology,To be Discontinued,4/21/21,4/21/21
6572,Nystatin Topical Cream,Sandoz,800-525-8747,"100,000 units per gram  (NDCs 0168-0054-15 and 0168-0054-30)",New,4/21/21,,,,,Dermatology,To be Discontinued,4/21/21,4/21/21
6573,Olanzapine and Fluoxetine (Symbyax) Capsules,Eli Lilly and Co.,800-545-5979,12mg/50mg per capsule (NDC Package Code 0002-3234-30),New,7/15/20,,The product distribution will continue until end of December 2020.,,,Psychiatry,To be Discontinued,7/15/20,7/15/20
6574,Olanzapine and Fluoxetine (Symbyax) Capsules,Eli Lilly and Co.,800-545-5979,6mg/50mg per capsule (NDC Package Code 0002-3233-30),New,7/15/20,,The product distribution will continue until end of December 2020.,,,Psychiatry,To be Discontinued,7/15/20,7/15/20
6575,Olopatadine Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"0.2%, 2.5 mL Bottle (NDC 0093-7684-32)",New,4/27/21,,Rx to OTC Switch. Current Rx customers on allocation through May 2021.,,,Ophthalmology,To be Discontinued,4/27/21,4/27/21
6576,Ombitasvir; Paritaprevir; Ritonavir (Technivie) Tablets,Abbvie,800-255-5162,212.5mg; 75mg; 50mg (NDC 0074-3082-28),New,5/22/18,,"Estimated product availability until January 1, 2019. The product discontinuation is voluntary",,,Antiviral,To be Discontinued,5/22/18,5/22/18
6577,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,2 mg/mL 2mL vial (NDC 70860-776-02),Reverified,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Demand increase for the drug,Gastroenterology,Current,,
6578,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,2 mg/mL 20mL vial (NDC 70860-777-20),Reverified,11/5/21,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Gastroenterology,Current,,
6579,Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,40mg/20mL EA 1 Vial (NDC 25021-782-20),Reverified,9/3/21,Available,,,,Gastroenterology,Current,,
6580,Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,4mg/2mL PK 25 Vials (NDC 25021-777-02),Reverified,9/3/21,Available,,,,Gastroenterology,Current,,
6581,Ondansetron Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 2 mL vial, 25 count (NDC 55150-125-02)",Reverified,11/5/21,On long term backorder,On long term backorder,,Delay in shipping of the drug,Gastroenterology,Current,,
6582,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"4mg/2mL, 10 (NDC 23155-547-41 )",Reverified,10/13/21,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
6583,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-4759-01),Revised,11/18/21,Available,,,Other,Gastroenterology,Current,,
6584,Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 2 mL vial (NDC 0641-6078-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
6585,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-4755-03),Revised,11/18/21,Available,,,Other,Gastroenterology,Current,,
6586,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1120-12),Revised,10/6/21,,Discontinuation of the manufacture of the drug,,,Gastroenterology,To be Discontinued,10/6/21,10/6/21
6587,Ondansetron Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 20 mL vial, 1 count (NDC 55150-126-20)",Reverified,11/5/21,On long term backorder,On long term backorder,,Delay in shipping of the drug,Gastroenterology,Current,,
6588,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02)",Reverified,11/23/21,Available,Check wholesalers for inventor,,Demand increase for the drug,Gastroenterology,Current,,
6589,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20)",Reverified,11/23/21,Backordered. Next release not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
6590,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
6591,Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9890-01)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
6592,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"Inj4mg/2mL, 25 (NDC 23155-549-31)",Reverified,10/13/21,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
6593,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,PPRx4mg/2mL (NDC 23155-548-41),Reverified,10/13/21,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
6594,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,PPRx4mg/2mL (NDC 23155-548-42),Reverified,10/13/21,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
6595,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,"2 mg/mL, 2 mL vial (NDC 72266-123-25)",Reverified,11/5/21,Available,Distributed by Fosun Pharma USA Inc. Company Contact Information:  833-291-9645,,Available,Gastroenterology,Current,,
6596,Ondansetron Hydrochloride Injection,Gland Pharma Limited,609-250-7990,"2 mg/mL, 20 mL vial (NDC 72266-124-01)",Reverified,11/5/21,Available,Distributed by Fosun Pharma USA Inc. Company Contact Information:  833-291-9645,,Available,Gastroenterology,Current,,
6597,Ondansetron Hydrochloride Injection,Baxter Healthcare,800-229-0001,"Ondansetron Injection, USP (2 mg/mL) 2 mL Single Use Glass Vial (25 x 2 mL) (NDC 36000-012-25)",Reverified,11/23/21,Available,For IV or IM injection,,,Gastroenterology,Current,,
6598,Ondansetron Hydrochloride Injection,Apotex Corp.,800-706-5575,Ondansetron 2mg/mL 2mL vials Box of 25 vials (NDC 60505-6130-05),Reverified,10/27/21,Available,,,Available,Gastroenterology,Current,,
6599,Oxalaplatin Injection,Gland Pharma Limited,833-291-9645,"50 mg/10 mL, 10 vials per pack (NDC 72266-125-10)",New,9/28/20,,"50 mg/10 mL and 100 mg/20 mL, 1 vial per packs (NDCs 72266-161-01 and 72266-162-01, respectively) will continue to be available; Gland Pharma Limited, Distributed by Fosun Pharma USA Inc. (Company Contact Information: 833-291-9645)",,,Oncology,To be Discontinued,9/28/20,9/28/20
6600,Oxalaplatin Injection,Gland Pharma Limited,833-291-9645,"100 mg/20 mL, 10 vials per pack (NDC 72266-126-10)",New,9/28/20,,"50 mg/10 mL and 100 mg/20 mL, 1 vial per packs (NDCs 72266-161-01 and 72266-162-01, respectively) will continue to be available; Gland Pharma Limited, Distributed by Fosun Pharma USA Inc. (Company Contact Information: 833-291-9645)",,,Oncology,To be Discontinued,9/28/20,9/28/20
6601,Oxytocin Injection (Synthetic),"Fresenius Kabi USA, LLC",888-386-1300,100 USP Units per 10 mL (10 USP units per mL); Multiple dose vial;  (NDC 63323-012-10),Revised,6/10/21,,,Available,,Reproductive,Resolved,6/10/21,
6602,Oxytocin Injection (Synthetic),"Fresenius Kabi USA, LLC",888-386-1300,300 USP Units per 30 mL (10 USP Units per mL); Multiple dose vial; (NDC 63323-012-30),Revised,6/10/21,,,Available,,Reproductive,Resolved,6/10/21,
6603,Oxytocin Injection (Synthetic),"Fresenius Kabi USA, LLC",888-386-1300,10 USP Units per mL (10 USP units per mL); (NDC 63323-012-01)( NDC 63323-0012-11),Revised,6/10/21,,,Available,,Reproductive,Resolved,6/10/21,
6604,Oxytocin Injection (Synthetic),Par Pharmaceutical,800-828-9393,"Packages of six 50 mL Pharmacy Bulk Packages, each containing 10 units of oxytocin per mL (total = 500 units of oxytocin per vial), (NDC 42023-130-06)",Revised,6/10/21,,,Available,,Reproductive,Resolved,6/10/21,
6605,Oxytocin Injection (Synthetic),Par Pharmaceutical,800-828-9393,"Packages of twenty-five oversized 1-mL vials, each containing 10 units of oxytocin, (NDC 42023-116-25)",Revised,6/10/21,,,Available,,Reproductive,Resolved,6/10/21,
6606,Oxytocin Injection (Synthetic),Par Pharmaceutical,800-828-9393,"Packages of twenty-five 10 mL multiple-dose vial, each containing 10 units of oxytocin per mL (total = 100 units of oxytocin per vial) (NDC 42023-116-02)",Revised,6/10/21,,,Available,,Reproductive,Resolved,6/10/21,
6607,Paclitaxel Injection (protein-bound particles),Bristol Myers Squibb Co.,877-417-1523,"Abraxane® 100 mg, single dose vial (NDC 68817-134-50)",Revised,11/15/21,Limited supply. Temporarily on allocation through January 2022.,Manufacturing delay,,Other,Oncology,Current,,
6608,"Paclitaxel Injection, USP",Mylan Institutional,800-796-9526,"100 mg in 16.7 mL (6 mg/mL), multi-dose vial (NDC 67457-449-17)",New,11/22/19,,19-Dec,,,Oncology,To be Discontinued,11/22/19,11/22/19
6609,Pantoprazole Sodium for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,"40 mg, 10 vials (NDC 62756-129-44)",Revised,8/26/21,Out of Stock,Expected to be back in stock by October 2021.,,Other,Gastroenterology,Current,,
6610,Pantoprazole Sodium for Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"40 mg, 10 vials (NDC 55150-202-10)",Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
6611,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-0923-55)",Revised,11/18/21,Available,,,Other,Gastroenterology,Current,,
6612,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-0923-60)",Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: December 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6613,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-2001-10; Amerinet)",Revised,11/18/21,Next Delivery and Estimated Recovery: February 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6614,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-2001-25; Amerinet)",Revised,11/18/21,Next Delivery and Estimated Recovery: February 2023,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6615,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-4001-10; PremierPro)",Revised,11/18/21,Available,,,Other,Gastroenterology,Current,,
6616,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-4001-25; PremierPro)",Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6617,Pantoprazole Sodium for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg, 10 vials (NDC 0143-9284-10)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
6618,Pantoprazole Sodium for Injection,Sandoz,800-525-8747,"40 mg, 10 vials (NDC 0781-3232-95)",Reverified,11/16/21,Available,,,Demand increase for the drug,Gastroenterology,Current,,
6619,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,25mcg Cartridge: (NDC 68875-0202-1); Carton: (NDC 68875-0202-2) (contains 2 cartridges),Reverified,12/11/20,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
6620,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,50mcg   Cartridge: (NDC 68875-0203-1); Carton: (NDC 68875-0203-2) (contains 2 cartridges),Reverified,12/11/20,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
6621,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,75mcg   Cartridge: (NDC 68875-0204-1); Carton: (NDC 68875-0204-2) (contains 2 cartridges),Reverified,12/11/20,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
6622,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,100mcg   Cartridge: (NDC 68875-0205-1); Carton: (NDC 68875-0205-2) (contains 2 cartridges),Reverified,12/11/20,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
6623,Paricalcitol Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,(Solution in Multi Dose Vials) [0.01 mg / 2 ml](NDC 67457-389-25),New,1/29/21,,,,,Endocrinology/Metabolism,To be Discontinued,1/29/21,1/29/21
6624,Paricalcitol Injection,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,(Solution in Single Dose Vials) [0.002 mg / 1 ml],New,1/29/21,,,,,Endocrinology/Metabolism,To be Discontinued,1/29/21,1/29/21
6625,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 200 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4347-01)",New,2/28/18,,This presentation will be discontinued on or near December 2019. For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
6626,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 300 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4348-01)",New,2/28/18,,This presentation will be discontinued on or near December 2019. For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
6627,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 600 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4349-01)",New,2/28/18,,This presentation will be discontinued on or near December 2018.  For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
6628,Peginterferon alfa-2b Injection,Merck Sharp & Dohme Corp.,800-672-6372,"PEGINTRON injection (peginterferon alfa-2b), 50 mcg per 0.5 mL; A box containing one 50 mcg per 0.5 mL vial of PEGINTRON Powder for Injection and one 5 mL vial of Diluent (Sterile Water for Injection USP), 2 BD Safety Lok syringes with a safety sleeve and 2 alcohol swabs (NDC 00085-4353-01)",New,4/23/21,,To be discontinued on or near May 2021,,,Antiviral,To be Discontinued,4/23/21,4/23/21
6629,Pentamidine Isethionate (Nebupent) For Inhalation Solution,"Fresenius Kabi USA, LLC",888-386-1300,"300 mg per vial, SDV, PF (NDC 63323-877-15)",Revised,9/13/19,,,,,Anti-Infective,Resolved,9/13/19,
6630,Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 100s (NDC 0378-0357-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/8/18,5/8/18
6631,Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 500s (NDC 0378-0357-05)",New,5/8/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/8/18,5/8/18
6632,Phenobarbital Oral Solution,Torrent Pharma Inc.,908-280-3333,1 pint 473mL (NDC 16571-330-16),New,11/25/19,,,,,Neurology,To be Discontinued,11/25/19,11/25/19
6633,"Phenytoin Sodium Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 2 mL vial (NDC 0641-0493-25)",Revised,9/3/19,,,Available,,Neurology,Resolved,9/3/19,
6634,"Phenytoin Sodium Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 5 mL vial (NDC 0641-2555-45)",Revised,9/3/19,,,Available,,Neurology,Resolved,9/3/19,
6635,Physostigmine Salicylate Injection,Akorn Pharmaceuticals,800-932-5676,"Physostigmine Salicylate Injection, USP  1mg/mL (10amps/box, 2mL each) (NDC 17478-510-02)",Revised,10/25/21,Unavailable. Expected to release Q4 2022.,,,Other,Neurology,Current,,
6636,Pindolol Tablets,Sun Pharmaceutical Industries Inc.,800-818-4555,"Pindolol Tablets, 5mg and 10mg (100 count bottles)(NDC 57664-655-88, 57664-656-88)",New,2/21/20,No product available. Product can be manufactured upon availability of API. Concrete estimated release dates cannot be provided at this moment.,,,Shortage of active ingredient,Cardiovascular,Current,,
6637,Pindolol Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Pindolol 5mg Tabs 100s (NDC 0378-0052-01),Reverified,11/29/21,Available,,,,Cardiovascular,Current,,
6638,Pindolol Tablets,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,Pindolol 10mg Tabs 100s (NDC 0378-0127-01),Reverified,11/29/21,Available,,,,Cardiovascular,Current,,
6639,Pindolol Tablets,Bayshore Pharmaceuticals,973-315-1819,5 mg/ 100 count (NDC 76385-131-01),Revised,11/18/20,Available,,,,Cardiovascular,Current,,
6640,Pindolol Tablets,Bayshore Pharmaceuticals,973-315-1819,10 mg/ 100 count (NDC 76385-132-01),Revised,11/18/20,Available,,,,Cardiovascular,Current,,
6641,Pindolol Tablets,"ANI Pharmaceuticals, Inc.",800-434-1121,"5 mg: Bottles of 100 tablets, (NDC 62559-560-01)",Revised,6/22/21,Available,,,,Cardiovascular,Current,,
6642,Pindolol Tablets,"ANI Pharmaceuticals, Inc.",800-434-1121,"10 mg; Bottles of 100 tablets, (NDC 62559-561-01)",Revised,6/22/21,Available,,,,Cardiovascular,Current,,
6643,Pindolol Tablets,"Nostrum Laboratories, Inc.",816-841-4636,"5 mg, Bottle of 100 tablets (NDC 29033-028-01)",New,11/30/20,"Currently Available; Predicted Shortage duration: 2 months, January and February 2021
Resupply: March 2021",,,Shortage of an active ingredient,Cardiovascular,Current,,
6644,Pindolol Tablets,"Nostrum Laboratories, Inc.",816-841-4636,"10 mg, Bottle of 100 tablets (NDC 29033-029-01)",New,11/30/20,"Currently available; Predicted Shortage duration: 1 month, February 2021
Resupply: March 2021",,,Shortage of an active ingredient,Cardiovascular,Current,,
6645,Pioglitazone/Metformin HCl (ACTOPLUS MET®) Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,15mg/500mg tablet (NDC 64764-0155-60),New,10/18/21,,Business reasons for discontinuation,,,Endocrinology/Metabolism,To be Discontinued,10/18/21,10/18/21
6646,Piroxicam Capsules,Pfizer Pharmaceuticals,800-533-4535,10 mg capsules; Bottles of 100 (NDC 59762-0140-1),New,8/10/21,,Stock anticipated to be available through February 2022,,,Analgesia/Addiction,To be Discontinued,8/10/21,8/10/21
6647,Piroxicam Capsules,Pfizer Pharmaceuticals,800-533-4535,20 mg capsules; Bottles of 100 (NDC 59762-0145-1),New,8/10/21,,Stock anticipated to be available through June 2022,,,Analgesia/Addiction,To be Discontinued,8/10/21,8/10/21
6648,Potassium Acetate Injection,"Hospira, Inc.",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3294-51)",Reverified,11/18/21,Next Delivery: March 2022; Estimated Recovery: June 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6649,Potassium Acetate Injection,"Hospira, Inc.",844-646-4398,"40 mEq/mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 00409-8183-01)",Reverified,11/18/21,Next Delivery: December 2021; Estimated Recovery: June 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6650,Potassium Acetate Injection,"Hospira, Inc.",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial NovaPlus (NDC 00409-3294-25)",Reverified,11/18/21,Next Delivery: May 2022; Estimated Recovery: June 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6651,Potassium Acetate Injection,"Hospira, Inc.",844-646-4398,"40 mEq/mL (2 mEq/mL), Single Dose Plastic Fliptop Vial NovaPlus (NDC 00409-8183-25)",Reverified,11/18/21,Next Delivery: December 2021; Estimated Recovery: June 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6652,Potassium Acetate Injection,"Exela Pharma Sciences, LLC",828-758-5474,Potassium Acetate Inj. 40mEq (2mEq/ml) 20mL (NDC 51754-2001-4),Revised,10/8/21,Available. Direct shipments to hospitals at 200 vials max per week. Order via on-line portal at www.exelapharma.com,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6653,Potassium Chloride Concentrate Injection,B. Braun Medical Inc.,800-227-2862,(2 mEq K /mL) 250mL bulk package Catalog# S9402-11(NDC 0264-1940-20),New,11/2/21,Product on allocation to contracted customers.,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6654,Potassium Chloride Concentrate Injection,"Hospira, Inc.",844-646-4398,10 mEq/5 mL (2 mEq/mL) Single Dose Glass Fliptop Vial (NDC 0409-6635-01),Reverified,11/18/21,Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6655,Potassium Chloride Concentrate Injection,"Hospira, Inc.",844-646-4398,20 mEq/10 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial (NDC 0409-6651-06),Reverified,11/18/21,Next Delivery: January 2022; Estimated Recovery: April 2022,,,Demand Increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6656,Potassium Chloride Concentrate Injection,"Hospira, Inc.",844-646-4398,40 mEq/20 mL (2 mEq/mL) Single Dose Plastic Fliptop Vial (NDC 00409-6653-05),Reverified,11/18/21,Next Delivery: November 2021 and Estimated Recovery: February 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6657,Potassium Chloride Concentrate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"60 mEq per 30 mL (2 mEq per mL), Multi dose, plastic vial, (NDC 63323-967-30)",Reverified,11/23/21,Backordered. Next release January 2022.,,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6658,Potassium Chloride Concentrate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mEq per 5 mL(2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-05)",Reverified,11/23/21,Backordered. Next release December 2021.,,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6659,Potassium Chloride Concentrate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"20 mEq per 10 mL (2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-10)",Reverified,11/23/21,Backordered. Next  release December 2021.,,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6660,Potassium Chloride Concentrate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"40 mEq per 20 mL (2 mEq per mL), Single dose, plastic vial, (NDC 63323-965-20)",Reverified,11/23/21,Backordered. Next release December 2021.,,,Manufacturing delays,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6661,Pravastatin Sodium (Pravachol) Tablets,Bristol Myers Squibb Co.,800-332-2056,20mg (NDC 0003-5178-05),New,3/24/21,,"Last batch expiry is October 31, 2021.",,,Cardiovascular,To be Discontinued,3/24/21,3/24/21
6662,Pravastatin Sodium (Pravachol) Tablets,Bristol Myers Squibb Co.,800-332-2056,40mg (NDC 0003-5194-10),New,3/24/21,,"Last batch expiry is October 31, 2021.",,,Cardiovascular,To be Discontinued,3/24/21,3/24/21
6663,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (Pred Forte) (NDC 11980-180-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6664,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6665,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (NDC 60758-119-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6666,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (NDC 60758-119-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6667,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 5mL in 1 bottle (NDC 61314-637-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6668,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 10mL in 1 bottle (NDC 61314-637-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6669,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 15mL in 1 bottle (NDC 61314-637-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6670,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6671,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (NDC 60758-119-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
6672,Procardia Capsules,Pfizer Pharmaceuticals,800-533-4353,10 mg capsule; Bottle of 100 (NDC 0069-2600-66),New,5/10/21,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,5/10/21,5/10/21
6673,"Progesterone Injection, USP",AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,500 mg/10 mL multiple dose vial (NDC 55150-306-10),Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
6674,ProHance® (Gadoteridol) Injection,Bracco Diagnostics,877-272-2269,"279.3 mg/mL, 5 x 10 mL pre-filled syringe, (NDC 0270-1111-16)",New,6/1/21,,"Bracco offers ProHance® products in a variety of packaging options including both single-dose vials and ProHance® MultiPackTM  bottles.  All of these options are available: ProHance® (Gadoteridol) Injection, 279.3 mg/mL - 5 x 5 mL Vial, NDC 0270-1111-04; ProHance® (Gadoteridol) Injection, 279.3 mg/mL - 5 x 10mL Vial, NDC 0270-1111-01; ProHance® (Gadoteridol) Injection, 279.3 mg/mL - 5 x 15 mL Vial, NDC 0270-1111-02; ProHance® (Gadoteridol) Injection, 279.3 mg/mL - 5 x 20 mL Vial, NDC 0270-1111-03; ProHance® MultiPackTM (Gadoteridol) Injection, 279.3 mg/mL - 5 x 50 mL Bottle, NDC 0270-1111-70",,,Medical Imaging,To be Discontinued,6/1/21,6/1/21
6675,ProHance® (Gadoteridol) Injection,Bracco Diagnostics,877-272-2269,"279.3 mg/mL, 5 x 17 mL pre-filled syringe, (NDC 0270-111-45)",New,6/1/21,,"Bracco offers ProHance® products in a variety of packaging options including both single-dose vials and ProHance® MultiPackTM  bottles.  All of these options are available: ProHance® (Gadoteridol) Injection, 279.3 mg/mL - 5 x 5 mL Vial, NDC 0270-1111-04; ProHance® (Gadoteridol) Injection, 279.3 mg/mL - 5 x 10mL Vial, NDC 0270-1111-01; ProHance® (Gadoteridol) Injection, 279.3 mg/mL - 5 x 15 mL Vial, NDC 0270-1111-02; ProHance® (Gadoteridol) Injection, 279.3 mg/mL - 5 x 20 mL Vial, NDC 0270-1111-03; ProHance® MultiPackTM (Gadoteridol) Injection, 279.3 mg/mL - 5 x 50 mL Bottle, NDC 0270-1111-70",,,Medical Imaging,To be Discontinued,6/1/21,6/1/21
6676,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL vial (NDC 0641-0928-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6677,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL ,1 mL vial (NDC 0641-0929-25)",Reverified,10/12/21,Inventory is currently available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6678,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL ampul (NDC 0641-1495-35)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6679,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 1 mL ampul (NDC 0641-1496-35)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6680,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL vial (NDC 0641-6084-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6681,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL ,1 mL vial (NDC 0641-6085-25)",Reverified,10/12/21,Inventory is currently available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6682,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL ampul (NDC 0641-6082-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6683,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL, 1 mL ampul (NDC 0641-6083-25)",Reverified,10/12/21,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6684,Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"25 mg/mL, Carton of 25 ampuls (NDC 39822-5525-3)",Reverified,2/25/21,Available,,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6685,Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"50 mg/mL, Carton of 25 ampuls (NDC 39822-5550-6)",Reverified,2/25/21,Available,,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
6686,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 1 vial Single-Dose (NDC 0703-2191-01)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
6687,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL Injection, 1 Vial Single-Dose (NDC 0703-2201-01)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
6688,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 25 in 1 tray (NDC 0703-2191-04)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
6689,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL, 25 in 1 tray (NDC 0703-2201-04)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
6690,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"1000 mg per 100 mL (10 mg per mL), single patient use only, 100 mL (NDC 63323-269-65)",Reverified,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6691,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,200mg per 20ml (NDC 25021-608-20),Reverified,9/3/21,Available. On Allocation,,,Demand increase due to Covid-19,Anesthesia,Current,,
6692,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 10X100ML VL (NDC 0591-2136-68),Revised,11/8/21,Limited supply available. Next Delivery ETA Late November 2021 and Estimated Recovery: TBD,Supply chain has been impacted by shipping delays due to COVID-19,,Other,Anesthesia,Current,,
6693,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-30),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: May 2022,,,Demand increase for the drug,Anesthesia,Current,,
6694,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-33),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia,Current,,
6695,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,1000 mg/100 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-24),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: January 2022,,,Demand increase for the drug,Anesthesia,Current,,
6696,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,200mg/20mL  10ct (NDC 43598-265-58),Revised,11/8/21,Pack size discontinued,,,,Anesthesia,Current,,
6697,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"200mg/20mL vial, individual (NDC 43598-265-20)",Revised,11/8/21,No current supply,Partial shipments on allocation April-December 2021,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
6698,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,500mg/50mL  20ct (NDC 43598-548-21),Revised,11/8/21,Allocating to Wholesalers,Check Wholesaler Inventory,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
6699,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"500mg/50mL vial, individual (NDC 43598-548-50)",Revised,11/8/21,Allocating to Wholesalers,Check Wholesaler Inventory,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
6700,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 20X50ML VL (NDC 0591-2136-51),Revised,11/8/21,Limited supply available. Next Delivery ETA Late November 2021 and Estimated Recovery: TBD,Supply chain has been impacted by shipping delays due to COVID-19,,Other,Anesthesia,Current,,
6701,Propofol Injectable Emulsion,Teva Pharmaceuticals,800-545-8800,10MG/ML 25X20ML VL (NDC 0591-2136-95),Revised,11/8/21,Limited supply available. Next Delivery ETA Late November 2021 and Estimated Recovery: TBD,Supply chain has been impacted by shipping delays due to COVID-19,,Other,Anesthesia,Current,,
6702,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 10 mL (10 mg per mL), single patient use only, 10 mL (NDC 63323-269-10)",Reverified,11/23/21,Available,Check wholesaler inventory,,,Anesthesia,Current,,
6703,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"200 mg per 20 mL (10 mg per mL), single patient use only, 20 mL (NDC 63323-269-29)",Reverified,11/23/21,Available,Check wholesaler inventory,,Demand increase for the drug,Anesthesia,Current,,
6704,Propofol Injectable Emulsion,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL (10 mg per mL), single patient use only, 50 mL (NDC 63323-269-50)",Reverified,11/23/21,Available,Check wholesaler inventory,,Demand increase for the drug,Anesthesia,Current,,
6705,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,500mg per 50ml (NDC 250-21-608-50),Reverified,9/3/21,Available,,,,Anesthesia,Current,,
6706,Propofol Injectable Emulsion,Sagent Pharmaceuticals,866-625-1618,1000mg per 100ml (NDC 25021-608-51),Reverified,9/3/21,Available,,,,Anesthesia,Current,,
6707,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0209-10),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia,Current,,
6708,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0234-20),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia,Current,,
6709,Propofol Injectable Emulsion,"Hospira, Inc.",844-646-4398,1000 mg/100 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0248-10),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia,Current,,
6710,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 20 mL vial (NDC 0641-6194-10)",Revised,10/12/21,Inventory is currently available.,Additional lots will be scheduled for manufacturing. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
6711,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 50 mL vial (NDC 0641-6195-20",Revised,10/12/21,This presentation is temporarily on backorder.  Recovery is TBD at this time.,Additional lots will be scheduled for manufacturing.   Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
6712,Propofol Injectable Emulsion,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 100 mL vial (NDC 0641-6196-10",Revised,10/12/21,This presentation is temporarily on backorder.  Recovery is TBD at this time.,Additional lots will be scheduled for manufacturing. Product will be made available as it is released.,,Demand increase for the drug,Anesthesia,Current,,
6713,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"1000mg/100mL vial, 10ct (NDC 43598-549-10)",Revised,11/8/21,Allocating to Wholesalers,Check Wholesaler Inventory,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
6714,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"1000mg/100mL vial, individual (NDC 43598-549-52)",Revised,11/8/21,Allocating to Wholesalers,Check Wholesaler Inventory,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
6715,Propofol Injectable Emulsion,"Dr. Reddy's Laboratories, Inc.",866-732-3952,"200mg/20mL vial, 25ct (NDC 43598-265-25)",Revised,11/8/21,No current supply,Partial shipments on allocation April-December 2021,,Demand increase for the drug.  Manufacturer extended lead times.,Anesthesia,Current,,
6716,Protamine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 5 mL (10 mg per mL), single dose vial, preservative free,  (NDC 63323-229-05)",Reverified,11/23/21,Available,Check wholesaler inventory,,,Hematology,Current,,
6717,Protamine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"250 mg per 25 mL (10 mg per mL), single dose vial, preservative free, (NDC 63323-229-30)",Reverified,11/23/21,Available,Check wholesaler inventory,,,Hematology,Current,,
6718,Rabeprazole Sodium Delayed Release Tablets,Teva Pharmaceuticals,800-545-8800,20mg  (NDC 0093-0064-56 ),New,1/22/21,,,,,Gastroenterology,To be Discontinued,1/22/21,1/22/21
6719,Ranolazine Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,500 mg  (NDC 45963-418-50),New,7/6/20,,,,,Cardiovascular,To be Discontinued,7/6/20,7/6/20
6720,Ranolazine Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,1000 mg  (NDC 45963-419-50),New,7/6/20,,,,,Cardiovascular,To be Discontinued,7/6/20,7/6/20
6721,Repaglinide Tablets,Sandoz,800-525-8747,1mg tablets (NDC 0781-5149-01),New,2/2/18,,,,,Endocrinology/Metabolism,To be Discontinued,2/2/18,2/2/18
6722,Rifampin (Rifadin) Capsules,Sanofi-Aventis,800-633-1610; Option 7,150 mg capsules (NDC 0068-0510-30),New,6/15/20,,,,,Anti-Infective,To be Discontinued,6/15/20,6/15/20
6723,Rifampin (Rifadin) Capsules,Sanofi-Aventis,800-633-1610; Option 7,300 mg capsules (NDC 0068-0508-60),New,6/15/20,,,,,Anti-Infective,To be Discontinued,6/15/20,6/15/20
6724,Rifampin Capsules,"Lannett Company, Inc.",215-333-9000,150 mg )NDC 0527-1393-30),New,2/2/21,,Lannett has made a business decision to discontinue the drug product.,,,Anti-Infective,To be Discontinued,2/2/21,2/2/21
6725,Rifampin Capsules,"Lannett Company, Inc.",215-333-9000,150 mg (NDC 0527-1393-01),New,2/2/21,,Lannett has made a business decision to discontinue the drug product.,,,Anti-Infective,To be Discontinued,2/2/21,2/2/21
6726,Rifampin Capsules,"Lannett Company, Inc.",215-333-9000,300 mg (NDC 0527-1315-30),New,2/2/21,,Lannett has made a business decision to discontinue the drug product.,,,Anti-Infective,To be Discontinued,2/2/21,2/2/21
6727,Rifampin Capsules,"Lannett Company, Inc.",215-333-9000,300 mg (NDC 0527-1315-06),New,2/2/21,,Lannett has made a business decision to discontinue the drug product.,,,Anti-Infective,To be Discontinued,2/2/21,2/2/21
6728,Rifampin Capsules,"Lannett Company, Inc.",215-333-9000,300 mg (NDC 0527-1315-01),New,2/2/21,,Lannett has made a business decision to discontinue the drug product.,,,Anti-Infective,To be Discontinued,2/2/21,2/2/21
6729,Rifampin Injection,"Fresenius Kabi USA, LLC",888-386-1300,"600 mg per vial, PF, Lyophilized powder (NDC 63323-351-20)",Revised,11/23/21,Backordered. Next release not available at this time.,Check wholesaler inventory,,,Anti-Infective,Current,,
6730,Rifampin Injection,Sanofi,800-633-1610,"600 mg/10 mL, Lyophilized powder (NDC 0068-0597-01)",Revised,6/22/21,Available,,,Requirements related to complying with good manufacturing practices,Anti-Infective,Current,,
6731,Rifampin Injection,"Mylan Institutional, a Viatris company",800-796-9526,"600 mg, (Lyophilizate in Single Dose Vials) (NDC 67457-445-60)",Reverified,11/29/21,Available,,,Demand increase for the drug,Anti-Infective,Current,,
6732,Rifampin/Isoniazid (Rifamate) Capsules,Sanofi-Aventis,800-633-1610; Option 7,150 mg/300 mg capsules (NDC 0068-0509-60),New,6/15/20,,,,,Anti-Infective,To be Discontinued,6/15/20,6/15/20
6733,Rifampin/Isoniazid/Pyrazinamide (Rifater) Tablets,Sanofi-Aventis,800-633-1610; Option 7,150 mg/300 mg/120 mg tablets (NDC 0088-0576-41),New,6/15/20,,,,,Anti-Infective,To be Discontinued,6/15/20,6/15/20
6734,Rifapentine Tablets,Sanofi,800-633-1610 Option 7,"Rifapentine (Piftin) Tablets, 150 mg (NDC 0088-2102-24)",Revised,6/22/21,Available,,,Demand increase for the drug,Anti-Infective,Current,3/25/20,
6735,Risedronate Tablets,Allergan Sales LLC,800-678-1605,5 mg tablets (NDC 0430-0471-15),New,12/9/19,,,,,Musculoskeletal,To be Discontinued,12/9/19,12/9/19
6736,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6737,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6738,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6739,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6740,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6741,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6742,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6743,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6744,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6745,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6746,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6747,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6748,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6749,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6750,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6751,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6752,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 3 mg (NDC 50458-330-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6753,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 2 mg (NDC 50458-320-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6754,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 1 mg (NDC 50458-300-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6755,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.5 mg (NDC 50458-302-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6756,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6757,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-01),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
6758,Rocuronium Bromide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,10 mg/mL 5mL vial (NDC 70860-651-05),Revised,11/2/18,Available,,,Available,Anesthesia,Resolved,11/2/18,
6759,Rocuronium Bromide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,10 mg/mL 10mL vial (NDC 70860-651-10),Revised,11/2/18,Available,,,Available,Anesthesia,Resolved,11/2/18,
6760,Ropivacaine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"0.5% 5mg/mL, 30mL, 1 Vial (NDC 17478-0081-30)",Revised,2/12/21,Available,,,Other,Anesthesia,Current,,
6761,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-10),Reverified,11/18/21,Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia,Current,,
6762,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-20),Reverified,11/18/21,Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Anesthesia,Current,,
6763,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9301-30),Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: November 2022,,,Demand increase for the drug,Anesthesia,Current,,
6764,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/20 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9302-20),Reverified,11/18/21,Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Anesthesia,Current,,
6765,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-10),Reverified,11/18/21,Available,,,Other,Anesthesia,Current,,
6766,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-20),Reverified,11/18/21,Available,,,Other,Anesthesia,Current,,
6767,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.2% 20 mL Single Dose Vials (NDC 55150-195-20),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6768,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.2% 100 mL Single Dose Infusion Bottles (NDC 55150-196-99),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6769,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 20 mL Single Dose Vials (NDC 55150-197-20),Reverified,11/5/21,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6770,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-198-30),Reverified,11/5/21,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6771,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 20 mL Single Dose Vials (NDC 55150-199-20),Reverified,11/5/21,"Currently on backorder, next shipment TBD",Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6772,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 10 mL Single Dose Vials (NDC 55150-200-10),Reverified,11/5/21,Currently on backorder - next shipment TBD,Sporadic availability expected.,,Demand increase for the drug,Anesthesia,Current,,
6773,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 20 mL Single Dose Vials (NDC 55150-201-20),Reverified,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
6774,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-10)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6775,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-20)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6776,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-286-20)",Revised,11/23/21,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6777,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-287-20)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6778,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Plastic Ampule, Sterile-Pak (63323-288-10)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6779,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-288-20)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6780,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Free Flex Bag (NDC 63323-285-61)",Revised,11/23/21,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6781,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Free Flex Bag (NDC 63323-285-63)",Revised,11/23/21,Backordered. Next release not available at this time.,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6782,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-285-65)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,
6783,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-285-64)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6784,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (500 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-286-00)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6785,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (1,000 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-286-63)",Revised,11/23/21,Available,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,
6786,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Single Dose Vial (NDC 63323-285-13)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6787,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Single Dose Vial (NDC 63323-285-23)",Revised,11/23/21,Backordered. Next release April 2021.,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,
6788,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Single Dose Vial (NDC 63323-286-35)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6789,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Single Dose Vial (NDC 63323-286-23)",Revised,11/23/21,Available,Check wholesaler for inventory,,Manufacturing delays,Anesthesia,Current,,
6790,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Single Dose Vial (NDC 63323-287-21)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6791,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Single Dose Vial (NDC 63323-288-11)",Revised,11/23/21,Available,Check wholesaler for inventory,,Available,Anesthesia,Current,,
6792,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Single Dose Vial (NDC 63323-288-21)",Revised,11/23/21,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
6793,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Sterile-Pack, Single Dose Vial (NDC 63323-286-31)",Revised,11/23/21,Available,Check wholesaler for inventory,,,Anesthesia,Current,,
6794,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,500 mg per 100 mL (5 mg per mL 0.5%) (NDC 25021-652-82 ),Reverified,9/3/21,Available,,,,Anesthesia,Current,,
6795,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,"1,000 mg per 200 mL (5 mg per mL 0.5%) (NDC 25021-652-87)",Reverified,9/3/21,Available,,,,Anesthesia,Current,,
6796,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,0.2% 2mg/mL 10x100mL (NDC 25021-671-82),Reverified,9/3/21,Available,,,,Anesthesia,Current,,
6797,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,0.2% 2mg/mL 10x200mL (NDC 25021-671-87),Reverified,9/3/21,Available,,,,Anesthesia,Current,,
6798,Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.2%, 40 mg/20 mL (2 mg/mL) single dose vial (NDC 43066-015-10)",New,12/22/20,Available,Distributed by Baxter Healthcare; Contact Baxter Healthcare: 1-888-229-0001,,,Anesthesia,Current,,
6799,Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.5%, 100 mg/20 mL (5 mg/mL) single dose vial (NDC 43066-019-10)",New,12/22/20,Available,Distributed by Baxter Healthcare; Contact Baxter Healthcare: 1-888-229-0001,,,Anesthesia,Current,,
6800,Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"0.5%, 150 mg/30 mL (5 mg/mL) single dose vial (NDC 43066-023-10)",New,12/22/20,Available,Distributed by Baxter Healthcare; Contact Baxter Healthcare: 1-888-229-0001,,,Anesthesia,Current,,
6801,Ropivacaine Hydrochloride Injection,Caplin Steriles Limited,,"1%, 200 mg/20 mL (10 mg/mL) single dose vial (NDC 43066-027-10)",New,12/22/20,Available,Distributed by Baxter Healthcare; Contact Baxter Healthcare: 1-888-229-0001,,,Anesthesia,Current,,
6802,Rosiglitasone Tablets,GlaxoSmithKline,888-825-5249,2 mg (NDC 0173-0861-18),New,4/23/21,,This product discontinuation is a business-related decision. GSK has ceased distribution of this product.,,,Endocrinology/Metabolism,To be Discontinued,4/23/21,4/23/21
6803,Rosiglitasone Tablets,GlaxoSmithKline,888-825-5249,4 mg (NDC 0173-0863-13),New,4/23/21,,This product discontinuation is a business-related decision. GSK has ceased distribution of this product.,,,Endocrinology/Metabolism,To be Discontinued,4/23/21,4/23/21
6804,Salmeterol Xinafoate Inhalational Powder,GlaxoSmithKline,888-825-5249,"50 mcg, 28 blisters (NDC 0173-0520-00)",New,4/23/21,,This product discontinuation is a business-related decision. GSK has ceased distribution of this product. The 60-blister presentation will continue to be available.,,,Pulmonary/Allergy,To be Discontinued,4/23/21,4/23/21
6805,Samarium SM 153 Lexidronam  (Quadramet) Injection,Lantheus Medical Imaging INC,800-362-2668,150mCi (NDC 11994-016-01),New,10/28/21,,Manufacturing is discontinued.  Please contact 800-362-2668 for additional information.,,,Oncology,To be Discontinued,10/28/21,10/28/21
6806,Saquinavir Mesylate (Invirase) 200mg Capsules,"Genentech, Inc",877-436-3683,200 mg capsules (NDC 0004-0245-15),New,2/6/18,,"Roche intends to stop-shipping Saquinavir Mesylate (Invirase) 200 mg Capsules on March 31, 2018 with product availability continuing until the September 2018 expiry date.  Saquinavir Mesylate (Invirase) 500mg Tablets are still available.",,,Antiviral,To be Discontinued,2/6/18,2/6/18
6807,Sclerosol Intrapleural Aerosol,Lymol Medical Corp.,781-935-0004,Sclerosol 4 GM (NDC 63256-100-30),Reverified,12/11/19,Unavailable,,,Other,Pulmonary/Allergy,Current,,
6808,Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 24s (NDC 0378-6470-44),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
6809,"Sertraline Hydrochloride Oral Solution, USP",Aurobindo Pharma,866-850-2876,20mg/ml (NDC 64980-409-06),Revised,4/13/21,,,Distributed by Rising Pharmaceuticals Contact Rising Pharmaceuticals : +1 (201) 961-9000,,Psychiatry,Resolved,4/13/21,
6810,"Sertraline Hydrochloride Oral Solution, USP","Upjohn US 1 LLC, a Viatris Company",800-796-9526,"Sertraline Hydrochloride 60 mL (20 mg/mL) oral concentrate, with 12% alcohol; bottle with calibrated dropper (NDC 59762-0067-1)",Revised,4/13/21,,,"Greenstone label. To order, contact Pfizer at 800-553-4535.",,Psychiatry,Resolved,4/13/21,
6811,"Sertraline Hydrochloride Oral Solution, USP","Upjohn US 1 LLC, a Viatris Company",800-796-9526,"Zoloft (sertraline hydrochloride) 60 mL (20 mg/mL) oral concentrate, with 12% alcohol; bottle with calibrated dropper (NDC 0049-0050-01)",Revised,4/13/21,,,"Pfizer label. To order, contact Pfizer at 800-553-4535.",,Psychiatry,Resolved,4/13/21,
6812,"Sertraline Hydrochloride Oral Solution, USP",Aurobindo Pharma,866-850-2876,"20mg/ml, 60ml  (NDC 16714-601-02)",Revised,4/13/21,,,Northstar Rx label. Product Distributed by McKesson:  +1 (972) 446-4800,,Psychiatry,Resolved,4/13/21,
6813,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 30 count (NDC 16729-215-10)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6814,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 90 count (NDC 16729-215-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6815,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","25 mg, 500 count (NDC 16729-215-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6816,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg, 90 count (NDC 16729-216-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6817,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","50 mg, 500 count (NDC 16729-216-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6818,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg, 90 count (NDC 16729-217-15)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6819,Sertraline Hydrochloride Tablets,Accord Healthcare Inc.,"866-941-7875, option 2","100 mg, 500 count (NDC 16729-217-16)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6820,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 30 count (NDC 65862-011-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6821,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 100 count (NDC 65862-011-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6822,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 500 count (NDC 65862-011-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6823,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 30 count (NDC 65862-012-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6824,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 100 count (NDC 65862-012-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6825,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 500 count (NDC 65862-012-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6826,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 30 count (NDC 65862-013-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6827,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 100 count (NDC 65862-013-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6828,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 500 count (NDC 65862-013-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6829,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 30 count (NDC 16714-611-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6830,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 100 count (NDC 16714-611-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6831,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 500 count (NDC 16714-611-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6832,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"25 mg, 1000 count (NDC 16714-611-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6833,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 30 count (NDC 16714-612-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6834,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 100 count (NDC 16714-612-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6835,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 500 count (NDC 16714-612-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6836,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"50 mg, 1000 count (NDC 16714-612-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6837,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 30 count (NDC 16714-613-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6838,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 100 count (NDC 16714-613-04)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6839,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 500 count (NDC 16714-613-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6840,Sertraline Hydrochloride Tablets,Aurobindo Pharma,866-850-2876,"100 mg, 1000 count (NDC 16714-613-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6841,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 25 mg; Bottle of 30 tablets (NDC 0049-4960-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6842,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 50 mg; Bottle of 30 tablets (NDC 0049-4900-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6843,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 50 mg; Blister of 10 tablets (NDC 0049-4900-41); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6844,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 100 mg; Bottle of 30 tablets (NDC 0049-4910-30); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6845,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,Zoloft 100 mg; Blister of 10 tablets (NDC 0049-4910-41); Pfizer label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6846,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,25 mg; Bottle of 30 tablets (NDC 59762-6347-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6847,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,50 mg; Bottle of 30 tablets (NDC 59762-6443-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6848,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,100 mg; Bottle of 30 tablets (NDC 59762-5160-1); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6849,Sertraline Hydrochloride Tablets,Viatris,800-796-9526,100 mg; Bottle of 100 tablets (NDC 59762-5160-2); Greenstone label,Revised,3/15/21,,,"To order these products, contact Pfizer at 800-553-4535",,Pediatric;Psychiatry,Resolved,3/15/21,
6850,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 30 count (NDC 68180-351-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6851,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 90 count  (NDC 68180-351-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6852,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"25 mg, 1000 count (NDC 68180-351-03)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6853,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 30 count (NDC 68180-352-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6854,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 90 count (NDC 68180-352-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6855,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 500 count (NDC 68180-352-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6856,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"50 mg, 5000 count (NDC 68180-352-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6857,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 30 count (NDC 68180-353-06)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6858,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 90 count (NDC 68180-353-09)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6859,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 500 count (NDC 68180-353-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6860,Sertraline Hydrochloride Tablets,Lupin,866-587-4617,"100 mg, 5000 count (NDC 68180-353-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6861,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 30 count (NDC 69097-833-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6862,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 90 count (NDC 69097-833-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6863,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 500 count (NDC 69097-833-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6864,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 30 count (NDC 69097-834-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6865,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 500 count (NDC 69097-834-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6866,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 30 count (NDC 69097-835-02)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6867,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 500 count (NDC 69097-835-12)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6868,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 30 count (NDC 76282-212-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6869,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 60 count (NDC 76282-212-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6870,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 90 count (NDC 76282-212-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6871,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 100 count (NDC 76282-212-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6872,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 180 count (NDC 76282-212-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6873,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"25 mg, 500 count (NDC 76282-212-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6874,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 30 count (NDC 76282-213-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6875,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 60 count (NDC 76282-213-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6876,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 90 count (NDC 76282-213-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6877,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 100 count (NDC 76282-213-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6878,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 180 count (NDC 76282-213-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6879,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"50 mg, 500 count (NDC 76282-213-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6880,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 30 count (NDC 76282-214-30)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6881,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 60 count (NDC 76282-214-60)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6882,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 90 count (NDC 76282-214-90)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6883,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 100 count (NDC 76282-214-01)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6884,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 180 count (NDC 76282-214-18)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6885,Sertraline Hydrochloride Tablets,InvaGen Pharmaceuticals (a subsidiary of Cipla Ltd),866-604-3268,"100 mg, 500 count (NDC 76282-214-05)",Revised,3/9/21,,,,,Pediatric;Psychiatry,Resolved,3/9/21,
6886,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/12.5 mL; vial (NDC 0069-0338-01),Revised,10/24/19,, ,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
6887,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,20 mg; tablets (NDC 0069-4190-68),Revised,10/24/19,, ,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
6888,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/mL (powder); bottle (NDC 0069-0336-21),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
6889,Sildenafil Citrate (REVATIO),Novitium Pharma LLC,845-652-0377,"10 mg/mL, (NDC 70954-168-10)",Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
6890,Simeprevir Capsules,Janssen Pharmaceuticals,800-526-7736,150mg capsules (NDC 59676-225-28),New,5/23/18,,,,,Antiviral,To be Discontinued,5/23/18,5/23/18
6891,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,5 mg (NDC 0093-7152-98),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
6892,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,10 mg (NDCs 0093-7153-93 / 0093-7153-56 / 0093-7153-19 / 0093-7153-31 / 0093-7153-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
6893,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,20 mg (NDCs 0093-7154-93 / 0093-7154-56 / 0093-7154-31 / 0093-7154-19 / 0093-7154-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
6894,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,40 mg (NDCs 0093-7155-93 / 0093-7155-56 / 0093-7155-31 / 0093-7155-19 / 0093-7155-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
6895,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,80 mg (NDCs 0093-7156-98 / 0093-7156-93 / 0093-7156-56 / 0093-7156-19 / 0093-7156-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
6896,Simvastatin (Zocor) Tablets,Merck Sharp & Dohme Corp.,800-637-2579,5 mg Tablets bottles of 30 (NDC 0006-0726-31),New,2/6/18,,,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
6897,Simvastatin Tablets,Merck Sharp & Dohme Corp.,800-672-6372,80 mg (NDCs 0006-0543-31 and 0006-0543-54),New,7/27/21,,,,,Cardiovascular,To be Discontinued,7/27/21,7/27/21
6898,Sincalide (Kinevac) Lyophilized Powder for Injection,Bracco Diagnostics,877-272-2269,Supplied in packages of 10 single dose vials containing 5 mcg of sincalide per vial (NDC 0270-0556-15),Reverified,7/16/21,Available,,,Delay in shipping of the drug,Medical Imaging;Other,Current,12/17/15,
6899,Sodium Acetate Injection,"Hospira, Inc.",844-646-4398,100 mEq/50 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3299-05),Reverified,11/18/21,Next Delivery: March 2022; Estimated Recovery: June 2022,,,Demand increase for the drug,Total Parenteral Nutrition,Current,,
6900,Sodium Acetate Injection,"Hospira, Inc.",844-646-4398,200 mEq/100 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3299-06),Reverified,11/18/21,Next Delivery: March 2022; Estimated Recovery: June 2022,,,Demand increase for the drug,Total Parenteral Nutrition,Current,,
6901,Sodium Acetate Injection,"Hospira, Inc.",844-646-4398,40 mEq/20 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-7299-73),Reverified,11/18/21,Next Delivery: December 2021; Estimated Recovery: June 2022,,,Demand increase for the drug,Total Parenteral Nutrition,Current,,
6902,Sodium Acetate Injection,"Fresenius Kabi USA, LLC",888-386-1300,32.8% 400 mEq 100mL PBP (NDC 63323-0032-00),Reverified,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Total Parenteral Nutrition,Current,,
6903,Sodium Acetate Injection,Milla Pharmaceuticals,833-251-8463,100 mEq/50 mL (2 mEq/mL) (NDC 69784-230-20),New,9/1/21,Available,"Distributed by Woodward Pharma Services LLC Contact Information:
Phone: 248-308-1120
Fax: 248-480-0153
Email: info@woodwardphrma.com",,Other,Total Parenteral Nutrition,Current,,
6904,Sodium Acetate Injection,Milla Pharmaceuticals,833-251-8463,200 mEq/100 mL (2 mEq/mL) (NDC 69784-231-20),New,9/1/21,Available,"Distributed by Woodward Pharma Services LLC Contact Information:
Phone: 248-308-1120
Fax: 248-480-0153
Email: info@woodwardphrma.com",,Other,Total Parenteral Nutrition,Current,,
6905,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,2.5 mEq/5 mL (0.5 mEq/mL) Fliptop Vial (4.2% Concentration) (NDC 0409-5555-02),Revised,11/2/21,Next Delivery and Estimated Recovery: November 2021,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6906,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,2.5 mEq/5 mL (0.5 mEq/mL) Fliptop Vial Novaplus®  (4.2% Concentration) (NDC 0409-5555-01),Revised,11/2/21,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6907,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,44.6 mEq/50 mL (0.9 mEq/mL) LifeShield™ ABBOJECT™ Glass Syringe (7.5% concentration) (NDC 0409-4916-14) (old NDC 0409-4916-34),Revised,11/18/21,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6908,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,50 mEq/50 mL (1 mEq/mL) Single Dose Glass Fliptop Vial (8.4% concentration) (NDC 0409-6625-14) (old NDC 0409-6625-02),Revised,11/18/21,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6909,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,50 mEq/50 mL (1 mEq/mL) Single Dose Vial Novaplus® (8.4% concentration) (NDC 0409-6625-35),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: April 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6910,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,Pediatric 10 mEq/10 mL (1 mEq/mL) LifeShield® ABBOJECT® Glass Syringe (8.4% Concentration) (NDC 0409-4900-14) (old NDC 0409-4900-34),Revised,11/18/21,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6911,Sodium Bicarbonate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4.2% Single dose vial, 2.5 mEq per 5 mL (0.5 mEq per mL) (42 mg per mL)(NDC 63323-083-05)",Revised,11/23/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6912,Sodium Bicarbonate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"8.4% Single dose vial, 50 mEq per 50 mL (1 mEq per mL)  (84 mg per mL)(NDC 63323-089-50)",Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6913,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,Neut (Sodium Bicarbonate Additive Solution); 200 mg/5 mL (4%); Single Dose Glass Fliptop Vial (NDC 0409-6609-02),Revised,11/2/21,Discontinued,,,Discontinuation of the manufacture of the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
6914,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,Infant 5 mEq/10 mL (0.5 mEq/mL) ABBOJECT® Glass Syringe (4.2% Concentration) (NDC 0409-5534-14) (old NDC 0409-5534-34),Revised,11/2/21,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
6915,Sodium Bicarbonate Injection,"Hospira, Inc.",844-646-4398,50 mEq/50 mL (1 mEq/mL) LifeShield® ABBOJECT® Glass Syringe (8.4% Concentration) (NDC 0409-6637-14) (old NDC 0409-6637-34),Revised,11/2/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: December 2021,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
6916,Sodium Bicarbonate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"Sodium Bicarbonate Inj. USP, 8.4%, 50mL Luer-Jet Prefilled Syringe, (NDC 0548-3352-00), (new NDC 76329-3352-1)",Revised,11/2/21,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
6917,Sodium Bicarbonate Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154,"Sodium Bicarbonate Inj. USP, 8.4%, 50mL (NDC 51754-5001-1)",Revised,5/6/21,Available,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
6918,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 50 mL Fleboflex Plastic Container (115 units/carton)(NDC 76297-001-11)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6919,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL flexible container (Legacy Hospira NDC 0409-7984-23)
(ICU Medical NDC 0990-7984-23)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6920,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 100 mL Fleboflex Plastic Container (70 units/carton)(NDC 76297-001-21)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6921,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 250 mL Fleboflex Plastic Container (28 units/carton)(NDC 76297-001-31)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6922,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 500 mL Fleboflex Plastic Container (20 units/carton)(NDC NDC 76297-001-01)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6923,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 1000 mL Fleboflex Plastic Container (10 units/carton)(NDC NDC 76297-001-41)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6924,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL Vis-IV container, PVC/DEHP-free (NDC 0409-7984-11)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6925,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL flexible container (Legacy Hospira NDC 0409-7984-36)
(ICU Medical NDC 0990-7984-36)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6926,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,25 mL flexible container (NDC 0409-7984-20),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6927,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL Vis-IV container, PVC/DEHP-free (NDC 0409-7984-06)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6928,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 250 mL, in VIAFLEX Container.   Product code FZB1322 (NDC 0338-9517-50)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6929,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 500 mL, in VIAFLEX Container.   Product code FZB1323 (NDC 0338-9517-30)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6930,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 1,000 mL, in VIAFLEX Container.   Product code FZB1324 (NDC 0338-9517-16)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6931,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,250 mL Product code 2B1322Q (NDC 00338-0049-02),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6932,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,500 mL  Product code 2B1323Q (NDC 00338-0049-03),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6933,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL Non-PVC, Dripless Access Container (DAC)  VIAFLO Container  Product code UE1323D (NDC 0338-9543-04)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6934,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,1000 mL Product code 2B1324X (NDC 00338-0049-04),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6935,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL Non-PVC, Dripless Access Container (DAC)  VIAFLO Container  Product code UE1324D (NDC 0338-9543-06)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6936,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL, Non-PVC, Dripless Access Container (DAC) VIAFLO Container Product code UE1322D (NDC 0338-9543-02)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
6937,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mL vials (NDC 63323-0088-61),Revised,11/23/21,Backordered. Next release December 2021.,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
6938,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mL vials (NDC 63323-0088-63),Revised,11/23/21,Backordered. Next release January 2022.,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
6939,Sodium Chloride 23.4% Injection,"Hospira, Inc.",844-646-4398,400 mEq/100 mL (4 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-1141-02),Reverified,11/18/21,Limited Supply Available. Next Delivery: March 2022; Estimated Recovery: August 2022,,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
6940,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,30 mL vials (NDC 63323-0187-30),Revised,11/23/21,Backordered. Next release date not available at this time.,,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
6941,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (18 mg per 2 mL)(9 mg per mL) (NDC 63323-186-02)",Revised,11/23/21,Backordered. Next release Q1-2022.,Check wholesalers for inventory,,Increase in Demand,Other,Current,,
6942,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (90 mg per 10 mL)(9 mg per mL) (NDC 63323-186-10)",Revised,11/23/21,Backordered. Next release January 2022.,Check wholesalers for inventory,,Manufacturing delay,Other,Current,,
6943,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (180 mg per 20 mL)(9 mg per mL) (NDC 63323-186-20)",Revised,11/23/21,Backordered. Next release not available at this time.,,,Manufacturing delay,Other,Current,,
6944,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose tear top vial, 0.9%, (900 mg per 100 mL)(9 mg per mL) (NDC 63323-186-00)",Revised,11/23/21,Backordered.  Next release date not available at this time.,,,Increase in Demand,Other,Current,,
6945,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,10 mL (0.9%); Single Dose Plastic Fliptop Vial (NDC 00409-4888-10),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: December 2022,,,Demand increase for the drug,Other,Current,,
6946,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,10 mL (0.9%); Single Dose LifeShield Plastic Fliptop Vial (NDC 00409-4888-12),Revised,11/18/21,Next Delivery: January 2022; Estimated Recovery: June 2022,,,Demand increase for the drug,Other,Current,,
6947,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-20),Revised,11/18/21,Limited Supply Available. Next Delivery and Estimated Recovery: December 2021,,,Demand increase for the drug,Other,Current,,
6948,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-50),Revised,11/18/21,Limited Supply Available. Next Delivery: November 2021; Estimated Recovery: July 2022,,,Demand increase for the drug,Other,Current,,
6949,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Medefil, Inc.",630-682-4600,"Sodium Chloride Injection, USP, 0.9%, in a plastic syringe (10 mL) (NDC 64253-202-30)",Reverified,2/23/21,Available,Check wholesalers for inventory,,Available,Other,Current,,
6950,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.9%, 2 mL vial (NDC 0641-0497-25)",Reverified,10/12/21,This presentation is temporarily on backorder.  Recovery is TBD at this time.,Additional lots will be scheduled for manufacturing as needed.  Product will be made available as it is released.,,Demand increase for the drug,Other,Current,,
6951,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-32),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Other,Current,,
6952,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-33),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Other,Current,,
6953,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-35),Revised,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug,Other,Current,,
6954,Sodium Phosphates Injection,"Hospira, Inc.",844-646-4398,"Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL, vial (NDC 0409-7391-72)",Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: April 2022,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6955,Sodium Phosphates Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 15 mmol/5 mL, Sodium 20 mEq/5 mL, vial (NDC 63323-170-05)",Revised,11/23/21,Backordered. Next release December 2021.,Manufacturing delay. Check wholesaler for inventory.,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6956,Sodium Phosphates Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL, vial (NDC 63323-170-15)",Revised,11/23/21,Backordered. Next release December 2021.,Manufacturing delay. Check wholesaler for inventory.,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
6957,Somatropin Recombinant (Humatrope) Injection,Eli Lilly and Co.,800-545-5979,5 mg kit (NDC 0002-7335-11) contains 5 mg/mL in 1 vial (NDC 0002-7349-01) of Humatrope and 5 mL in 1 vial (NDC 0002-7336-01) of Sterile Diluent,New,7/7/20,,Other Somatropin Recombinant (Humatrope) Injection products will continue to be available to treat patients.  The product distribution will continue until end of December 2020.,,,Hematology,To be Discontinued,7/7/20,7/7/20
6958,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 100 (NDC 0228-2803-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
6959,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 500 (NDC 0228-2803-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
6960,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 100 (NDC 0228-2672-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
6961,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 500 (NDC 0228-2672-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
6962,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 100 (NDC 0228-2673-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
6963,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 500 (NDC 0228-2673-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
6964,Stavudine Capsules,Mylan Pharmaceuticals Inc.,800-496-9526,20mg capsules (NDC 0378-5041-91),New,4/30/18,,,,,Antiviral,To be Discontinued,4/30/18,4/30/18
6965,Sterile Water,American Regent/Luitpold,800-645-1706,5 mL vial (NDC 00517-3005-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
6966,Sterile Water,American Regent/Luitpold,800-645-1706,10 mL vial (NDC 00517-3010-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
6967,Sterile Water,American Regent/Luitpold,800-645-1706,20 mL vial (NDC 00517-3020-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
6968,Sterile Water,West-Ward Pharmaceuticals,800-631-2174,10 mL Single Dose Vial (NDC 0641-6147-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
6969,Sterile Water for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 mL vial (NDC 0641-6147-10),New,11/23/21,This presentation is temporarily on backorder.,Additional lots have been manufactured and will be available in the December 2021 timeframe. Product will be made available as it is released.,,Demand increase for the drug,Other,Current,11/23/21,11/23/21
6970,Sterile Water for Injection,"Hospira, Inc.",844-646-4398,10 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-10),New,11/23/21,Limited Supply. Next delivery: December 2021; Estimated recovery: December 2022,,,Demand increase for the drug,Other,Current,11/23/21,11/23/21
6971,Sterile Water for Injection,"Hospira, Inc.",844-646-4398,20 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-20),New,11/23/21,Next delivery: December 2021; Estimated recovery: April 2022,,,Demand increase for the drug,Other,Current,11/23/21,11/23/21
6972,Sterile Water for Injection,"Hospira, Inc.",844-646-4398,50 mL Single Dose Plastic Fliptop Vial (NDC 00409-4887-50),New,11/23/21,Next delivery: December 2021; Estimated recovery: June 2022,,,Demand increase for the drug,Other,Current,11/23/21,11/23/21
6973,Sterile Water for Injection,"Hospira, Inc.",844-646-4398,100 mL Single Dose Glass Fliptop Vial (NDC 00409-4887-99),New,11/23/21,Next delivery: December 2021; Estimated recovery: December 2022,,,Demand increase for the drug,Other,Current,11/23/21,11/23/21
6974,Sterile Water for Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mL Vial (NDC 63323-0185-10),New,11/23/21,TBD,,,TBD,Other,Current,11/23/21,11/23/21
6975,Sterile Water for Injection,"Fresenius Kabi USA, LLC",888-386-1300,20 mL Vial (NDC 63323-0185-20),New,11/23/21,TBD,,,TBD,Other,Current,11/23/21,11/23/21
6976,Sterile Water for Injection,"Fresenius Kabi USA, LLC",888-386-1300,50 mL Vial (NDC 63323-0185-50),New,11/23/21,TBD,,,TBD,Other,Current,11/23/21,11/23/21
6977,Succimer (Chemet) Capsules,Recordati Rare Diseases,866-209-7604,100 mg capsules (NDC 55292-201-11),Revised,9/14/21,,,Available,,Hematology,Resolved,9/14/21,9/14/21
6978,Sulfacetamide Sodium and Prednisolone Acetate Ophthalmic Ointment,Abbvie,800-678-1605,Blephamide S.O.P. (sulfacetamide sodium 10% and prednisolone acetate 0.2%) 1 TUBE in 1 CARTON 3.5 g in 1 TUBE (NDC 0023-0313-04),New,9/13/21,,Discontinuation of the manufacture of the drug,,,Ophthalmology,To be Discontinued,9/13/21,9/13/21
6979,Sulfasalazine Tablets,Chartwell Pharma,845-232-1683,500 mg tablets; Bottle of 100 (NDC 23155-019-01),Reverified,9/14/21,"Product being allocated.  Distributed by Avet. For inquiries, call Customer Service number 1-855-228-9470",,,Other,Gastroenterology,Current,,
6980,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 100 (NDC 0013-0101-10),Reverified,11/18/21,Available,,,Other,Gastroenterology,Current,,
6981,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE (Sulfasalazine tablets) 500 mg tablets; Bottle of 300 (NDC 0013-0101-20/0013-0101-30),Reverified,11/18/21,Available,,,Other,Gastroenterology,Current,,
6982,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 100 (NDC 0013-0102-50),Reverified,11/18/21,Next Delivery: November 2021; Estimated Recovery: December 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6983,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,AZULFIDINE EN-tabs® (Sulfasalazine delayed release tablets) 500 mg Delayed-Release tablets; Bottle of 300 (NDC 0013-0102-20/0013-0102-60),Reverified,11/18/21,Available,,,Other,Gastroenterology,Current,,
6984,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 100 (NDC 59762-0104-1/59762-0104-5),Reverified,11/18/21,Next Delivery: January 2022; Estimated recovery: April 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6985,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,Sulfasalazine Delayed-Release Tablets 500 mg Delayed-Release tablets; bottle of 300 (NDC 59762-0104-6),Reverified,11/18/21,Next Delivery: December 2021; Estimated recovery: March 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6986,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets; bottle of 100 (NDC 59762-5000-1/59762-5000-5),Reverified,11/18/21,Next Delivery: January 2022; Estimated Recovery: April 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6987,Sulfasalazine Tablets,Pfizer Pharmaceuticals,800-533-4535,500 mg tablets; bottle of 300 (NDC 59762-5000-6),Reverified,11/18/21,Next Delivery: December 2021; Estimated recovery: March 2022,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
6988,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 100 Count (NDC 00591-0796-01),Reverified,11/8/21,Available,This product is on allocation.,,,Gastroenterology,Current,,
6989,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 1000 Count (NDC 00591-0796-10),Reverified,11/8/21,Available,This product is on allocation.,,,Gastroenterology,Current,,
6990,Sulfasalazine Tablets,Teva Pharmaceuticals,800-545-8800,500 mg 500 Count (NDC 00591-0796-05),Reverified,11/8/21,Available,This product is on allocation.,,,Gastroenterology,Current,,
6991,Sumatriptan (Sumavel DosePro) Injection,"Endo Pharmaceuticals, Inc.",800-462-3636,Sumavel DosePro (sumatriptan injection) 6mg/0.5mL (NDC 63481-367-06),New,2/27/18,,A business decision has been made to discontinue Sumavel DosePro 6 mg/0.5mL.,,,Neurology,To be Discontinued,2/27/18,2/27/18
6992,Sumatriptan Succinate Injection,Teva Pharmaceuticals,800-545-8800,6 mg/0.5 mL  (NDC 0703-7351-01),New,12/5/19,,,,,Neurology,To be Discontinued,12/5/19,12/5/19
6993,Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"0.5 mg, 100s (NDC 0378-2045-01)",Reverified,11/29/21,Available,,,,Transplant,Current,,
6994,Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"1 mg, 100s (NDC 0378-2046-01)",Reverified,11/29/21,Available,,,,Transplant,Current,,
6995,Tacrolimus Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"5 mg, 100s (NDC 0378-2047-01)",Reverified,11/29/21,Available,,,,Transplant,Current,,
6996,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",0.5 mg 100 count (NDC 1672904101),Reverified,6/8/21,Limited supply availability. Product will be allocated until Q3 2021,,,Limited API availability,Transplant,Current,,
6997,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",1 mg 100 count (NDC 1672904201),Reverified,6/8/21,Limited supply availability. Product will be allocated until Q3 2021,,,Limited API availability,Transplant,Current,,
6998,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",5 mg 100 count (NDC 1672904301),Reverified,6/8/21,Product is available,,,,Transplant,Current,,
6999,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 30 count (NDC 68992-3075-3),Reverified,6/14/21,Available,,,,Transplant,Current,,
7000,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 100 count (NDC 68992-3075-1),Reverified,6/14/21,Available,,,,Transplant,Current,,
7001,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 30 count (NDC 68992-3010-3),Reverified,6/14/21,Available,,,,Transplant,Current,,
7002,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 100 count (NDC 68992-3010-1),Reverified,6/14/21,Available,,,,Transplant,Current,,
7003,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 30 count (NDC 68992-3040-3),Reverified,6/14/21,Available,,,,Transplant,Current,,
7004,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 100 count (NDC 68992-3040-1),Reverified,6/14/21,Available,,,,Transplant,Current,,
7005,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,1 mg 100 count bottles (NDC 64338-721-06),Reverified,11/2/21,Available,,,,Transplant,Current,,
7006,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,0.5 mg 100 count bottles (NDC 64380-720-06),Reverified,11/2/21,Available,,,,Transplant,Current,,
7007,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,5 mg 100 count bottles (NDC 64380-722-06),Reverified,11/2/21,Available,,,,Transplant,Current,,
7008,Tacrolimus Capsules,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-2102-01),Reverified,11/16/21,Available,,,Demand increase for the drug,Transplant,Current,,
7009,Tacrolimus Capsules,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-2103-04),Reverified,11/16/21,Available,,,Demand increase for the drug,Transplant,Current,,
7010,Tacrolimus Capsules,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-2104-01),Reverified,11/16/21,Available,,,Demand increase for the drug,Transplant,Current,,
7011,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 0.5 mg 100 count bottle (NDC 0469-0607-73),Reverified,6/9/21,Available,,,,Transplant,Current,,
7012,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 5 mg 100 count bottle (NDC 0469-0657-73),Reverified,6/9/21,Available,,,,Transplant,Current,,
7013,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 1 mg 100 count bottle (NDC 0469-0617-73),Reverified,6/9/21,Available,,,,Transplant,Current,,
7014,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 0.5 mg 30 count bottle (NDC 0469-0647-73),Reverified,6/9/21,Available,,,,Transplant,Current,,
7015,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 1 mg 30 count bottle (NDC 0469-0677-73),Reverified,6/9/21,Available,,,,Transplant,Current,,
7016,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 5 mg 30 count bottle (NDC 0469-0687-73),Reverified,6/9/21,Available,,,,Transplant,Current,,
7017,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 0.2 mg unit dose packets (NDC 0469-1230-50),Reverified,6/9/21,Available,,,,Transplant,Current,,
7018,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 1 mg unit dose packets (NDC 0469-1330-50),Reverified,6/9/21,Available,,,,Transplant,Current,,
7019,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,0.5 mg (NDC 55111-525-01),Reverified,11/8/21,Available,,,,Transplant,Current,,
7020,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,1 mg (NDC 55111-526-01),Reverified,11/8/21,Available,,,,Transplant,Current,,
7021,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,5 mg (NDC 55111-527-01),Reverified,11/8/21,Available,,,,Transplant,Current,,
7022,Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,0.5 mg 100’s count (NDC 67877-278-01),Revised,6/9/21,Available,,,,Transplant,Current,,
7023,Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,1 mg 100’s count (NDC 67877-279-01),Revised,6/9/21,Available,,,,Transplant,Current,,
7024,Tacrolimus Capsules,Ascend Laboratories LLC.,860-667-7081,5 mg 100’s count (NDC 67877-280-01),Revised,6/9/21,Available,,,,Transplant,Current,,
7025,Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,0.5 mg 100 count bottles (NDC 68462-685-01),Revised,6/10/21,Available,,,,Transplant,Current,,
7026,Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,1 mg 100 count bottles (NDC 68462-686-01),Revised,6/10/21,Available,,,,Transplant,Current,,
7027,Tacrolimus Capsules,Glenmark Pharmaceuticals,888-721-7115,5 mg 100 count bottles (NDC 68462-687-01),Revised,6/10/21,Available,,,,Transplant,Current,,
7028,Tacrolimus Capsules,"BPI Labs, LLC",727-471-0850 ext. 275,1 mg 100 count bottle (NDC 54288-135-01),Reverified,6/8/21,Available,,,,Transplant,Current,,
7029,"Talwin (Pentazocine Lactate Injection, USP, CIV)","Hospira, Inc.",844-646-4398,30 mg/mL; 1 mL glass ampul (NDC 00409-1941-01),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Analgesia/Addiction,To be Discontinued,4/16/18,4/16/18
7030,Technetium Tc99m Succimer Injection (DMSA),Theragnostics Inc.,617-286-7479,ROTOP DMSA (Kit for the Preparation of Technetium Tc99m Succimer Injection). One vial contains 1.74 mg powder with the active substance: 1.0 mg succimer.  Five vials included in a carton (NDC 71647-001-01),Revised,1/7/21,Available,"Due to the current critical shortage of DMSA Kit for the Preparation of Technetium Tc99m Succimer, Theragnostics Inc. (Theragnostics) is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of the drug.  Theragnostics has initiated temporary importation of DMSA Kit for the Preparation of Technetium Tc99m Succimer Injection into the U.S. market. This product is marketed in Germany and is manufactured in Dresden, Germany by ROTOP Pharmaka GmbH for Theragnostics.",,Other,Medical Imaging,Current,,
7031,Telmisartan and Amlodipine (Twynsta) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",203-798-4375,"Telmisartan and Amlodipine (Twynsta) tablets 80mg/10mg, 30 count blister (NDC 0597-0127-37)",New,3/6/18,,"Discontinuation is the result of a business decision made by Boehringer lngelheim Pharmaceuticals, Inc. All other strengths of Twynsta® tablets are still available.",,,Cardiovascular,To be Discontinued,3/6/18,3/6/18
7032,Temozolomide Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"TEMODAR Capsules, 100 mg; child-resistant sachets, 5 count (NDC 0085-1366-03)",New,4/23/21,,To be discontinued on or near October 2021,,,Oncology,To be Discontinued,4/23/21,4/23/21
7033,Temozolomide Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"TEMODAR Capsules, 100 mg; child-resistent sachets, 14-count (NDC 0085-1366-04)",New,4/23/21,,To be discontinued on or near October 2021,,,Oncology,To be Discontinued,4/23/21,4/23/21
7034,Temozolomide Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"TEMODAR Capsules, 140 mg, child-resistant sachets, 14-count (NDC 0085-1425-04)",New,4/23/21,,To be discontinued on or near October 2021,,,Oncology,To be Discontinued,4/23/21,4/23/21
7035,Temozolomide Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"TEMODAR Capsules, 180 mg; child-resistent sachets, 5 count (NDC 0085-1430-03)",New,4/23/21,,To be discontinued on or near October 2021,,,Oncology,To be Discontinued,4/23/21,4/23/21
7036,Temozolomide Capsules,Merck Sharp & Dohme Corp.,800-672-6372,"TEMODAR Capsules, 250 mg; child-resistent sachets, 5 count (NDC 0085-1417-02)",New,4/23/21,,To be discontinued on or near April 2022,,,Oncology,To be Discontinued,4/23/21,4/23/21
7037,Teprotumumab-trbw,Horizon Therapeutics,866-479-6742,500 mg lyophilized powder (NDC 75987-130-15),Revised,3/31/21,Product available.,Manufacturing delays due to limited capacity at manufacturing facility,,Other,Ophthalmology,Current,,
7038,Thiothixene Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"1 mg, 100 count bottle (NDC 0378-1001-01)",Reverified,11/29/21,Available,,,Other,Psychiatry,Current,,
7039,Thiothixene Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"2 mg, 100 count bottle (NDC 0378-2002-01)",Reverified,11/29/21,Available,,,Other,Psychiatry,Current,,
7040,Thiothixene Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"5 mg, 100 count bottle (NDC 0378-3005-01)",Reverified,11/29/21,Available,,,Other,Psychiatry,Current,,
7041,Thiothixene Capsules,"Mylan Pharmaceuticals Inc., a Viatris Company",800-796-9526,"10 mg, 100 count bottle (NDC 0378-5010-01)",Reverified,11/29/21,Available,,,Other,Psychiatry,Current,,
7042,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"1 mg, 100 count bottle (NDC 70954-014-10)",Reverified,4/27/21,Available,,,,Psychiatry,Current,,
7043,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"2 mg, 100 count bottle (NDC 70954-015-10)",Reverified,4/27/21,Available,,,,Psychiatry,Current,,
7044,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"5 mg, 100 count bottle (NDC 70954-016-10)",Reverified,4/27/21,Available,,,,Psychiatry,Current,,
7045,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"10 mg, 100 count bottle (NDC 70954-017-10)",Reverified,4/27/21,Available,,,,Psychiatry,Current,,
7046,Timolol Maleate Ophthalmic Gel Forming Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Gel Forming Solution 0.5%, 5 mL bottle (NDC 61314-225-05)",Revised,10/4/21,,,Available,,Ophthalmology,Resolved,10/4/21,
7047,Timolol Maleate Ophthalmic Gel Forming Solution,Sandoz,800-525-8747,Timolol Maleate Ophthalmic Gel Forming Solution 0.25% 5 mL bottle (NDC 61314-224-05),Revised,10/4/21,,,Available,,Ophthalmology,Resolved,10/4/21,
7048,Timolol Maleate Ophthalmic Gel Forming Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC-XE®, 0.25% timolol equivalent gel forming solution, 5 mL in a 7.5 mL bottle (NDC 24208-814-25)",Revised,10/4/21,,,,,Ophthalmology,Resolved,10/4/21,
7049,Timolol Maleate Ophthalmic Gel Forming Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC-XE®, 0.5% timolol equivalent, gel forming solution 5 mL in a 7.5 mL bottle (NDC 24208-816-05)",Revised,10/4/21,,,,,Ophthalmology,Resolved,10/4/21,
7050,Timolol Maleate Ophthalmic Gel Forming Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% timolol gel forming solution, 5 mL in a 7.5 mL bottle (NDC 24208-818-25)",Revised,10/4/21,,,,,Ophthalmology,Resolved,10/4/21,
7051,Timolol Maleate Ophthalmic Gel Forming Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Gel Forming Solution, equivalent and 0.5%, 5 mL in a 7.5 mL bottle (NDC 24208-819-05)",Revised,10/4/21,,,,,Ophthalmology,Resolved,10/4/21,
7052,Timolol Maleate Ophthalmic Gel Forming Solution,Alembic Pharmaceuticals,908-393-9604,Timolol GFS 0.25 % - 5 mL fill (NDC 62332-545-05),Revised,10/4/21,,,Available,,Ophthalmology,Resolved,10/4/21,
7053,Timolol Maleate Ophthalmic Gel Forming Solution,Alembic Pharmaceuticals,908-393-9604,Timolol GFS 0.5 % - 5 mL fill (NDC 62332-546-05),Revised,10/4/21,,,Available,,Ophthalmology,Resolved,10/4/21,
7054,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.25%, 5 mL in a 7.5 mL bottle (NDC 24208-812-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7055,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.5%, 5 mL in a 7.5 mL bottle (NDC 24208-813-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7056,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® (timolol maleate ophthalmic solution), 0.5%, 10 mL in a 10 mL bottle (NDC 24208-813-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7057,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,Authorized Generic Timolol Maleate Ophthalmic Solution 0.5% 5 mL in a 7.5 mL bottle (NDC 68682-813-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7058,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® in OCUDOSE® (timolol maleate) Sterile Ophthalmic Solution, 0.25% 0.3 mL in 60 individual doses (NDC 0187-1498-25)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7059,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"TIMOPTIC® in OCUDOSE®  (timolol maleate) Sterile Ophthalmic Solution, 0.5% 0.3 mL in 60 individual doses (NDC 0187-1496-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7060,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Istalol, Timolol Maleate Ophthalmic solution 0.5% in a 7.5 mL bottle (NDC 24208-004-01)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7061,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Istalol, Timolol Maleate Ophthalmic solution 0.5% in a 10 ml bottle (NDC 24208-004-03)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7062,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Solution 0.5%,  2.5ml (NDC 68682-045-25)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7063,Timolol Maleate Ophthalmic Solution,"Bausch Health Americas, Inc.",800-321-4576,"Timolol Maleate Ophthalmic Solution 0.5%, 5ml (NDC 68682-045-50)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7064,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25% 5mL (NDC 64980-513-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7065,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25%  10 mL (NDC 64980-513-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7066,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.25% 15 mL (NDC 64980-513-15),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7067,Timolol Maleate Ophthalmic Solution,FDC Limited,201-964-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 5mL (NDC 64980-514-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7068,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 10mL (NDC 64980-514-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7069,Timolol Maleate Ophthalmic Solution,FDC Limited,201-961-9000,TIMOLOL MALEATE OPHTHAMIC SOLUTION 0.5% 15mL (NDC 64980-514-15),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7070,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.25% OS 1x5ml BTL (NDC 60758-802-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7071,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.25% OS 1x10ml BTL (NDC 60758-802-10),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7072,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.5% OS 1x5ml BTL (NDC 60758-801-05),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7073,Timolol Maleate Ophthalmic Solution,Allergan,800-678-1605,Timolol Maleate 0.5% OS 1x10ml BTL (NDC 60758-801-10),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7074,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5% 5mg/mL, 5mL, 1 Bottle/EA (NDC 17478-0288-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7075,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5%, 10mL, 1 Bottle / EA (NDC 17478-0288-11)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7076,Timolol Maleate Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Timolol Maleate Ophth Sol 0.5%, 15mL, 1 Bottle / EA (NDC 17478-0288-12)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7077,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 5 mL bottle, (NDC 61314-227-05)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7078,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 10 mL bottle (NDC 61314-227-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7079,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.5%, 15 mL bottle (NDC 61314-227-15)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7080,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 5 mL bottle, ()NDC 61314-226-05",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7081,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 10 mL bottle, (NDC 61314-226-10)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7082,Timolol Maleate Ophthalmic Solution,Sandoz,800-525-8747,"Timolol Maleate Ophthalmic Solution, USP 0.25%, 15 mL bottle, (NDC 61314-226-15)",Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7083,Timolol Maleate Ophthalmic Solution,Apotex Corp.,800-706-5575,Timolol Maleate Ophthalmic Solution 0.5% 2.5mL bottle (NDC 60505-1005-04),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7084,Timolol Maleate Ophthalmic Solution,Apotex Corp.,800-706-5575,Timolol Maleate Ophthalmic Solution 0.5% 5mL bottle (NDC 60505-1005-01),Revised,4/16/21,,,,,Ophthalmology,Resolved,4/16/21,
7085,Tipranavir Oral Solution,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,100mg/mL (NDC 0597-0002-01),New,6/29/21,,,,,Antiviral,To be Discontinued,6/29/21,6/29/21
7086,Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",2 mg  (NDC 49884-611-53),New,6/30/21,,,,,Neurology,To be Discontinued,6/30/21,6/30/21
7087,Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",4 mg (NDC 49884-719-53),New,6/30/21,,,,,Neurology,To be Discontinued,6/30/21,6/30/21
7088,Tizanidine Hydrochloride Capsules,"Endo Pharmaceuticals, Inc.","800-828-9393, option 5, then option 2",6 mg (NDC 49884-765-53),New,6/30/21,,,,,Neurology,To be Discontinued,6/30/21,6/30/21
7089,Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,4 mg (NDC 0378-0724-19),New,11/21/19,,,,,Neurology,To be Discontinued,11/21/19,11/21/19
7090,Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0722-19),New,11/21/19,,,,,Neurology,To be Discontinued,11/21/19,11/21/19
7091,Tobramycin Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-51)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,4/12/21,
7092,Tobramycin Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-55), Novaplus",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,4/12/21,
7093,Tobramycin Lyophilized Powder for Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"1.2 g, pharmacy bulk package, bottle (NDC 39822-0412-1)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,4/12/21,
7094,Tobramycin Lyophilized Powder for Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"1.2 g, pharmacy bulk package, pack of 6 bottles (NDC 39822-0412-6)",Revised,4/12/21,,,,,Anti-Infective;Pediatric,Resolved,4/12/21,
7095,Tocilizumab Injection,"Genentech, Inc",800-551-2231,"200mg/10mL, (NDC 50242-0136-01)",Reverified,11/1/21,Available,,,Demand increase for the drug,Rheumatology,Current,,
7096,Tocilizumab Injection,"Genentech, Inc",800-551-2231,"400mg/20mL, (NDC 50242-0137-01)",Reverified,11/1/21,Available,,,Demand increase for the drug,Rheumatology,Current,,
7097,Tocilizumab Injection,"Genentech, Inc",800-551-2231,"80mg/4mL, (NDC 50242-0135-01)",Reverified,11/1/21,Available,,,Demand increase for the drug,Rheumatology,Current,,
7098,Tolcapone Tablets,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",100mg tablets (NDC 49884-254-09),New,10/5/20,,,,,Neurology,To be Discontinued,10/5/20,10/5/20
7099,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"4 mg tablets, 100 count (NDC 16252-543-90)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
7100,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"2 mg tablets, 100 count (NDC 16252-542-90)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
7101,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"1 mg tablets, 100 count (NDC 16252-541-30)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
7102,Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 30 Tablets per Bottle,  (NDC 60505-3638-3)",New,12/4/19,,Apotex has decided to Discontinue the manufacture of the drug,,,Hematology,To be Discontinued,12/4/19,12/4/19
7103,Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 100 Tablets per Bottle,  (NDC 60505-3638-1)",New,12/4/19,,Apotex has decided to Discontinue the manufacture of the drug,,,Hematology,To be Discontinued,12/4/19,12/4/19
7104,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/1g (NDC 40085-029-80),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
7105,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1mg/1g (NDC 40085-029-16),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
7106,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,0.25mg/1g (NDC 40085-028-80),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
7107,Triamcinolone Acetonide Injectable Suspension,Novartis,888-669-6682,"40mg/mL vial, 1mL in 1 vial (NDC 0065-0543-01)",Revised,11/23/21,Availability through wholesalers: Not available. Estimated Duration of Supply Shortage: November 2021,,,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,
7108,Triamcinolone Hexacetonide Injectable suspension,Medexus,1-855-336-3322 Option 9,"Hexatrione 2% (triamcinolone hexacetonide) Injectable suspension, 20mg/ml, 2-mL glass ampoule (NDC 59137-570-01)",Reverified,10/8/21,Available,"Medexus in conjunction with FDA has initiated a temporary importation of Triamcinolone Hexacetonide (Hexatrione 2%) injectable suspension, to the U.S. market to address drug shortage. To place an order, please contact Medexus at 1-855-336-3322, Option # 9.",,,Rheumatology,Current,,
7109,Triamterene and Hydrochlorothiazide (Dyazide) Capsules,GlaxoSmithKline,888-825-5249,25 mg; 37.5 mg (NDC 0007-3650-22),New,11/16/20,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of the product is approximately December 2020.,,,Cardiovascular,To be Discontinued,11/16/20,11/16/20
7110,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 0781-5068-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
7111,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 0781-5068-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
7112,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 0781-5067-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
7113,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 0781-5067-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
7114,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 68001-0216-00)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
7115,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 68001-0216-03)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
7116,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 68001-0215-00)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
7117,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 68001-0215-03)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
7118,Trimethobenzamide Hydrochloride Capsules,Pfizer Pharmaceuticals,800-533-4535,"300 mg, 100 count bottle (NDC 61570-079-01)",New,12/14/20,,Discontinuation of the manufacturing of the drug.,,,Gastroenterology,To be Discontinued,12/14/20,12/14/20
7119,Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 30 (NDC 43386-660-03)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,
7120,Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 100 (NDC 43386-660-24)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,
7121,Trimethobenzamide Hydrochloride Capsules,Lupin,866-587-4617,"300 mg, bottle of 500 (NDC 43386-660-26)",Reverified,10/25/21,Currently unavailable. Estimated shortage duration: TBD,,,Shortage of an active ingredient.,Gastroenterology,Current,,
7122,Trimethobenzamide Hydrochloride Capsules,Pfizer Pharmaceuticals,800-533-4535,"300 mg, bottle of 100 (NDC 61570-079-01)",Reverified,11/18/21,Discontinued,,,Discontinuation of the manufacture of the drug.,Gastroenterology,Current,,
7123,Trimethobenzamide Hydrochloride Capsules,Sun Pharmaceutical Industries Inc.,800-810-4555,"300 mg, bottle of 100 (NDC 53489-376-01)",Revised,10/26/21,Unavailable,,,Shortage of an active ingredient.,Gastroenterology,Current,,
7124,Trimethobenzamide Hydrochloride Capsules,Sun Pharmaceutical Industries Inc.,800-810-4555,"300 mg, bottle of 100 (NDC 53489-376-01)",New,10/26/21,,Non-Availability of Active Ingredient.,,,Gastroenterology,To be Discontinued,10/26/21,10/26/21
7125,Ursodiol (Actigall) Capsules,Allergan Sales LLC,800-678-1605,300 mg (NDC 0023-6145-01),New,1/15/21,,,,,Urology,To be Discontinued,1/15/21,1/15/21
7126,Valacyclovir Tablets,GlaxoSmithKline,888-825-5249,"500 mg, 100-count unit dose pack (NDC 0173-0933-56)",New,4/23/21,,This product discontinuation is a business-related decision. The anticipated date that GSK will cease distribution of the product is approximately November 2021. 30-count and 90-count bottles will continue to be available.,,,Antiviral,To be Discontinued,4/23/21,4/23/21
7127,Valproate Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg/mL, 5 mL vial (NDC 0143-9785-10)",Revised,10/12/21,Inventory is currently available.,Additional lots will be scheduled for manufacturing. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
7128,Valproate Sodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,500 mg per 5 mL (100 mg per mL) (NDC 63323-494-05),Reverified,11/23/21,Available,Check wholesaler for inventory,,Manufacturing delays,Neurology,Current,,
7129,Vancomycin Hydrochloride for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vancomycin Hydrochloride Injection (Lyophilisate in Single Dose Vials) [250 mg] (NDC 67457-822-99),New,7/26/21,,,,,Anti-Infective,To be Discontinued,7/26/21,7/26/21
7130,Vardenafil Hydrochloride Tablets,Bayer,888-842-2937,Levitra 20mg (NDC 0173-0831-13),New,4/8/21,,"Discontinue distribution April 30, 2021.  Discontinuation of the manufacture of the drug.",,,Other;Reproductive,To be Discontinued,4/8/21,4/8/21
7131,Vardenafil Hydrochloride Tablets,Bayer,888-842-2937,Levitra 10 mg (NDC 0173-0830-13),Revised,9/1/20,,Discontinuation of the manufacture of the drug.,,,Other;Reproductive,To be Discontinued,9/1/20,9/1/20
7132,Vardenafil Hydrochloride Tablets,Bayer,888-842-2937,Staxyn 10 mg (NDC 0173-0822-04),Revised,9/1/20,,Discontinuation of the manufacture of the drug.,,,Other;Reproductive,To be Discontinued,9/1/20,9/1/20
7133,Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 0.5 mg; bottle of 56 tablets (NDC 60505-4765-5),New,7/16/21,Available,"Apotex Corp., in coordination with the U.S. FDA, has initiated temporary importation of Apo-Varenicline (varenicline tartrate) 0.5 mg and 1 mg tablets into the U.S. market to address a drug shortage of CHANTIX®. The varenicline tartrate tablets marketed in Canada under the name Apo-Varenicline by Apotex Inc. are approved by Health Canada as a generic equivalent to CHAMPIX® tablets manufactured by Pfizer Canada, Inc. CHAMPIX® is the brand name of CHANTIX® sold in Canada. Product is available via Apotex’s authorized distributors. Contact your primary wholesaler/distributor to place orders.",,,Analgesia/Addiction,Current,,
7134,Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 1 mg; bottle of 56 tablets (NDC 60505-4766-6),New,7/16/21,Available,"Apotex Corp., in coordination with the U.S. FDA, has initiated temporary importation of Apo-Varenicline (varenicline tartrate) 0.5 mg and 1 mg tablets into the U.S. market to address a drug shortage of CHANTIX®. The varenicline tartrate tablets marketed in Canada under the name Apo-Varenicline by Apotex Inc. are approved by Health Canada as a generic equivalent to CHAMPIX® tablets manufactured by Pfizer Canada, Inc. CHAMPIX® is the brand name of CHANTIX® sold in Canada. Product is available via Apotex’s authorized distributors. Contact your primary wholesaler/distributor to place orders.",,,Analgesia/Addiction,Current,,
7135,Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 0.5 mg and 1 mg; Starter Blister Pack of 53 tablets; (NDC 60505-4767-0),New,7/16/21,Estimated Date Available; TBD,"Apotex Corp., in coordination with the U.S. FDA, has initiated temporary importation of Apo-Varenicline (varenicline tartrate) 0.5 mg and 1 mg tablets into the U.S. market to address a drug shortage of CHANTIX®. The varenicline tartrate tablets marketed in Canada under the name Apo-Varenicline by Apotex Inc. are approved by Health Canada as a generic equivalent to CHAMPIX® tablets manufactured by Pfizer Canada, Inc. CHAMPIX® is the brand name of CHANTIX® sold in Canada. Product is available via Apotex’s authorized distributors. Contact your primary wholesaler/distributor to place orders.",,,Analgesia/Addiction,Current,,
7136,Varenicline Tartrate (Chantix) Tablets,Apotex Corp.,800-706-5575,Apo-Varenicline 1 mg: Continuation Blister Pack of 56 tablets (NDC 60505-4766-5),New,7/16/21,Estimated Date Available; TBD,"Apotex Corp., in coordination with the U.S. FDA, has initiated temporary importation of Apo-Varenicline (varenicline tartrate) 0.5 mg and 1 mg tablets into the U.S. market to address a drug shortage of CHANTIX®. The varenicline tartrate tablets marketed in Canada under the name Apo-Varenicline by Apotex Inc. are approved by Health Canada as a generic equivalent to CHAMPIX® tablets manufactured by Pfizer Canada, Inc. CHAMPIX® is the brand name of CHANTIX® sold in Canada. Product is available via Apotex’s authorized distributors. Contact your primary wholesaler/distributor to place orders.",,,Analgesia/Addiction,Current,,
7137,Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix 0.5 mg; bottle of 56 (NDC 0069-0468-56),Reverified,11/18/21,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Analgesia/Addiction,Current,,
7138,Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix 1 mg; bottle of 56 (NDC 0069-0469-56),Reverified,11/18/21,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Analgesia/Addiction,Current,,
7139,Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix Starting wallet; 0.5 mg 1x11 1 mg FCT 3x14 BLS WL US (NDC 0069-0471-03),Reverified,11/18/21,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Analgesia/Addiction,Current,,
7140,Varenicline Tartrate (Chantix) Tablets,Pfizer Pharmaceuticals,800-533-4535,Chantix Continuing wallet; 1 mg FCT 4x14 BLS WL US (NDC 0069-0469-03),Reverified,11/18/21,Next Delivery and Estimated Recovery: TBD,Shortage per Manufacturer: Product manufacturing and release delay due to product/ingredient testing,,Other,Analgesia/Addiction,Current,,
7141,Varenicline Tartrate (Chantix) Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","0.5 mg, 56 ‘s count bottle pack (NDC 49884-155-76)",New,9/22/21,Available,More batches will be available by end of September or Early October.,,,Analgesia/Addiction,Current,,
7142,Varenicline Tartrate (Chantix) Tablets,Par Pharmaceutical,"800-828-9393, option 5 then option 2","1 mg, 56 ‘s count bottle pack (NDC 49884-156-76)",New,9/22/21,Available,More batches will be available by end of September or Early October.,,,Analgesia/Addiction,Current,,
7143,Vecuronium Bromide for Injection,Teva Pharmaceuticals,800-545-8800,10 mg* 10 X 10 mL *1 mg/mL when reconstituted to 10 mL (NDC 0703-2914-03),Reverified,11/8/21,Backordered – Estimated date of availability TBD,,,,Anesthesia,Current,,
7144,Vecuronium Bromide for Injection,"Hospira, Inc.",844-646-4398,10 mg Single Dose Glass Fliptop Vial (NDC 00409-1632-01),Revised,11/18/21,Next Delivery: November 2021; Estimated Recovery: July 2022,,,Demand increase for the drug,Anesthesia,Current,,
7145,Vecuronium Bromide for Injection,"Hospira, Inc.",844-646-4398,20 mg Single Dose Glass Fliptop Vial (NDC 00409-1634-01),Revised,11/18/21,Next Delivery: January 2022; Estimated Recovery: June 2022,,,Demand increase for the drug,Anesthesia,Current,,
7146,Vecuronium Bromide for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [10 mg](NDC 67457-438-10),Reverified,11/29/21,Available,,,Demand increase for the drug,Anesthesia,Current,,
7147,Vecuronium Bromide for Injection,"Mylan Institutional, a Viatris company",800-796-9526,Vecuronium Bromide Injection (Lyophilizate in Single Dose Vials) [20 mg](NDC 67457-475-20),Reverified,11/29/21,Available,,,Demand increase for the drug,Anesthesia,Current,,
7148,Vecuronium Bromide for Injection,Gland Pharma Limited,,10 mg/vial (NDC 63323-781-10),Reverified,10/20/21,Available,Distributed by marketing partner: Fresenius Kabi  LLC (888-386-1300),,,Anesthesia,Current,,
7149,Vecuronium Bromide for Injection,Gland Pharma Limited,,20 mg/vial (NDC 63323-782-20),Reverified,10/20/21,Available,Distributed by marketing partner: Fresenius Kabi  LLC (888-386-1300),,,Anesthesia,Current,,
7150,Vecuronium Bromide for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,10 mg (NDC 47335-931-44),Reverified,10/22/21,Available,,,Demand increase of the drug,Anesthesia,Current,,
7151,Vecuronium Bromide for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,20 mg (NDC 47335-932-44),Reverified,10/22/21,Available,,,Demand increase of the drug,Anesthesia,Current,,
7152,Vecuronium Bromide for Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"10 mg/vial, packages of 10 (NDC 55150-235-10)",Revised,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
7153,Vecuronium Bromide for Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"20 mg/vial, packages of 10 (NDC 55150-236-20)",Revised,11/5/21,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
7154,Vibramycin Hyclate (Doxycycline Hyclate) for Suspension,Pfizer Pharmaceuticals,800-533-4535,25 mg/5 mL oral suspension; 1 x 60 mL bottle (NDC 0069-0970-65),New,11/16/21,,Discontinuation of the manufacture of the drug.,,,Anti-Infective,To be Discontinued,11/16/21,11/16/21
7155,Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-06),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Oncology,To be Discontinued,4/16/18,4/16/18
7156,Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 50 mg/5mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-09),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Oncology,To Be Discontinued,4/16/18,4/16/18
7157,Vitamin A Palmitate (Aquasol A) Injection,"Casper Pharma, LLC",844-522-7737,"50,000 USP units/mL (15 mg retinol), single dose vial (NDC 61703-418-18)",New,10/21/21,Anticipated availability: January 2022,Delay is due to manufacturing delays at the contract manufacturing facility.,,Manufacturing delay,Endocrinology/Metabolism;Gastroenterology,Current,,
7158,Zinc Acetate Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, bottle of 250 (NDC 57844-215-52)",Revised,5/18/21,,,Available,,Other;Pediatric,Resolved,5/18/21,
7159,Zinc Acetate Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, bottle of 250 (NDC 57844-208-52)",Revised,5/18/21,,,Available,,Other;Pediatric,Resolved,5/18/21,
7160,Zolpidem Tartrate (Edluar) Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0037-6010-30),Revised,11/21/18,,,Available,,Psychiatry,Resolved,11/21/18,